
<html lang="en"     class="pb-page"  data-request-id="5b9c3c3b-978e-4699-8c41-def048d07b19"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.5b00928;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-23;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders" /></meta><meta name="dc.Creator" content="Adrian D.  Hobson" /></meta><meta name="dc.Creator" content="Christopher M.  Harris" /></meta><meta name="dc.Creator" content="Elizabeth L.  van der Kam" /></meta><meta name="dc.Creator" content="Sean C.  Turner" /></meta><meta name="dc.Creator" content="Ayome  Abibi" /></meta><meta name="dc.Creator" content="Ana L.  Aguirre" /></meta><meta name="dc.Creator" content="Peter  Bousquet" /></meta><meta name="dc.Creator" content="Tegest  Kebede" /></meta><meta name="dc.Creator" content="Donald B.  Konopacki" /></meta><meta name="dc.Creator" content="Gary  Gintant" /></meta><meta name="dc.Creator" content="Youngjae  Kim" /></meta><meta name="dc.Creator" content="Kelly  Larson" /></meta><meta name="dc.Creator" content="John W.  Maull" /></meta><meta name="dc.Creator" content="Nigel S.  Moore" /></meta><meta name="dc.Creator" content="Dan  Shi" /></meta><meta name="dc.Creator" content="Anurupa  Shrestha" /></meta><meta name="dc.Creator" content="Xiubo  Tang" /></meta><meta name="dc.Creator" content="Peng  Zhang" /></meta><meta name="dc.Creator" content="Kathy K.  Sarris" /></meta><meta name="dc.Description" content="S1P5 is one of 5 receptors for sphingosine-1-phosphate and is highly expressed on endothelial cells within the blood–brain barrier, where it maintains barrier integrity in in vitro models (J. Neuro..." /></meta><meta name="Description" content="S1P5 is one of 5 receptors for sphingosine-1-phosphate and is highly expressed on endothelial cells within the blood–brain barrier, where it maintains barrier integrity in in vitro models (J. Neuro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 23, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00928" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00928" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00928" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00928" /></link>
        
    
    

<title>Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00928" /></meta><meta property="og:title" content="Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0028.jpeg" /></meta><meta property="og:description" content="S1P5 is one of 5 receptors for sphingosine-1-phosphate and is highly expressed on endothelial cells within the blood–brain barrier, where it maintains barrier integrity in in vitro models (J. Neuroinflamm. 2012, 9, 133). Little more is known about the effects of S1P5 modulation due to the absence of tool molecules with suitable selectivity and drug-like properties. We recently reported that molecule A-971432 (Harris , 2010) (29 in this paper) is highly efficacious in reversing lipid accumulation and age-related cognitive decline in rats (Van der Kam, , AAIC 2014). Herein we describe the development of a series of selective S1P5 agonists that led to the identification of compound 29, which is highly selective for S1P5 and has excellent plasma and CNS exposure after oral dosing in preclinical species. To further support its suitability for in vivo studies of S1P5 biology, we extensively characterized 29, including confirmation of its selectivity in pharmacodynamic assays of S1P1 and S1P3 function in rats. In addition, we found that 29 improves blood–brain barrier integrity in an in vitro model and reverses age-related cognitive decline in mice. These results suggest that S1P5 agonism is an innovative approach with potential benefit in neurodegenerative disorders involving lipid imbalance and/or compromised blood–brain barrier such as Alzheimer’s disease or multiple sclerosis." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00928"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00928">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00928&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00928&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00928&amp;href=/doi/10.1021/acs.jmedchem.5b00928" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 9154-9170</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00933" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01018" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P<sub>5</sub>) Agonist for the Potential Treatment of Neurodegenerative Disorders</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+D.++Hobson">Adrian D. Hobson</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+M.++Harris">Christopher M. Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+L.++van+der+Kam">Elizabeth L. van der Kam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean+C.++Turner">Sean C. Turner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ayome++Abibi">Ayome Abibi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ana+L.++Aguirre">Ana L. Aguirre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Bousquet">Peter Bousquet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tegest++Kebede">Tegest Kebede</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+B.++Konopacki">Donald B. Konopacki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Gintant">Gary Gintant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Youngjae++Kim">Youngjae Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Larson">Kelly Larson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+W.++Maull">John W. Maull</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigel+S.++Moore">Nigel S. Moore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Shi">Dan Shi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anurupa++Shrestha">Anurupa Shrestha</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiubo++Tang">Xiubo Tang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peng++Zhang">Peng Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy+K.++Sarris">Kathy K. Sarris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">AbbVie, Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">AbbVie Deutschland GmbH & Co KG, Knollstrasse 50, 67061 Ludwigshafen, Germany</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">∥</span> <span class="aff-text">Shanghai ChemPartner Co. Ltd., Building 10, 998 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>Phone: 508-688-8017. Fax: 508-688-8100. E-mail: <a href="/cdn-cgi/l/email-protection#79181d0b1018175711161b0a161739181b1b0f101c571a1614"><span class="__cf_email__" data-cfemail="345550465d555a1a5c5b56475b5a74555656425d511a575b59">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00928&amp;href=/doi/10.1021%2Facs.jmedchem.5b00928" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 9154–9170</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 28, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 June 2015</li><li><span class="item_label"><b>Published</b> online</span>23 November 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00928" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00928</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9154%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAdrian%2BD.%2BHobson%252C%2BChristopher%2BM.%2BHarris%252C%2BElizabeth%2BL.%2Bvan%2Bder%2BKam%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D23%26contentID%3Dacs.jmedchem.5b00928%26title%3DDiscovery%2Bof%2BA-971432%252C%2BAn%2BOrally%2BBioavailable%2BSelective%2BSphingosine-1-Phosphate%2BReceptor%2B5%2B%2528S1P5%2529%2BAgonist%2Bfor%2Bthe%2BPotential%2BTreatment%2Bof%2BNeurodegenerative%2BDisorders%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9170%26publicationDate%3DDecember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00928"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3518</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00928" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;D. Hobson&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;M. Harris&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;L. van der Kam&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;C. Turner&quot;},{&quot;first_name&quot;:&quot;Ayome&quot;,&quot;last_name&quot;:&quot;Abibi&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;L. Aguirre&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Bousquet&quot;},{&quot;first_name&quot;:&quot;Tegest&quot;,&quot;last_name&quot;:&quot;Kebede&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;B. Konopacki&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Gintant&quot;},{&quot;first_name&quot;:&quot;Youngjae&quot;,&quot;last_name&quot;:&quot;Kim&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Larson&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;W. Maull&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;S. Moore&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Anurupa&quot;,&quot;last_name&quot;:&quot;Shrestha&quot;},{&quot;first_name&quot;:&quot;Xiubo&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Peng&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;K. Sarris&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;9154-9170&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00928&quot;},&quot;abstract&quot;:&quot;S1P5 is one of 5 receptors for sphingosine-1-phosphate and is highly expressed on endothelial cells within the blood–brain barrier, where it maintains barrier integrity in in vitro models ( J. Neuroinflamm. 2012, 9, 133 ). Little more is known about the effects of S1P5 modulation due to the absence of tool molecules with suitable selectivity and drug-like properties. We recently reported that molecule A-971432 ( Harris , 2010 ) (29 in this paper) is highly efficacious in reversing lipid accumulation and age-related cognitive decline in rats ( Van der Kam , , AAIC 2014 ). Herein we describe the development of a series of selective S1P5 agonists that led to the identification of compound 29, which is highly selective for S1P5 and has excellent plasma and CNS exposure after oral dosing in preclinical species. To further support its suitability for in vivo studies of S1P5 biology, we extensively characterized 29, including confirmation of its selectivity in pharmacodynamic assays of S1P1 and S1P3 function in rats&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00928&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00928" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00928&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00928" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00928&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00928" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00928&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00928&amp;href=/doi/10.1021/acs.jmedchem.5b00928" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00928" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00928" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00928%26sid%3Dliteratum%253Aachs%26pmid%3D26509640%26genre%3Darticle%26aulast%3DHobson%26date%3D2015%26atitle%3DDiscovery%2Bof%2BA-971432%252C%2BAn%2BOrally%2BBioavailable%2BSelective%2BSphingosine-1-Phosphate%2BReceptor%2B5%2B%2528S1P5%2529%2BAgonist%2Bfor%2Bthe%2BPotential%2BTreatment%2Bof%2BNeurodegenerative%2BDisorders%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D23%26spage%3D9154%26epage%3D9170%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292236" title="Aldehydes">Aldehydes</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/jmcmar.2015.58.issue-23/20151210/jmcmar.2015.58.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">S1P<sub>5</sub> is one of 5 receptors for sphingosine-1-phosphate and is highly expressed on endothelial cells within the blood–brain barrier, where it maintains barrier integrity in in vitro models ( <cite>J. Neuroinflamm.</cite> <span class="NLM_year">2012</span>, <em>9</em>, 133). Little more is known about the effects of S1P<sub>5</sub> modulation due to the absence of tool molecules with suitable selectivity and drug-like properties. We recently reported that molecule A-971432 (<contrib-group person-group-type="allauthors">Harris</contrib-group>, <span class="NLM_year">2010</span>) (<b>29</b> in this paper) is highly efficacious in reversing lipid accumulation and age-related cognitive decline in rats (<span class="references__authors">Van der Kam</span>, , <conf-name>AAIC 2014</conf-name>). Herein we describe the development of a series of selective S1P<sub>5</sub> agonists that led to the identification of compound <b>29</b>, which is highly selective for S1P<sub>5</sub> and has excellent plasma and CNS exposure after oral dosing in preclinical species. To further support its suitability for in vivo studies of S1P<sub>5</sub> biology, we extensively characterized <b>29</b>, including confirmation of its selectivity in pharmacodynamic assays of S1P<sub>1</sub> and S1P<sub>3</sub> function in rats. In addition, we found that <b>29</b> improves blood–brain barrier integrity in an in vitro model and reverses age-related cognitive decline in mice. These results suggest that S1P<sub>5</sub> agonism is an innovative approach with potential benefit in neurodegenerative disorders involving lipid imbalance and/or compromised blood–brain barrier such as Alzheimer’s disease or multiple sclerosis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The pleiotropic signaling factor sphingosine-1-phosphate is recognized by a family of five receptors called S1P<sub>1</sub>, S1P<sub>2</sub>, S1P<sub>3</sub>, S1P<sub>4</sub>, and S1P<sub>5</sub>.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Synthetic agonists of S1P<sub>1</sub> drive lymphocyte sequestration and immune suppression.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Most notably, the pro-drug FTY720 (Fingolimod) reduces relapse rate and lesion activity in multiple sclerosis, and it also results in cardiovascular events.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In addition to agonizing S1P<sub>1</sub>, the phosphorylated form of FTY720 activates S1P<sub>3</sub>, S1P<sub>4</sub>, and S1P<sub>5</sub>.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Many other chemotypes of S1P<sub>1</sub> agonists interact with multiple S1P receptors, especially S1P<sub>5</sub>.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> S1P<sub>5</sub> is most highly expressed in the central nervous system, particularly on oligodendrocytes and brain endothelium.<a onclick="showRef(event, 'ref1 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref8">(1, 8)</a> Activation of S1P<sub>5</sub> on brain endothelial cells enhances barrier integrity and reduces transendothelial migration of monocytes in vitro.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There is indirect evidence that some of the efficacy of Gilenya in models of multiple sclerosis is from a direct, neuroprotective effect within the CNS.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> On the basis of the findings above, we hypothesized that a selective S1P<sub>5</sub> agonist may be efficacious for neurodegenerative disorders. If so, the lack of S1P<sub>1</sub>-driven immune suppression and cardiovascular effects would be advantageous. There are previous reports of selective S1P<sub>5</sub> agonists,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> but our profiling indicates these have insufficient pharmacodynamic properties to establish S1P<sub>5</sub> target validation in vivo (see <a class="ref internalNav" href="#sec2" aria-label="Results and Discussion">Results and Discussion</a> section). Herein we describe the optimization of the first S1P<sub>5</sub> agonists with the selectivity and drug-like properties to interrogate S1P<sub>5</sub> biology in vitro and in vivo.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To test the hypothesis that a selective S1P<sub>5</sub> agonist would be efficacious for neurodegenerative disorders, it would require a compound with the requisite potency as an S1P<sub>5</sub> agonist, selectivity profile, primarily at the other S1P family receptors, and PK properties to enable once daily oral dosing. However, at the offset of this project, there were no such selective S1P<sub>5</sub> agonists reported in the literature and so a medicinal chemistry program was initiated to identify such a compound to enable POC studies. Cognizant of Sir James Black’s famous comment that the best way to find a new drug is to start with an existing one, we decided to leverage the experience from our sphingosine-1 phosphate receptor agonist program. This was a very successful collaboration with the University of Virginia based on the S1P<sub>1</sub> chemical matter discovered by MacDonald et al. at UVA.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> As part of this project, we identified<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> cyclopentyl amino alcohol compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). This compound is phosphorylated on the hydroxyl of the amino alcohol in vivo, affording a highly potent S1P<sub>1</sub> receptor agonist <b>2</b>. This meant that to enable in vitro SAR in this drug series the amino alcohols had to be phosphorylated in an additional synthetic step prior to screening. To facilitate a more rapid screening cascade a replacement for the amino alcohol “head group” was therefore desired.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0001.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of literature S1P<sub>1</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scientists at Merck<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> had elegantly shown that azetidine-3-carboxylic acid was a suitable direct agonist surrogate for amino alcohol-based prodrugs such as those reported previously. Incorporation of the azetidine onto a high-throughput screening hit afforded selective and orally bioavailable S1P<sub>1</sub> receptor agonist <b>3</b>. Not only would the azetidine carboxylic acid afford compounds that could be screened directly in our in vitro assays, it was ideal for exploration via parallel synthesis. It was envisaged that libraries would be constructed from a reductive amination of the azetidine and substituted benzaldehydes in the presence of polymer supported sodium cyanoborohydride in the centralized High Throughput Chemistry Group at AbbVie (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Reductive Amination of an Aldehyde with Azetidine-3-carboxylic Acid Using Polymer Supported NaCNBH<sub>3</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Prior to library synthesis, both (a) the robustness of the reductive amination procedure and (b) the tolerance for replacement of the cyclopentyl amino alcohol with azetidine carboxylic acid needed to be confirmed. From the ongoing S1P<sub>1</sub> program, data showed that the alkyloxy tail of compound <b>2</b> drove selectivity between S1P<sub>1</sub>and S1P<sub>3</sub>. On the basis of this observation, commercially available benzaldehydes with a <i>para</i>-alkyl chain of varying length were sourced through Aldrich Market Select<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> to test the reductive amination step. Aldehydes were selected that had both carbon and ether group attachment of the chain to the aryl ring. Reductive amination of the aldehyde with azetidine-3-carboxylic acid was performed using polymer supported NaCNBH<sub>3</sub>, with the target compounds purified using mass-directed HPLC.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> To confirm the tolerance for the cyclopentyl amino alcohol replacement with azetidine carboxylic acid, 4-(octyloxy)benzaldehyde was included in this study as this would afford the direct crossover analogue, compound <b>6</b>.</div><div class="NLM_p">This approach generated extensive chemical matter, some of which had failed to progress in the S1P<sub>1</sub> project due to a lack of potency on S1P<sub>1</sub> and/or selectivity against S1P<sub>3</sub> due to its implication in bradycardia.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Extensive data mining identified approximately 500 S1P<sub>1</sub> project compounds that had failed these potency and/or selectivity criteria. This set was screened in an S1P<sub>5</sub> radio-ligand binding assay to identify S1P<sub>5</sub>-selective agents. This screen, along with existing S1P<sub>1</sub> and S1P<sub>3</sub> selectivity data, afforded a great launching point for further optimization shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR and Selectivity of Compounds <b>4</b>–<b>10</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0016.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">n</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>3</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> >30</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char="."> <0.001</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">7</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.018</td><td class="colsep0 rowsep0" align="char" char=".">0.040</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.197</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.048</td><td class="colsep0 rowsep0" align="char" char=".">5.29</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">3</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.18</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char="."> >100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">3.03</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char="."> >300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">1</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">3.46</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char="."> >1000</td></tr></tbody></table></div></div><div class="NLM_p">The compounds were screened in assays for S1P<sub>1</sub>, S1P<sub>3</sub>, and S1P<sub>5</sub> as a representative set of the five sphingosine receptors, and this identified some striking SAR. Compound <b>1</b> clearly demonstrated the requirement for phosphorylation of the amino alcohol for activity with the compound being inactive at both S1P<sub>1</sub> and S1P<sub>3</sub>. In stark contrast, phosphorylated compound <b>2</b> was shown to be extremely potent at S1P<sub>1</sub>, S1P<sub>3</sub>, and S1P<sub>5</sub>. Compounds <b>4</b> and <b>5</b> with decyl and nonyl alkyl chains respectively were equipotent at both S1P<sub>1</sub> and S1P<sub>3</sub>, with compound <b>5</b> also being potent at S1P<sub>5</sub>. Compound <b>6</b> is the azetidine analogue of compound <b>1</b> with an octyl alkyl chain and maintained a high level of potency at S1P<sub>1</sub> and S1P<sub>5</sub> but was more than 40-fold selective over S1P<sub>3</sub> versus the other 2 S1P receptors tested. This trend continued with compound <b>7</b> with a heptyl alkyl chain. This compound maintained its potency at both S1P<sub>1</sub> and S1P<sub>5</sub> but was now >500-fold selective versus S1P<sub>3</sub>. Of particular note was compound <b>8</b> with a hexyl alkyl chain. This compound maintained a high level of potency against S1P<sub>5</sub> but now >1000-fold selective versus S1P<sub>3</sub> and had introduced a selectivity window of around 130 versus S1P<sub>1</sub>. On the basis of the encouraging data with compound <b>8</b>, compound <b>9</b> with a pentyl alkyl chain was only screened against S1P<sub>1</sub> and S1P<sub>5</sub>. The compound again maintained a high level of potency against S1P<sub>5</sub>, but now the selectivity versus S1P<sub>1</sub> was >300-fold. Compound <b>10</b> demonstrated that substitution on the alkyl chain was tolerated, with the compound maintaining a high potency at S1P<sub>5</sub> with an increased selectivity versus S1P<sub>1</sub> of >1000. These compounds were determined to be full agonists in a GTPγS activation assay, using S1P<sub>5</sub>-transfected HEK cell membranes. EC<sub>50</sub> values were similar between GTPγS and radio-ligand binding formats, and so compound optimization was driven by binding data, with occasional confirmation in the GTPγS assay.</div><div class="NLM_p">These initial compounds designed around compound <b>1</b> had identified a critical structural link to selectivity among the S1P family of receptors with an alkyl chain length of 5 or 6 optimal for both S1P<sub>5</sub> potency and selectivity. Having identified a selectivity pharmacophore for S1P<sub>5</sub>, this information was used to design follow up libraries.</div><div class="NLM_p">As there was no structural information available on the S1P<sub>5</sub> receptor to drive compound design, it was planned to use parallel synthesis to generate a pharmacophore of the target. To enable this, compound <b>6</b> was divided into four regions shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>. Libraries would then be designed to sequentially interrogate these regions using parallel synthesis. Using the SAR from these libraries, compounds combining the best structural motifs would then be designed and synthesized by dedicated synthesis.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Regions of compound <b>6</b> selected for SAR investigation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three main criteria were used for selection of the monomers for the libraries. The first was their commercial availability from Aldrich Market Select. Second the choice of monomers was based on the Topliss Tree.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Monomers were selected to interrogate the effect of both electronics (halogen, methoxy) and steric constraints (methyl, ethyl) on both S1P<sub>5</sub> binding and selectivity across the S1P family of receptors. The final criteria was the calculated physicochemical properties of the resulting compounds based on medicinal chemistry guidelines like drug-like properties,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Golden Triangle<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and 3/75.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">For clarity, only a single representative of each library is shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. From the radar plot visualization, it is clearly evident that all the compounds have excellent predicted drug-like properties. The radar plot data is also shown in tabular form below (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). All the compounds were also predicted to have both good clearance and oral absorption using the Golden Triangle. In addition, the compounds all have calculated PSA and cLogP that suggest a reduced risk of toxicity based on the 3/75 rule.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Calculated Physicochemical Properties of Compounds <b>10</b>, <b>29</b>, <b>31</b>, <b>43</b>, and <b>60</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th><th class="colsep0 rowsep0" align="center" char=".">PSA</th><th class="colsep0 rowsep0" align="center" char=".">mol wt</th><th class="colsep0 rowsep0" align="center" char=".">HBD</th><th class="colsep0 rowsep0" align="center" char=".">HBA</th><th class="colsep0 rowsep0" align="center" char=".">NAR</th><th class="colsep0 rowsep0" align="center" char=".">NRB</th><th class="colsep0 rowsep0" align="center" char=".">FSP<sub>3</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">277.4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">0.56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">366.2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">331.8</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">363.4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">383.3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr></tbody></table></div></div><div class="NLM_p">The first library was designed to explore the headgroup region of compound <b>6</b>. As lead compound <b>1</b> contained the larger cyclopentyl ring, analogues with both pyrrolidine and piperidine replacements of azetidine were considered. It was also recognized that the larger piperidine ring afforded multiple opportunities to vary the carboxylic acid group orientation and analogues exploring this included in the library.</div><div class="NLM_p">Racemic pyrrolidine-3-carboxylic acid analogue <b>11</b> suggested that ring expansion of the azetidine ring was tolerated while the (<i>R</i>)-isomer <b>12</b> revealed important information on the desired stereochemistry of the carboxylic acid group. This was further exemplified with the piperidine-3-carboxylic acid analogues <b>13</b> and <b>14</b>, the (<i>R</i>)-isomer being more than 10 times more potent than the (<i>S</i>). Compounds incorporating piperidine-4-carboxylic acid afforded the most potent analogues. Compound <b>15</b> had an IC<sub>50</sub> of 16 nM and substituted piperidine <b>16</b> only slightly less potent (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR and Selectivity of Compounds <b>11</b>–<b>16</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0017.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0018.gif" alt="" id="fx3" /></img><div></div></div><div class="NLM_p">Next a library was designed to expand the SAR of the spacer and tail regions of compound <b>6</b>. The library interrogated the steric limits by reducing the length of the spacer region between the tail and the aryl ring proximal to the azetidine-3-carboxylic acid. These compounds would afford more conformationally restricted analogues that might have improved oral bioavailability.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> A series of phenyl and phenoxy benzaldehydes was sourced again though Aldrich Market Select and reacted with azetidine carboxylic acid.</div><div class="NLM_p">Compounds <b>17</b>, <b>18</b>, and <b>19</b> with either a 4-substituted or 3,4-disubstituted aryl ring directly attached to the 1-benzylazetidine-3-carboxylic acid were potent at S1P<sub>5</sub>, with at least a 200-fold window over S1P<sub>1</sub> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Surprisingly, the potency at S1P<sub>5</sub> for compound <b>20</b> with a trifluoromethyl substituent in the 3-position was greatly reduced. This also resulted in much lower selectivity against S1P<sub>1</sub>. Compound <b>21</b> was included to vary the substitution pattern around the aryl ring and while tolerated resulted in a large reduction in potency at S1P<sub>5</sub>. Introduction of an oxygen atom linker between the two aryl rings was not so promising. Compound <b>22</b> based on a biphenyl ether had greatly reduced potency at S1P<sub>5</sub>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR and Selectivity of Compounds <b>17</b>–<b>22</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0019.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>3</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">3,4-DiClPh</td><td class="colsep0 rowsep0" align="char" char=".">4.41</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">4-MePh</td><td class="colsep0 rowsep0" align="char" char=".">7.21</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char="."> >1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">4-EtPh</td><td class="colsep0 rowsep0" align="char" char=".">0.656</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char="."> >200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>Ph</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.409</td><td class="colsep0 rowsep0" align="char" char="."> >24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">3,5-DiClPh</td><td class="colsep0 rowsep0" align="char" char=".">9.81</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.148</td><td class="colsep0 rowsep0" align="char" char=".">66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4-ClPhO</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.789</td><td class="colsep0 rowsep0" align="char" char="."> >12</td></tr></tbody></table></div></div><div class="NLM_p">The previous library established that both straight alkyl chains, like in compound <b>6</b>, and more sterically demanding groups, like aryl in compound <b>18</b>, were tolerated off the para position of 1-benzylazetidine-3-carboxylic acid. As a result, a follow up library was planned that combined these SAR observations. Incorporating the key observation from the compounds in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> with regard to overall chain length and S1P<sub>5</sub> selectivity, it was recognized that the total chain length must be maintained at six to seven atoms. Consequently, a library of benzyl ethers was designed and synthesized.</div><div class="NLM_p">It was pleasing that compound <b>23</b>, the unsubstituted analogue, was as expected potent at S1P<sub>5</sub> while being more than a 100-fold selective against both S1P<sub>1</sub> and S1P<sub>3</sub>. Compounds <b>24</b>, <b>25</b>, <b>26</b>, and <b>27</b>, having a monosubstituted aryl ring, all had improved potency at S1P<sub>5</sub> and increased selectivity versus S1P<sub>1</sub> (for <b>27</b> S1P<sub>1</sub> data was not generated) (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). Similarly, the 2,4-dichloro analogue <b>28</b> had both impressive S1P<sub>5</sub> potency and selectivity versus S1P<sub>1</sub>. Compound <b>29</b>, with a 3,4-dicloro substitution motif, displayed a very interesting profile. The compound was essentially inactive at S1P<sub>3</sub> while having more than a 50 fold window over S1P<sub>1</sub>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR and Selectivity of Compounds <b>23</b>–<b>29</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0020.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>3</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.077</td><td class="colsep0 rowsep0" align="char" char="."> >100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="char" char=".">5.26</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="char" char=".">151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="char" char=".">1.78</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">174</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1.06</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">248</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">2,4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.835</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">225</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">3,4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.362</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">60</td></tr></tbody></table></div></div><div class="NLM_p">Suitable benzaldehydes to examine substitution in both the tail and aryl regions simultaneously were then considered. However, the commercial availability of such suitably substituted benzaldehydes was very limited and only a few analogues were secured.</div><div class="NLM_p">Compounds <b>30</b>, <b>31</b>, <b>32</b>, <b>33</b>, and <b>34</b> displayed good to excellent potency at S1P<sub>5</sub>, with a wide selectivity window over S1P<sub>1</sub> ranging from 10 to >900-fold (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). However, with the limited commercial availability of suitable benzaldehydes to enable an extensive parallel synthetic approach, it was difficult to draw any meaningful SAR information from these analogues. To afford the SAR from substitution of both aryl rings, dedicated synthesis of specific examples was deemed necessary and pursued later in the project (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR and Selectivity of Compounds <b>30</b>–<b>34</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0021.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">4.17</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char="."> >500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">4.23</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char="."> >900</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">2,4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">3-NO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3,4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="char" char=".">6.23</td><td class="colsep0 rowsep0" align="char" char=".">0.115</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr></tbody></table></div></div><div class="NLM_p">For exploration of the spacer region of compound <b>6</b>, no suitable benzaldehydes were available from commercial sources and so dedicated synthesis of the key compounds would need to be conducted. The first structural modification to be considered in the spacer region was replacement of the oxygen in the linker between the two aryl rings with carbon. Such a replacement was known to be tolerated for our S1P<sub>1</sub> agonists, and so it was considered likely it would also be at least tolerated here. Protection of 4-cyano benzaldehyde <b>35</b> with ethylene glycol afforded the dioxolane <b>36</b>, which underwent a Grignard reaction with commercially available benzyl bromide <b>37</b> to yield advanced intermediate <b>38</b>. Subsequent deprotection of the dioxolane under acidic conditions afforded the free aldehyde <b>39</b>, which was reacted with azetidine carboxylic acid under the standard conditions with sodium cyano borohydride. Hydrogenation of ketone <b>40</b> in the presence of palladium on carbon gave the desired compounds <b>41</b>.</div><div class="NLM_p">Surprisingly, while compound <b>42</b> with the unsubstituted aryl ring to the azetidine headgroup maintained good potency at S1P<sub>5</sub>, it was now equipotent at S1P<sub>1</sub> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). This was in contrast to compound <b>23</b>, which while having a similar potency at S1P<sub>5</sub> displayed a selectivity window versus S1P<sub>1</sub> of >100-fold. Pleasingly, introduction of a meta-electron withdrawing group on the distal aryl ring again established a high selectivity versus S1P<sub>1</sub>, compound <b>43</b> with R = CF<sub>3</sub> being over 250-fold selective (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route toward 1,2-Diphenylethane Analogues <b>42</b> and <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethane-1,2-diol, PTSA, PhMe; (b) Mg, I<sub>2</sub>, Et<sub>2</sub>O; (c) <b>36</b>, Et<sub>2</sub>O; (d) 10% HCl, THF, reflux; (e) azetidine-carboxylic acid, NaCNBH<sub>3</sub>, MeOH; (f) 1% H<sub>2</sub>SO<sub>4</sub>/EtOH, Pd/C, H<sub>2</sub>.</p></p></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. SAR and Selectivity of Compounds <b>42</b> and <b>43</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0022.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.221</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">260</td></tr></tbody></table></div></div><div class="NLM_p">Having established the synthetic route to compound <b>40</b>, which contains a ketone in the linker region, additional ketone containing analogues were pursued. As ketones, particularly aryl ketones, are not considered drug-like molecules, this would provide useful internal data around this functional group. The key aldehyde intermediates <b>39</b> were synthesized in sufficient quantity to enable analogues with both azetidine-3-carboxylic acid and pyrrolidine-3-carboxylic acid to be secured.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. SAR and Selectivity of Compounds <b>44</b>–<b>51</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0023.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0024.gif" alt="" id="fx9" /></img><div></div></div><div class="NLM_p">For analogues <b>44</b> and <b>46</b> with the alkyl chain, introduction of the carbonyl moiety had little impact compared to the corresponding analogues with the oxygen in the linker <b>8</b> and <b>7</b>, respectively (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). Compounds <b>45</b> and <b>47</b> also demonstrated that increasing the ring size of the amino acid had little effect on potency. The SAR was more striking, with the analogues containing an aryl ring off the linker. Compound <b>48</b> was slightly less potent than the corresponding <i>des</i>-carbonyl compound <b>42</b>, whereas compound <b>49</b> with the larger pyrrolidine-3-carboxylic acid was >15-fold less potent. Varying the size of the ring of the amino acid headgroup had little impact on either of the 3,4-dichloro substituted compounds <b>50</b> and <b>51</b>, which both showed similar potency to the corresponding ether linked compound <b>32</b>. Such SAR suggests that investigation of the amino acid headgroup and other structural modifications would need to be done in parallel to identify the optimal design.</div><div class="NLM_p">The expeditious use of parallel synthesis had furnished a large amount of structural information that drove both S1P<sub>5</sub> binding and selectivity across the S1P family of receptors. However, this information was generated in the four discrete regions of compound <b>6</b> that had been used to enable library design. The final set of compounds was designed by combining this SAR on to the benzyl ether scaffold of compound <b>23</b>.</div><div class="NLM_p">To explore simultaneous substitution on both aryl rings of the benzyl ether scaffold, a synthesis was designed starting from the appropriately substituted benzyl alcohols <b>52</b> and 4-cyano phenols <b>53</b>. These components could be coupled efficiently using a Mitsunobu reaction. The resulting cyano compounds <b>54</b> were reduced to the desired aldehydes <b>55</b> using DIBAL. Introduction of the azetidine-3-carboxylic acid headgroup was effected under the standard conditions to afford the desired compounds <b>56</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><div class="NLM_p">Compound <b>57</b> suggested that substitution on the aryl ring proximal to the azetidine carboxylic acid may drive selectivity over S1P<sub>1</sub> while having a slightly negative effect on S1P<sub>5</sub> potency. Disappointingly, introduction of halogens to both aryl rings furnished flat SAR. 3,4-Dichlorophenyl containing compounds <b>58</b> and <b>59</b> had demonstrated essentially the same profile as the <i>des</i>-fluoro parent compound <b>29</b> (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). In the 3-trifluoromethylphenyl containing compounds, it was a similar story, with fluoro-substituted compounds <b>60</b> and <b>61</b> and chloro-substituted compounds <b>62</b> and <b>63</b> showing little differentiation from the <i>des</i>-halo parent compound <b>26</b>. While introduction of a halogen had not greatly improved potency or selectivity, it was pleasing to see that its effect on the cLogP of the compounds was not too detrimental. As a result, halogen incorporation was identified as a strategy to block possible sites of metabolism on the proximal aryl ring to the amino acid headgroup should this be required later in development.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route toward (Benzyloxy)benzene Analogues <b>57</b>–<b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P, DIAD, THF; (b) DIBAL, PhMe; (c) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. SAR and Selectivity of Compounds <b>26</b>, <b>29</b>, <b>57</b>–<b>63</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0025.gif" alt="" id="fx10" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> MFB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th><th class="colsep0 rowsep0" align="center" char=".">cLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3,4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.362</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.041</td><td class="colsep0 rowsep0" align="char" char=".">244</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3,4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.472</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">3,4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.217</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">1.06</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">248</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.68</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">340</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.401</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.256</td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.109</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td></tr></tbody></table></div></div><div class="NLM_p">Because of the limited commercial availability of alkyl substituted 4-hydroxy phenols, an alternative synthetic route was required to investigate methyl analogues of compound <b>23</b>. Mitsunobu reaction of appropriately substituted benzyl alcohols <b>52</b> with 4-bromo-3-methylphenol <b>64</b> gave key bromo intermediates <b>65</b>, which were subsequently converted to compounds <b>66</b> by treatment with copper(I) cyanide. Treatment with DIBAL gave aldehydes <b>67</b>, which were reacted with azetidine-3-carboxylic acid under the usual conditions to afford target compounds <b>68</b>.</div><div class="NLM_p">Introduction of the methyl substituent resulted in dramatic SAR. While both compounds <b>69</b> and <b>70</b> were observed to be more potent at S1P<sub>1</sub> than their central aryl ring <i>des</i>-methyl analogues <b>26</b> and <b>29</b>, respectively, they were significantly more potent at S1P<sub>5</sub> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). This increased selectivity versus S1P<sub>1</sub> is also apparent when considering compound <b>30</b> (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>). Compound <b>30</b> has an unsubstituted distal aryl ring and the 2-methyl substituent on the central aryl ring as in <b>69</b> and <b>70</b>. SAR from this set of compounds suggests the importance of substitution on the central aryl ring for driving selectivity while substitution on the distal aryl ring drives potency at both S1P<sub>1</sub> and S1P<sub>5</sub>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route toward Substituted 1-(4-(Benzyloxy)-2-methylbenzyl)azetidine-3-carboxylic Acids <b>69</b> and <b>70</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P, DIAD, THF; (b) CuCN, NMP; (c) DIBAL, PhMe; (d) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. SAR and Selectivity of Compounds <b>26</b>, <b>29</b>, <b>30</b>, <b>69</b>, and <b>70</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0026.gif" alt="" id="fx11" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> MFB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">1.06</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">248</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">3,4-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.362</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">4.17</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char="."> >500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.333</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">3,4-Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="char" char=".">0.166</td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">150</td></tr></tbody></table></div></div><div class="NLM_p">To complete the SAR around the spacer region of compound <b>6</b>, substitution from the benzylic carbon was explored. Introduction of a methyl was chosen, as this would greatly affect the conformation of the resulting compound and hence alter the trajectory of the tail aryl ring relative to the headgroup. The synthesis was initially conducted with 1-phenylethanol <b>71</b> using the typical three-step procedure. A Mitsunobu reaction with 4-cyanophenol <b>72</b> afforded compound <b>73</b>, which was then treated with DIBAL to furnish aldehyde <b>74</b>. Subsequent reaction with azetidine-3-carboxylic acid gave the desired racemic compound <b>75</b>. The enantiomerically pure (<i>R</i>)-isomer <b>76</b> was secured using the same synthetic sequence but using (<i>S</i>)-1-phenylethanol (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route toward Substituted 1-(4-(Benzyloxy)-2-methylbenzyl)azetidine-3-carboxylic Acids <b>75</b> and <b>76</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: Ph<sub>3</sub>P, DIAD, THF; (b) DIBAL, PhMe; (c) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><div class="NLM_p">Unfortunately substitution off the benzylic carbon was at best tolerated and is likely detrimental. Both the racemate <b>75</b> and pure enantiomer <b>76</b> had a reduced selectivity window versus S1P<sub>1</sub>, and neither was more potent than the H analogue <b>23</b> (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>).</div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. SAR and Selectivity of Compounds <b>23</b>, <b>75</b>, and <b>76</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0027.gif" alt="" id="fx12" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>1</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub> RLB IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">S1P<sub>5</sub>/S1P<sub>1</sub> selectivity</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.077</td><td class="colsep0 rowsep0" align="char" char="."> >100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">racemic Me</td><td class="colsep0 rowsep0" align="char" char="."> >10</td><td class="colsep0 rowsep0" align="char" char=".">0.255</td><td class="colsep0 rowsep0" align="char" char="."> >39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">(<i>R</i>)-Me</td><td class="colsep0 rowsep0" align="char" char=".">3.87</td><td class="colsep0 rowsep0" align="char" char=".">0.108</td><td class="colsep0 rowsep0" align="char" char=".">35</td></tr></tbody></table></div></div><div class="NLM_p">The project goal was to identify a compound with the requisite potency as an S1P<sub>5</sub> agonist, selectivity profile, primarily at the other S1P family receptors, and PK properties to enable once daily oral dosing. The expeditious use of parallel synthesis in combination with the dedicated synthesis of key singletons had facilitated extensive in vitro profiling, which enabled the construction of a comprehensive pharmacophore around both S1P<sub>5</sub> potency and selectivity versus the S1P family of receptors. To permit additional in vivo profiling, larger compound inventories would be necessary. Because of project resource constraints, it was only possible to scale up a limited number of analogues and so five compounds were selected. The compound selection for additional profiling was based on the in vitro data using potency at S1P<sub>5</sub> and selectivity versus S1P<sub>1</sub>, with examples selected to ensure the broadest coverage of chemical matter. The compounds selected for scale up are shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>: compound <b>10</b> with an alkyloxy chain, compound <b>29</b> with a substituted distal aryl ring, compound <b>31</b> with a substituted central aryl ring, compound <b>43</b> with an ethyl linker, and compound <b>60</b> with substitution on both aryl rings. It should be noted that in addition to this series with the azetidine carboxylic acid headgroup, three additional compound series of S1P<sub>5</sub> selective agonists were identified and are currently being developed.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of five compounds selected for scale up to enable additional profiling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative examples from each library design showing (a) excellent calculated physicochemical properties, (b) good projected clearance and oral absorption, and (c) predicted reduced risk of toxicity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The five compounds were profiled in a high-throughput ADME panel to assess solubility, plasma protein binding, permeability, and inhibition of CYP enzymes. All the compounds had good solubility and free fraction. Of note was compound <b>10</b> with the branched alkyl chain that exhibited very low levels of plasma protein binding (<a class="ref internalNav" href="#tbl12" aria-label="Table 12">Table 12</a>). Despite the incorporation of the azetidine-3-carboxylic acid headgroup, the compounds displayed reasonable permeability as assessed by the PAMPA assay. Pleasingly, none of the compounds were identified as inhibitors of the four most common CYP enzymes. All the compounds were then tested in the micronucleus assay and found to be nonclastogenic.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. High-Throughput ADME Data for Compounds <b>10</b>, <b>29</b>, <b>31</b>, <b>43</b>, and <b>60</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">inhibition (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">solubility (μM)</th><th class="colsep0 rowsep0" align="center" char=".">PPB (% bound)</th><th class="colsep0 rowsep0" align="center" char=".">PAMPA (cm s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char=".">Cyp1A2</th><th class="colsep0 rowsep0" align="center" char=".">Cyp2C9</th><th class="colsep0 rowsep0" align="center" char=".">Cyp2D6</th><th class="colsep0 rowsep0" align="center" char=".">Cyp3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">4.2</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">9.4</td><td class="colsep0 rowsep0" align="char" char=".">16.7</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td><td class="colsep0 rowsep0" align="char" char="."> >20</td></tr></tbody></table></div></div><div class="NLM_p">Screening PK was then conducted with the compounds being dosed at 10 mpk po in female Balb/C mice (<b>29</b> was tested in CD1 mice). As predicted by the physicochemical properties, all the compounds displayed excellent PK characteristics (<a class="ref internalNav" href="#tbl13" aria-label="Table 13">Table 13</a>). The compounds exhibited good <i>t</i><sub>1/2</sub> ranging from 3.3 to 5.7 h, with large maximum concentrations achieved in an hour or less. Most notable was the very large AUC observed with trifluoromethyl analogue <b>43</b> of 127000 ng·h/mL.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. Mouse PK for Compounds <b>10</b>, <b>29</b>, <b>31</b>, <b>43</b>, and <b>60</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (ng·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">11800</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="char" char=".">17300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b><a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">2500</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">35000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">4230</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">16800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">4.9</td><td class="colsep0 rowsep0" align="char" char=".">17900</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="char" char=".">127000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">4.6</td><td class="colsep0 rowsep0" align="char" char=".">6480</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">37700</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>a</sup><p class="last"><b>29</b> was tested in CD1 mice.</p></div></div></div><div class="NLM_p">The comprehensive data package generated for compounds <b>10</b>, <b>29</b>, <b>31</b>, <b>43</b>, and <b>60</b> showed them all to be excellent candidates for in vivo studies. All the compounds were potent S1P<sub>5</sub> agonists and selective across the S1P family of receptors. No issues had been identified from the HT-ADME screen, and pleasingly all the compounds had excellent solubility. The PK profiles of the compounds were similarly all suitable for advancing to the planned in vivo studies. From these five compounds, it was decided to advance compound <b>29</b> for large-scale synthesis to enable further characterization. The selection of compound <b>29</b> was based on it having the longest <i>t</i><sub>1/2</sub> which it was thought would be the most appropriate for future studies. It should be noted however that all five compounds have profiles suitable for advancing in vivo.</div><div class="NLM_p">While 4-((3,4-dichlorobenzyl)oxy)benzaldehyde <b>79</b> was commercially available, due to the high cost it was synthesized from more readily available starting materials. A mixture of 3,4-dichlorobenzyl chloride <b>77</b>, 4-hydroxybenzaldehyde <b>78</b>, potassium carbonate, and acetone was refluxed overnight to afford 4-(3, 4-dichlorobenzyloxy)benzaldehyde <b>79</b> in 79% yield after filtration and washing. Reaction with azetidine-3-carboxylic acid proceeded smoothly in the presence of sodium cyanoborohydride in methanol at room temperature. The product <b>29</b> was again collected by filtration in 60% yield<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).</div><div class="NLM_p">Potency and selectivity SAR was developed with radio-ligand binding assays. To confirm S1P<sub>5</sub> agonism, <b>29</b> was profiled in two in vitro functional assays. FTY720-phosphate was used to define 100% agonism, as it gave more consistent results than the lipid S1P. In a GTPγS assay using membranes from S1P<sub>5</sub>-transfected HEK cells, <b>29</b> induced full agonism and had an EC<sub>50</sub> = 5.7 nM (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a). In a forskolin-induced cAMP inhibition assay in S1P<sub>5</sub>-transfected CHO cells, <b>29</b> was also a full agonist and had an EC<sub>50</sub> = 4.1 nM (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b). By comparison, FTY720-phosphate had an EC<sub>50</sub> of 3.4 and 11 nM in the GTPγS and cAMP assays, respectively.</div><figure id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0015.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Large Scale Synthetic Route for 1-(4-((3,4-Dichlorobenzyl)oxy)benzyl)azetidine-3-carboxylic Acid <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro functional S1P<sub>5</sub> assays. (a) GTPγS binding in membranes from S1P<sub>5</sub>-transfected HEK cells. (b) Inhibition of forskolin-induced cAMP in S1P<sub>5</sub>-transfected CHO cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>29</b> was profiled in receptor binding assays against the other S1P receptors and found to have no measurable binding up to 10 μM on S1P<sub>2</sub>, S1P<sub>3</sub>, and S1P<sub>4</sub> (data not shown). At S1P<sub>1</sub>, <b>29</b> has weak potency (0.36 μM). To address agonism versus antagonism at S1P<sub>1</sub>, we first used an S1P<sub>1</sub> GTPγS assay to demonstrate a complete lack of S1P<sub>1</sub> activation up to 10 μM <b>29</b> (data not shown). We then determined <b>29</b> to be a competitive antagonist at S1P<sub>1</sub> with a <i>K</i><sub>B</sub> = 0.4 μM in the same system (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Lastly, we confirmed a lack of S1P<sub>1</sub> activity by dosing <b>29</b> in Sprague–Dawley rats and monitoring lymphopenia. We found no change in lymphocyte counts at 5 h after a single oral dose of 3, 10, 30, or 100 mg/kg (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Plasma exposure was dose-proportional and attained 15000 ng/mL at the highest dose. These data clearly show <b>29</b> is devoid of S1P<sub>1</sub> agonism up to the highest doses tested.</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Selectivity of <b>29</b> against S1P<sub>1</sub> is confirmed by a lack of lymphopenia. Sprague–Dawley rats were administered 10, 30, or 100 mg/kg of <b>29</b> or vehicle (0.5% HPMC/0.02% Tween 80) by oral gavage. Five hours later, blood was collected via cardiac puncture under isoflurane anesthesia. Mean number of lymphocytes ± SEM are reported (<i>n</i> = 4). Plasma exposures were determined to be 1800, 5000, and 15000 ng/mL respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In rodents, S1P<sub>3</sub> agonism results in bradycardia,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> although in humans these effects are likely mediated by S1P<sub>1</sub>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> To confirm selectivity against S1P<sub>3</sub> in vivo, we evaluated <b>29</b> in cardiovascular safety studies. In anesthetized Sprague–Dawley rats, <b>29</b> induced no significant change in heart rate during sequential 30 min IV infusions at 3, 10, and 30 mg/kg (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>), achieving plasma concentrations of 1840, 8660, and 20300 ng/mL, respectively. Overall, the 10 mg/kg dose had minimal hemodynamic effects, and the 30 mg/kg dose produced a 16% increase in mean arterial pressure (not statistically significant) and a 10% decrease in cardiac contractility. These studies confirm in vivo that <b>29</b> has no activity at S1P<sub>3</sub>, and when interpreted in the context of efficacy studies to be disclosed separately, also demonstrates a favorable safety margin. While the lack of lymphopenia and bradycardia responses from <b>29</b> is implied by its in vitro profile, these data demonstrate for the first time a lack of any S1P<sub>1</sub>-related activity in an S1P<sub>5</sub> agonist and support the use of <b>29</b> in differentiating S1P<sub>1</sub> versus S1P<sub>5</sub> biology in vivo.</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>29</b> does not cause bradycardia in anesthetized rats. <b>29</b> was administered by three sequential 30 min IV infusions at 3, 10, and 30 mg/kg. No effects on heart rate were observed through the highest mean exposure of 20.3 μg/mL. Similarly, no statistically significant effects on mean arterial pressure were observed. Cardiac contractility (d<i>P</i>/d<i>t</i><sub>50</sub>) was decreased 10% (change from baseline) during the end of the third infusion period (<i>P</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There are two previous reports of S1P<sub>5</sub>-selective compounds.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Our in vitro profiling of these molecules showed significantly weaker potency than the agonists we describe. In addition, we were unable to formulate these molecules in a manner resulting in any measurable in vivo exposure.</div><div class="NLM_p">To confirm compound <b>29</b> was also selective outside the S1P receptor family, it was profiled in two large screening panels. <b>29</b> was found to have an IC<sub>50</sub> > 10 μM at all 129 kinases of an AbbVie internal panel (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Of the 79 receptors tested on the CEREP<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> panel, <b>29</b> only bound to two members at a threshold of >50%, 5-HT2<sub>a</sub> (75%) and DA transporter (63%) (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">Compound <b>29</b> was screened in the Ames test and found to be nonclastogenic. It was negative in the Alarm NMR assay,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> suggesting little likelihood of thiol reactivity, for example, with glucuronide. It was also profiled in a dofetilide binding assay and had an IC<sub>50</sub> of 77 μM.</div><div class="NLM_p">Pharmacokinetic analyses (<a class="ref internalNav" href="#tbl14" aria-label="Table 14">Table 14</a>) of <b>29</b> in mouse, rat, dog, and cynomolgus monkey indicates high oral bioavailability, high exposure, low clearance, a long half-life, and at least where tested in rodents, good brain exposure. Despite moderate to high plasma protein binding, total brain exposure of as little as 20 ng/g brain tissue results in full efficacy in studies to be discussed in subsequent publications.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> These data indicate <b>29</b> can achieve sufficient exposure to saturate S1P<sub>5</sub> in peripheral tissues as well as the central nervous system.</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Pharmacokinetics of <b>29</b> in Multiple Species</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IV</th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">PO</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">sample analyzed</th><th class="colsep0 rowsep0" align="center">protein binding (%)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC (ng·h/mL)</th><th class="colsep0 rowsep0" align="center">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (ng·h/mL)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BALB/C mouse</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="center">93</td><td class="colsep0 rowsep0" align="center">7.6</td><td class="colsep0 rowsep0" align="center">8500</td><td class="colsep0 rowsep0" align="center">0.24</td><td class="colsep0 rowsep0" align="center">1.9</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="center">2.0</td><td class="colsep0 rowsep0" align="char" char=".">300</td><td class="colsep0 rowsep0" align="char" char=".">4800</td><td class="colsep0 rowsep0" align="center">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BALB/C mouse</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="center">nd<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">9.8</td><td class="colsep0 rowsep0" align="center">3200 (<i>C</i><sub>max</sub> = 133 ng/nL)</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="center">2–24</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">1600</td><td class="colsep0 rowsep0" align="center">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD rat</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="center">93</td><td class="colsep0 rowsep0" align="center">9.0</td><td class="colsep0 rowsep0" align="center">6400</td><td class="colsep0 rowsep0" align="center">0.16</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="center">4.3</td><td class="colsep0 rowsep0" align="char" char=".">400</td><td class="colsep0 rowsep0" align="char" char=".">8700</td><td class="colsep0 rowsep0" align="center"> >100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD rat</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">brain</td><td class="colsep0 rowsep0" align="center">99.5</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="center">nd</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="center">8</td><td class="colsep0 rowsep0" align="char" char=".">120</td><td class="colsep0 rowsep0" align="char" char=".">3100</td><td class="colsep0 rowsep0" align="center">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">beagle dog</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="center">96</td><td class="colsep0 rowsep0" align="center">9.3</td><td class="colsep0 rowsep0" align="center">12000</td><td class="colsep0 rowsep0" align="center">0.09</td><td class="colsep0 rowsep0" align="center">1.2</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="char" char=".">690</td><td class="colsep0 rowsep0" align="char" char=".">11000</td><td class="colsep0 rowsep0" align="center">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cyno monkey</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">plasma</td><td class="colsep0 rowsep0" align="center">97</td><td class="colsep0 rowsep0" align="center">3.5</td><td class="colsep0 rowsep0" align="center">6400</td><td class="colsep0 rowsep0" align="center">0.16</td><td class="colsep0 rowsep0" align="center">0.82</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="char" char=".">650</td><td class="colsep0 rowsep0" align="char" char=".">5500</td><td class="colsep0 rowsep0" align="center">86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup>a</sup><p class="last">nd = not determined.</p></div></div></div><div class="NLM_p">Compound <b>29</b> underwent a 14 day Sprague–Dawley rat tolerability study at 10 and 100 mg/kg, po, qd. One of three females in the 100 mg/kg group was euthanized on day 8 due to 22% weight loss, and the other females had no weight changes at either dose. All other animals survived to the scheduled necropsy with no adverse clinical signs. Body weights of males on day 14 were 10% less than vehicle controls at both doses. There were increased liver weights in high dose groups (20% for male, 30% for female) but no corresponding increase in serum ALT. There were no remarkable changes in weights of spleen or thymus, in clinical chemistry, or in hematology, including no changes in lymphocytes. The exposure AUC was 43–54 μg·h/mL at 10 mg/kg, and 670–820 μg·h/mL at 100 mg/kg, and was the same at day 2 and at day 14.</div><div class="NLM_p">Because of the paucity of pharmacology data around S1P<sub>5</sub>, we profiled <b>29</b> in a panel of 41 multiplexed in vivo screening assays at Melior Discovery.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> This panel was designed to efficiently query many biological systems and should be interpreted as hypothesis-generating, not as “gold-standard” versions of these assays. <b>29</b> was dosed in CD1 mice at 0.3, 3, and 30 mg/kg, qd, po. <b>29</b> roughly doubled food intake over a 4 day observation period but did not result in any change in body weight compared to vehicle (data not shown). Effects were smallest at the mid-dose. Additional hits that did not achieve significance and/or a dose response include (a) anticonvulsant activity in response to pentylenetetrazole challenge, (b) a decrease in MCP-1 following pulmonary antigen challenge, and (c) an increase in urination frequency (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). No additional hits were found in the other 36 end points evaluated. S1P<sub>5</sub> agonism does not appear to have pleiotropic effects.</div><div class="NLM_p">S1P<sub>5</sub> is highly expressed in brain endothelium, and its activation has been shown to enhance barrier function in an in vitro model of blood–brain barrier integrity. We confirmed this role for S1P<sub>5</sub> by showing that <b>29</b> increases electrical resistance of hCMEC/D3 cells in vitro at 1 μM (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). This finding confirms previously published data on the impact of S1P<sub>5</sub> agonism on endothelial barrier integrity.</div><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0008.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>29</b> impacts transendothelial electrical resistance as assessed through ECIS in hCMEC/D3 cells; DMSO (<i>n</i> = 4) or 1 μM <b>29</b> (<i>n</i> = 2) was added to the cell layer and resistance (Ω·cm<sup>2</sup>) was assessed over 75 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As S1P<sub>5</sub> is highly expressed in the brain, we explored the impact of S1P<sub>5</sub> activation on a functional read-out, namely reversal of age-related cognitive deficits in male C57BL6J mice. After 21 days of treatment with <b>29</b>, cognitive function was assessed by spontaneous alternation in the T maze, 225 min after the final dose (estimated <i>T</i><sub>max</sub> of the compound). Compound <b>29</b> reversed the cognitive deficits with an exposure of 41.6 ± 2.5 ng/mL (mean + SEM) and 28.3 ± 1.9 ng/g (mean + SEM) (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Further experiments confirmed the pro-cognitive impact of <b>29</b> in a dose-dependent manner and that 0.1 mg/kg is the lowest effective dose.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a></div><figure id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0009.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <b>29</b> reverses age-related cognitive decline as seen in the spontaneous alternation assay in the T-maze in aged male C57BL6J mice after subacute treatment. <b>29</b> (0.1 mg/kg) was administered for 21 days, qd. Testing was performed 225 min after the final dose. One-way ANOVA: ** <i>p</i> < 0.05 in comparison to young vehicle-treated animals, <sup>∧ </sup><i>p</i> < 0.05 in comparison to aged vehicle-treated animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Azetine-3-carboxylic acid was recognized as a bioisostere for the synthetically challenging phosphorylated cyclopentyl amino alcohol. This enabled the application of parallel synthesis at AbbVie’s centralized High Throughput Chemistry Group to rapidly secure the desired compounds. Diligent data mining of these compounds led to the discovery of the first S1P<sub>5</sub> agonists that are clearly selective within the S1P receptor family. These leads were optimized further using parallel synthesis and dedicated synthesis, affording a comprehensive pharmacophore for S1P<sub>5</sub> potency and selectivity. Multiple leads with excellent oral exposure were identified with A-971432 (<b>29</b>) selected for extensive evaluation. It was confirmed with <b>29</b> that the in vitro selectivity against S1P<sub>1</sub> and S1P<sub>3</sub> translated to a lack of lymphopenia and bradycardia, respectively, in rats. <b>29</b> was then shown to have highly favorable properties in both kinase and receptor liability panels, Cyp inhibition assays, AMES test, micronucleus test, rat cardiovascular safety, 14-day rat tolerability, and the Melior Discovery panel of 41 in vivo end points. Finally, it was demonstrated that <b>29</b> enhanced brain endothelial integrity, and previously presented data showed an impact on age-related cognitive decline and lipid accumulation in the central nervous system.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> We will show in subsequent publications that <b>29</b> is highly efficacious in preclinical models of neurodegenerative diseases.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound <b>29</b> is available through an MTA for research purposes.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74767" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74767" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The general synthetic methods used in each general procedure follow and include an illustration of a compound that was synthesized using the designated general procedure. Compounds of the present invention were synthesized and their activity assayed as described below. Unless otherwise stated, reagents were purchased from Sigma-Aldrich, Acros, Alfa Aesar, or the Sigma-Aldrich Custom Packaged Reagent service. Reagent/reactant names given are as named on the commercial bottle or as generated by IUPAC conventions or CambridgeSoft ChemDraw Ultra 9.0.7. Compound names are generated by IUPAC conventions or CambridgeSoft ChemDraw Ultra 9.0.7.</div><div class="NLM_p">Analytical data is included within the procedures below, in the illustrations of the general procedures, or in the tables of examples. Unless otherwise stated, all <sup>1</sup>H and <sup>13</sup>C NMR data were collected on a Varian Mercury Plus 400 MHz or a Bruker AVIII 300 MHz or a Bruker 500 MHz instrument; chemical shifts are quoted in parts per million (ppm). HPLC analytical data are either detailed within the experimental or referenced to the table of LCMS and HPLC conditions, using the lower case letter in Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>.</div><div class="NLM_table-wrap" id="tbl15"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 15. List of HPLC Methods</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">method</th><th class="colsep0 rowsep0" align="center">HPLC conditions</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">a</td><td class="colsep0 rowsep0" align="left">Analytical LCMS was performed on a Waters ZMD mass spectrometer and Alliance HPLC system running MassLynx 3.4 and Openlynx 3.4 software. The ZMD mass spectrometer was operated under positive APCI ionization conditions. The HPLC system comprised a Waters 2795 autosampler sampling from 96-well plates, a Waters 996 diode-array detector, and Sedere Sedex-75 evaporative light scattering detector. The column used was a Phenomenex Luna Combi-HTS C8(2) 5 μm 100 Å (2.1 mm × 30 mm). A gradient of 10–100% acetonitrile (A) and 0.1% trifluoroacetic acid in water (B) was used, at a flow rate of 2.0 mL/min (0–0.1 min 10% A, 0.1–2.6 min 10–100% A, 2.6–2.9 min 100% A, 2.9–3.0 min 100–10% A. 0.5 min postrun delay.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">b</td><td class="colsep0 rowsep0" align="left">Analytical LCMS was performed on either a Waters LCT Premier mass spectrometer and 1525 binary HPLC pump running MassLynx 4.0 and OpenLynx 4.0 software or a Waters Quattro Ultima mass spectrometer and Agilent 1100 HPLC system controlled by MassLynx 4.0 and OpenLynx 4.0 software. The gradient was 5–60% B in 1.5 min then 60–95% B to 2.5 min with a hold at 95% B for 1.2 min (1.3 mL/min flow rate). Mobile phase A was 10 mM ammonium acetate, mobile phase B was HPLC grade acetonitrile. The column used for the chromatography is a 4.6 mm × 50 mm MAC-MOD Halo C8 column (2.7 μm particles). Detection methods are DAD and ELSD detection as well as positive/negative electrospray ionization.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c</td><td class="colsep0 rowsep0" align="left">Analytical LCMS was performed on Agilent 1200 HPLC/6100 SQ system. Mobile Phase: A, water (0.05% TFA); B, acetonitrile (0.05% TFA). Gradient phase: 5% −95% in 1.3 min; flow rate, 1.6 mL/min. Column: XBridge, 2.5 min. Oven temp 50 °C.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">d</td><td class="colsep0 rowsep0" align="left">Analytical LCMS was performed on a Waters ZMD mass spectrometer and Alliance HPLC system running MassLynx 3.4 and Openlynx 3.4 software. The ZMD mass spectrometer was operated under positive APCI ionization conditions. The HPLC system comprised a Waters 2795 autosampler sampling from 96-well plates, a Waters 996 diode-array detector, and Sedere Sedex-75 evaporative light scattering detector. The gradient was 5–60% B in 1.5 min then 60–95% B to 2.5 min with a hold at 95% B for 1.2 min (1.3 mL/min flow rate). Mobile phase A was 10 mM ammonium acetate, mobile phase B was HPLC grade acetonitrile. The column used for the chromatography is a 4.6 mm × 50 mm MAC-MOD Halo C18 column (2.7 μm particles). Detection methods are diode array (DAD) and evaporative light scattering (ELSD) detection as well as positive/negative electrospray ionization.</td></tr></tbody></table></div></div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-(4-(Hexyloxy)benzyl)azetidine-3-carboxylic Acid (<b>8</b>)</h3><div class="NLM_p last">A mixture of 4-(hexyloxy)benzaldehyde (1950 mg, 9.45 mmol), methanol (20 mL), and AcOH (6 drops) was stirred at ambient temperature for 3 days. The solvent was removed under reduced pressure and the residue dissolved in methanol (20 mL). The resulting solution was divided in to 12 × 2 mL fractions and subjected to purification molecular ion directed prep-HPLC. The combined fractions were evaporated to dryness and dried in vacuo at 60 °C for 4 h. This afforded 1-(4-(hexyloxy)benzyl)azetidine-3-carboxylic acid (683 mg, 2.34 mmol, 24.8% yield) as an off-white solid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method d). <i>R</i><sub>t</sub> = 1.96 min. MS <i>m</i>/<i>z</i>: 292.16 (M + H)<sup>+</sup>. Purity 100%. <sup>1</sup>H NMR (400 MHz, DMSO) δ ppm 6.85–6.80 (m, 2H), 7.17–7.11 (m, 2H), 3.91 (t, <i>J</i> = 6.52 Hz, 2H), 3.43 (s, 2H), 3.29 (t, <i>J</i> = 7.61 Hz, 2H), 3.10 (t, <i>J</i> = 7.20 Hz, 2H), 2.99 (t, <i>J</i> = 7.34 Hz, 1H), 1.75–1.62 (m, 2H), 1.47–1.23 (m, 6H), 0.87 (ddd, <i>J</i> = 7.14, 3.25, 1.55 Hz, 3H). HRMS: found, 291.1835 C<sub>17</sub>H<sub>25</sub>NO<sub>3</sub> requires 291.1834.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Compound <b>4</b>–<b>7</b> and <b>9</b>–<b>35</b></h3><div class="NLM_p last">Compounds were synthesized in a similar manner using the appropriate commercially available aldehyde and azetidine-3-carboxylic acid unless otherwise stated following this general procedure. In a 20 mL vial, a solution of the aldehyde monomer (1.2 equiv) dissolved in dichloromethane (1.1 mL) was added, followed by the addition of azetidine-3-carboxylic acid (29 mg, 1eq ) dissolved in dichloromethane (0.4 mL), followed by acetic acid (3 equiv) dissolved in dichloromethane (0.4 mL), followed by MP-cyanoborohydride resin (3 equiv) The mixture was shaken at room temperature for 5 h. The reaction was checked by LCMS and concentrated to dryness. The residue was dissolved in 1:1 DMSO:MeOH and purified by preparative HPLC on a Phenomenex Luna C8(2) 5 μm 100 Å AXIA column (30 mm × 75 mm). A gradient of acetonitrile (A) and 0.1% trifluoroacetic acid in water (B) was used at a flow rate of 50 mL/min (0–0.5 min 10% A, 0.5–6.0 min linear gradient 10–100% A, 6.0–7.0 min 100% A, 7.0–8.0 min linear gradient 100–10% A). Samples were injected in 1.5 mL of DMSO:MeOH (1:1). An Agilent 1100 series purification system was used, consisting of the following modules: Agilent 1100 series LCMSD SL mass spectrometer with API-electrospray source, two Agilent 1100 series preparative pumps, Agilent 1100 series isocratic pump, Agilent 1100 series diode array detector with preparative (0.3 mm) flow cell, Agilent active-splitter, and IFC-PAL fraction collector/autosampler. The makeup pump for the mass spectrometer used 3:1 methanol:water with 0.1% formic acid at a flow rate of 1 mL/min. Fraction collection was automatically triggered when the extracted ion chromatogram for the target mass exceeded the threshold specified in the method. The system was controlled using Agilent Chemstation (Rev B.10.03), Agilent A2Prep, and Leap FractPal software, with custom Chemstation macros for data export. Products were characterized by MS and LCMS (<a class="ref internalNav" href="#tbl15" aria-label="Table 15">Table 15</a>, method a).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-(4-(Decyloxy)benzyl)azetidine-3-carboxylic Acid (<b>4</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(decyloxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method d) <i>R</i><sub>t</sub> = 2.36 min. MS <i>m</i>/<i>z</i>: 348.2. (M + H)<sup>+</sup>. Purity 100%. <sup>1</sup>H NMR (400 MHz, pyridine) δ ppm 7.35 (d, <i>J</i> = 8.65 Hz, 2H), 7.03–6.98 (m, 2H), 3.89 (t, <i>J</i> = 6.49 Hz, 3H), 3.64–3.42 (m, 7H), 1.69 (dd, <i>J</i> = 8.29, 6.78 Hz, 3H), 1.38 (s, 3H), 1.29–1.11 (m, 14H), 0.82 (dd, <i>J</i> = 7.79, 5.99 Hz, 4H). HRMS: found, 347.2457 C<sub>21</sub>H<sub>33</sub>NO<sub>3</sub> requires 347.2460.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(4-(Nonyloxy)benzyl)azetidine-3-carboxylic Acid (<b>5</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(nonyloxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method d). <i>R</i><sub>t</sub> = 2.48 min. MS <i>m</i>/<i>z</i>: 334.3 (M + H)<sup>+</sup>. Purity 99%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36–7.30 (m, 2H), 6.91–6.84 (m, 2H), 4.16 (t, <i>J</i> = 8.0 Hz, 2H), 4.11 (s, 2H), 3.99 (t, <i>J</i> = 9.6 Hz, 2H), 3.93 (t, <i>J</i> = 6.5 Hz, 2H), 3.44–3.31 (m, 1H), 2.05 (s, 3H), 1.81–1.69 (m, 2H), 1.41 (d, <i>J</i> = 7.1 Hz, 2H), 1.33–1.19 (m, 8H), 0.92–0.83 (m, 3H). HRMS: found, 333.2304 C<sub>20</sub>H<sub>31</sub>NO<sub>3</sub> requires 333.2304.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(4-(Octyloxy)benzyl)azetidine-3-carboxylic Acid (<b>6</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(octyloxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method d) <i>R</i><sub>t</sub> = 2.00 min. MS <i>m</i>/<i>z</i>: 320.2 (M + H)<sup>+</sup>. Purity 96%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.36 (d, <i>J</i> = 8.65 Hz, 2H), 6.89 (d, <i>J</i> = 8.68 Hz, 2H), 3.46–3.26 (m, 1H), 1.78 (dd, <i>J</i> = 14.69, 6.73 Hz, 2H), 1.55–1.41 (m, 2H), 1.34 (ddd, <i>J</i> = 14.64, 10.47, 2.94 Hz, 8H), 0.91 (t, <i>J</i> = 6.92 Hz, 3H), 4.11 (s, 4H), 4.07–3.87 (m, 4H). HRMS: found, 319.2147 C<sub>19</sub>H<sub>29</sub>NO<sub>3</sub> requires 319.2147.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-(4-(Heptyloxy)benzyl)azetidine-3-carboxylic Acid (<b>7</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(heptyloxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method d). <i>R</i><sub>t</sub> = 2.07 min. MS <i>m</i>/<i>z</i>: 306.3 (M + H)<sup>+</sup>. Purity 100%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37–7.31 (m, 2H), 6.91–6.84 (m, 2H), 4.17 (d, <i>J</i> = 7.7 Hz, 2H), 4.10 (s, 2H), 4.02–3.88 (m, 4H), 2.07 (s, 2H), 1.77 (dt, <i>J</i> = 14.5, 6.7 Hz, 2H), 1.43 (td, <i>J</i> = 9.7, 8.6, 4.5 Hz, 2H), 1.38–1.23 (m, 6H), 0.95–0.84 (m, 3H). HRMS: found, 305.1991 C<sub>18</sub>H<sub>27</sub>NO<sub>3</sub> requires 305.1991.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-(4-(Pentyloxy)benzyl)azetidine-3-carboxylic Acid (<b>9</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(pentyloxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.36 min. MS <i>m</i>/<i>z</i>: 278.1 (M + H)<sup>+</sup>. Purity 100%. HRMS: found, 277.1678 C<sub>16</sub>H<sub>23</sub>NO<sub>3</sub> requires 277.1678.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-(4-(Isopentyloxy)benzyl)azetidine-3-carboxylic Acid (<b>10</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(isopentyloxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.22 min. MS <i>m</i>/<i>z</i>: 278 (M + H)<sup>+</sup>. Purity 100%. HRMS: found, 277.1698 C<sub>16</sub>H<sub>23</sub>NO<sub>3</sub> requires 277.1678.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-(4-(Hexyloxy)benzyl)pyrrolidine-3-carboxylic Acid (<b>11</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(hexyloxy)benzaldehyde and pyrrolidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.35 min. MS <i>m</i>/<i>z</i>: 306.4 (M + H)<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>R</i>)-1-(4-(Hexyloxy)benzyl)pyrrolidine-3-carboxylic Acid (<b>12</b>)</h3><div class="NLM_p last">Synthesized from 4-(hexyloxy)benzaldehyde and (<i>R</i>)-pyrrolidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.35 min. MS <i>m</i>/<i>z</i>: 306.4 (M + H)<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>R</i>)-1-(4-(Hexyloxy)benzyl)piperidine-3-carboxylic Acid (<b>13</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(hexyloxy)benzaldehyde and (<i>R</i>)-piperidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.37 min. MS <i>m</i>/<i>z</i>: 320.5 (M + H)<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-1-(4-(Hexyloxy)benzyl)piperidine-3-carboxylic Acid (<b>14</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(hexyloxy)benzaldehyde and (<i>S</i>)-piperidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.36 min. MS <i>m</i>/<i>z</i>: 320.4 (M + H)<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(4-(Hexyloxy)benzyl)piperidine-4-carboxylic Acid (<b>15</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(hexyloxy)benzaldehyde and piperidine-4-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.35 min. MS <i>m</i>/<i>z</i>: 320.4 (M + H)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(4-(Hexyloxy)benzyl)-3-methylpiperidine-4-carboxylic Acid (<b>16</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(hexyloxy)benzaldehyde 3-methylpiperidine-4-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.40 min. MS <i>m</i>/<i>z</i>: 334.4 (M + H)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-((3′,4′-Dichloro-[1,1′-biphenyl]-4-yl)methyl)azetidine-3-carboxylic Acid (<b>17</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 3′,4′-dichloro-[1,1′-biphenyl]-4-carbaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.45 min. MS <i>m</i>/<i>z</i>: 336 (M + H)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-((4′-Methyl-[1,1′-biphenyl]-4-yl)methyl)azetidine-3-carboxylic Acid (<b>18</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4′-methyl-[1,1′-biphenyl]-4-carbaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.35 min. MS <i>m</i>/<i>z</i>: 282 (M + H)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-((4′-Ethyl-[1,1′-biphenyl]-4-yl)methyl)azetidine-3-carboxylic Acid (<b>19</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4′-methyl-[1,1′-biphenyl]-4-carbaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.34 min. MS <i>m</i>/<i>z</i>: 296 (M + H)<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-((3′-(Trifluoromethyl)-[1,1′-biphenyl]-4-yl)methyl)azetidine-3-carboxylic Acid (<b>20</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 3′-(trifluoromethyl)-[1,1′-biphenyl]-4-carbaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.26 min. MS <i>m</i>/<i>z</i>: 336 (M + H)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 1-((3′,5′-Dichloro-[1,1′-biphenyl]-4-yl)methyl)azetidine-3-carboxylic Acid (<b>21</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 3′,5′-dichloro-[1,1′-biphenyl]-4-carbaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.40 min. MS <i>m</i>/<i>z</i>: 336 (M + H)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(4-(4-Chlorophenoxy)benzyl)azetidine-3-carboxylic Acid (<b>22</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(4-chlorophenoxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.27 min. MS <i>m</i>/<i>z</i>: 318 (M + H)<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-(4-(Benzyloxy)benzyl)azetidine-3-carboxylic Acid (<b>23</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(benzyloxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.16 min. MS <i>m</i>/<i>z</i>: 298 (M + H)<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(4-((2-Methylbenzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>24</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((2-methylbenzyl)oxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.30 min. MS <i>m</i>/<i>z</i>: 310 (M + H)<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(4-((3-Chlorobenzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>25</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((3-chlorobenzyl)oxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.22 min. MS <i>m</i>/<i>z</i>: 332 (M + H)<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-(4-((3-(Trifluoromethyl)benzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>26</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((3-(trifluoromethyl)benzyl)oxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.28 min. MS <i>m</i>/<i>z</i>: 366 (M + H)<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(4-((4-Fluorobenzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>27</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((4-fluorobenzyl)oxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.25 min. MS <i>m</i>/<i>z</i>: 316 (M + H)<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-(4-((2,4-Dichlorobenzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>28</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((2,4-dichlorobenzyl)oxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.41 min. MS <i>m</i>/<i>z</i>: 364 (M + H)<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-(4-((3,4-Dichlorobenzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>29</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((3,4-dichlorobenzyl)oxy)benzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.37 min. MS <i>m</i>/<i>z</i>: 366 (M + H)<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-(4-(Benzyloxy)-2-methylbenzyl)azetidine-3-carboxylic Acid (<b>30</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(benzyloxy)-2-methylbenzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.32 min. MS <i>m</i>/<i>z</i>: 312 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.45–7.43 (2H, d), 7.40–7.37 (2H, t), 7.34–7.31 (2H, t), 6.98 (1H, s), 6.94–6.92 (1H, q), 5.12 (2H, s), 4.42 (2H, s), 4.35–4.29 (4H, m), 3.73–3.66 (1H, m), 2.42 (3H, s).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-(4-(Benzyloxy)-2-chlorobenzyl)azetidine-3-carboxylic Acid (<b>31</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-(benzyloxy)-2-chlorobenzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.01 min. MS <i>m</i>/<i>z</i>: 332 (M + H)<sup>+</sup>. Purity 99%. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.51–7.49 (1H, d), 7.46–7.44 (2H, d), 7.41–7.38 (2H, q), 7.35–7.32 (1H, q), 7.21–7.20 (1H, d), 7.08–7.06 (1H, q), 5.15 (2H, s), 4.45 (2H, s), 4.22–4.18 (4H, m), 3.46–3.41 (1H, m). HRMS: found, 331.0974 C<sub>18</sub>H<sub>18</sub>NO<sub>3</sub>Cl requires 331.0975.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-(4-((2,4-Dichlorobenzyl)oxy)-3-methoxybenzyl)azetidine-3-carboxylic Acid (<b>32</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((2,4-dichlorobenzyl)oxy)-3-methoxybenzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.27 min. MS <i>m</i>/<i>z</i>: 396 (M + H)<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-(4-((3,4-Dichlorobenzyl)oxy)-3-nitrobenzyl)azetidine-3-carboxylic Acid (<b>33</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((3,4-dichlorobenzyl)oxy)-3-nitrobenzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.35 min. MS <i>m</i>/<i>z</i>: 411 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 7.77 (d, <i>J</i> = 2.1, 1H), 7.65 (d, <i>J</i> = 1.9, 1H), 7.56 (d, <i>J</i> = 8.3, 1H), 7.51 (dd, <i>J</i> = 2.2, 8.6, 1H), 7.44–7.36 (m, 1H), 7.21 (d, <i>J</i> = 8.6, 1H), 5.20 (s, 2H), 3.59 (s, 2H), 3.45 (t, <i>J</i> = 7.6, 2H), 3.30 (t, <i>J</i> = 6.7, 2H), 3.24 (dd, <i>J</i> = 7.2, 13.9, 1H).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-(4-((2-Chlorobenzyl)oxy)-3-methoxybenzyl)azetidine-3-carboxylic Acid (<b>34</b>)</h3><div class="NLM_p last">Synthesized from aldehyde 4-((2-chlorobenzyl)oxy)-3-methoxybenzaldehyde. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method a) <i>R</i><sub>t</sub> = 1.27 min. MS <i>m</i>/<i>z</i>: 360 (M + H)<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 4-(1,3-Dioxolan-2-yl)benzonitrile (<b>36</b>)</h3><div class="NLM_p last">A mixture of 4-formylbenzonitrile <b>35</b> (13.1 g, 0.1 mol), ethylene glycol (62 g, 1 mol), and <i>p</i>-toluenesulfonic acid monohydrate (1.9 g, 0.01 mol) in 150 mL of toluene were refluxed overnight. After cooling the mixture to room temperature, it was added to 200 mL of ice-cold water and stirred for 15 min. The organic layer was dried over with Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed in vacuo. Purification on silica-gel column chromatography (PE/EA from 10:1 to 4:1) afforded 4-(1,3-dioxolan-2-yl)benzonitrile <b>36</b> as a white solid (14.2 g, yield 81%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 0.66 min; <i>m</i>/<i>z</i> 176.7 (M + H)<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 4-(2-Phenylacetyl)benzaldehyde</h3><div class="NLM_p last">Under N<sub>2</sub>, to magnesium turnings (792 mg, 32.98 mmol) and I<sub>2</sub> (7 mg) in Et<sub>2</sub>O (5 mL) was added a solution of (bromomethyl) benzene (3.76 g, 21.99 mmol) at room temperature. After stirring for 1 h, the mixture was cooled to 0–15 °C. A solution of 4-(1,3-dioxolan-2-yl)benzonitrile <b>38</b> (2.89 g, 16.5 mmol) in Et<sub>2</sub>O (10 mL) was added dropwise, then refluxed for 1 h. The solution was cooled to room temperature and treated with ice–water. Subsequently, aqueous 5 M HCl was added, whereby two clear phases were formed. Then the organic phase was separated and the aqueous phase was extracted with EtOAc. The combined organic phase was washed with satd NaHSO<sub>3</sub> and satd NaHCO<sub>3</sub>, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo to get the crude 1-(4-(1,3-dioxolan-2-yl)phenyl)-2-phenylethanone. The crude 1-(4-(1,3-dioxolan-2-yl)phenyl)-2-phenylethanone was dissolved in THF (20 mL) and 10% HCl (30 mL) added to the solution. The reaction mixture was refluxed for 16 h then cooled to room temperature. EtOAc was added and the organic layer was (Na<sub>2</sub>SO<sub>4</sub>). After removal of solvent, it was purified by silica-gel column chromatography (PE/EA from 50:1 to 10:1) to afford 4-(2-phenylacetyl)benzaldehyde as a white solid (1.1 g, yield 43%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.57 min; <i>m</i>/<i>z</i> 225.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 1-(4-(2-Phenylacetyl)benzyl)azetidine-3-carboxylic Acid (<b>41</b>)</h3><div class="NLM_p last">4-(2-Phenylacetyl)benzaldehyde (133 mg, 0.59 mmol) was added to a stirred solution of azetidine-3-carboxylic acid (60 mg, 0.59 mmol) and HOAc (107 mg, 1.78 mmol) in 10 mL of MeOH. The mixture was heated to 40 °C. After 15 min, NaCNBH<sub>3</sub> (110 mg, 1.78 mmol) was added in a single portion and stirred at 40 °C overnight. After acidifying with 1 M HCl, purification by prep-HPLC afforded 1-(4-(2-phenylacetyl)benzyl)pyrrolidine-3-carboxylic acid (38.7, yield 21%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.23 min; <i>m</i>/<i>z</i> 310.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.16–8.14 (2H, d), 7.61–7.59 (2H, d), 7.32–7.24 (5H, m), 4.51–4.50 (2H, s), 4.39–4.36 (4H, m), and 4.35–4.33 (2H, m).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-(4-Phenethylbenzyl)azetidine-3-carboxylic Acid (<b>42</b>)</h3><div class="NLM_p last">1-(4-(2-Phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>41</b> (200 mg, 0.65 mmol)was dissolved in 1% (V/V) H<sub>2</sub>SO<sub>4</sub>/EtOH (50 mL), to which Pd/C (10 mg) was added and the hydrogenation reaction carried out at room temperature for 32 h. After completion of the reaction, the catalyst was filtered off and ethanol solution neutralized with NaOH, followed by distillation of the solvent. HPLC afforded 1-(4-phenethylbenzyl)azetidine-3-carboxylic acid (100 mg, 52%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.35 min; <i>m</i>/<i>z</i> 296.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.24–7.23 (2H, d), 7.18–7.16 (2H, d), 7.13–7.10 (2H, t), 7.05–7.03 (2H, t), 7.02 (1H, s), 4.25 (2H, s), 4.19–4.18 (2H, m), 4.17–4.15 (2H, m), 3.22–3.20 (1H, m), 2.87–2.84 (2H, m), and 2.82–2.79 (2H, m).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-(4-(3-(Trifluoromethyl)phenethyl)benzyl)azetidine-3-carboxylic Acid (<b>43</b>)</h3><div class="NLM_p last">1-(4-(3-(Trifluoromethyl)phenethyl)benzyl)azetidine-3-carboxylic acid was synthesized using the same procedure as 1-(4-phenethylbenzyl)azetidine-3-carboxylic acid starting from 1-(bromomethyl)-3-(trifluoromethyl)benzene. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 0.63 min; <i>m</i>/<i>z</i> 364.2 (M + H)<sup>+</sup>. Purity 96%. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.35–7.28 (4H, m), 7.09–7.08 (2H, d), 7.02–7.00 (2H, d), 3.49 (2H, s), 3.43–3.40 (2H, t), 3.25–3.23 (2H, d), 3.12–3.06 (1H, m), 2.90–2.87 (2H, t) and 2.83–2.79 (2H, t). HRMS: found, 363.1444 C<sub>20</sub>H<sub>20</sub>NO<sub>2</sub>F<sub>3</sub> requires 363.1446.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-(4-Hexanoylbenzyl)azetidine-3-carboxylic Acid (<b>44</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(2-phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>51</b> using 1-bromopentane. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.32 min; <i>m</i>/<i>z</i> 290.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.07–8.05 (2H, d), 7.59–7.57 (2H, d), 4.37 (2H, s), 4.16–4.14 (4H, m), 3.43–3.40 (1H, m), 3.06–3.03 (2H, t), 1.76–1.70 (2H, m), 1.40–1.35 (4H, m), and 0.96–0.93 (3H, t).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-(4-Hexanoylbenzyl)pyrrolidine-3-carboxylic Acid (<b>45</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(2-phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>51</b> using 1-bromopentane and pyrrolidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.32 min; <i>m</i>/<i>z</i> 304.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.06–8.04 (2H, d), 7.66–7.64 (2H, d), 4.38–4.31 (2H, q), 3.48–3.46 (1H, m), 3.33–3.31 (2H, m), 3.25–3.08 (2H, m), 3.06–3.03 (2H, t), 2.32–2.26 (2H, m), 1.74–1.70 (2H, m), 1.40–1.37 (4H, m), and 0.96–0.93 (3H, t).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-(4-Heptanoylbenzyl)azetidine-3-carboxylic Acid (<b>46</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(2-phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>51</b> using 1-bromohexane. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.39 min; <i>m</i>/<i>z</i> 304.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.08–8.06 (2H, d), 7.59–7.58 (2H, d), 4.38 (2H, s), 4.18–4.12 (4H, m), 3.45–3.40 (1H, m), 3.06–3.03 (2H, t), 1.75–1.70 (2H, m), 1.42–1.31 (6H, m), and 0.94–0.92 (3H, t).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-(4-Heptanoylbenzyl)pyrrolidine-3-carboxylic Acid (<b>47</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(2-phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>53</b> using 1-bromohexane and pyrrolidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.40 min; <i>m</i>/<i>z</i> 318.3 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.04–8.02 (2H, d), 7.67–7.65 (2H, d), 4.39–4.33 (2H, q), 3.49 (1H, s), 3.37–3.32 (2H, m), 3.27–3.23 (2H, m), 3.04–3.01 (2H, t), 2.37–2.23 (2H, m), 1.73–1.67 (2H, m), 1.44–1.37 (2H, m), 1.36–1.31 (4H, m), and 0.93–0.90 (3H, t).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1-(4-(2-Phenylacetyl)benzyl)pyrrolidine-3-carboxylic Acid (<b>49</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(2-phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>53</b> using pyrrolidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.24 min; <i>m</i>/<i>z</i> 324.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.17–8.15 (2H, d), 7.68–7.66 (2H, d), 7.34–7.30 (2H, t), 7.29–7.27 (2H, d), 7.26–7.22 (2H, t), 4.53–4.47 (2H, t), 4.38 (2H, s), 3.77–3.76 (6H, m), 2.45–2.34 (2H, d).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1-(4-(2-(3,4-Dichlorophenyl)acetyl)benzyl)azetidine-3-carboxylic Acid (<b>50</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(2-phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>51</b> using 4-(bromomethyl)-1,2-dichlorobenzene. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.39 min; <i>m</i>/<i>z</i> 378.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.05–8.03 (2H, d), 7.53–7.51 (2H, d), 7.37–7.36 (2H, d), 7.10–7.08 (1H, m), 4.40 (2H, s), 4.31 (2H, s), 4.27–4.22 (4H, m), 3.62–3.59 (1H, m).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1-(4-(2-(3,4-Dichlorophenyl)acetyl)benzyl)pyrrolidine-3-carboxylic Acid (<b>51</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(2-phenylacetyl)benzyl)azetidine-3-carboxylic acid <b>51</b> using 4-(bromomethyl)-1,2-dichlorobenzeneand pyrrolidine-3-carboxylic acid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.40 min; <i>m</i>/<i>z</i> 392.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.14–8.13 (2H, d), 7.66–7.65 (2H, d), 7.48–7.47 (2H, m), 7.23–7.21 (1H, q), 4.36–4.28 (2H, q), 3.42–3.41 (1H, m), 3.30–3.11 (4H, m), 2.32–2.24 (2H, m).</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 4-(Benzyloxy)-3-fluorobenzonitrile</h3><div class="NLM_p last">Under N<sub>2</sub>, DIAD (0.32 g, 1.54 mmol) was treated with Ph<sub>3</sub>P (0.41 g, 4.54 mmol) at 0 °C in dry THF (10 mL). The mixture was stirred until there was a precipitate. Then 3-fluoro-4-hydroxybenzonitrile (0.2 g, 1.46 mmol) and benzyl alcohol (0.17 g, 1.54 mmol) were added at the same time. The mixture was warmed to room temperature and stirred overnight. The reaction mixture was concentrated and purified by silica-gel column chromatography (PE/EA = 4:1) to afford 4-(benzyloxy)-3-fluorobenzonitrile as a white solid (0.28 g, yield 84%). GC-MS RT 10.83 min; <i>m</i>/<i>z</i> 227.1 (M).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 4-(Benzyloxy)-3-fluorobenzaldehyde</h3><div class="NLM_p last">4-(Benzyloxy)-3-fluorobenzonitrile (645 mg,2.84 mmol) was dissolved in toluene (10 mL) and cooled to 0 °C. A portion of 1 M DIBAL (4.55 mmol, 4.55 mL) in hexane was added dropwise under N<sub>2</sub>. The solution was further stirred for 1 h at 0 °C. Chloroform (12 mL) was then added followed by 10% HCl (30 mL), and the resulting solution stirred at room temperature for 1 h. The organic layer was separated, washed with distilled water, dried with Na<sub>2</sub>SO<sub>4</sub>, and filtered. After removal of the solvent, the residue was purified by silica-gel column chromatography (PE/EA = 4:1) to afford 4-(benzyloxy)-3-fluorobenzaldehyde as a white solid (0.62 g, yield 95%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.26 min; <i>m</i>/<i>z</i> 231.1 (M + H)<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 1-(4-(Benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic Acid (<b>57</b>)</h3><div class="NLM_p last">4-(Benzyloxy)-3-fluorobenzaldehyde (653 mg, 2.84 mmol) was added to a stirred solution of azetidine-3-carboxylic acid (287 mg, 2.84 mmol) and HOAc (536 mg, 8.52 mmol) in 5 mL of MeOH. The mixture was heated to 40 °C. After 15 min, NaCNBH<sub>3</sub> (512 mg, 8.52 mmol) was added in a single portion and stirred at 40 °C overnight. After acidifying with 1 M HCl, the residue was purified by Prep-HPLC, affording 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid (571 mg, yield 63%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 0.95 min; <i>m</i>/<i>z</i> 316.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.44–7.43 (2H, d), 7.39–7.36 (2H, m), 7.33–7.30 (1H, m), 7.28–7.25 (1H, m), 7.23–7.22 (1H, d), 7.20–7.18 (1H, m), 5.19 (2H, s), 4.32 (2H, s), 4.29–4.25 (4H, m), and 3.68–3.63 (1H, m).</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-(4-((3,4-Dichlorobenzyl)oxy)-2-fluorobenzyl)azetidine-3-carboxylic Acid (<b>58</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid <b>60</b> using 4-(bromomethyl)-1,2-dichlorobenzene and 2-fluoro-4-hydroxybenzonitrile. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.10 min; <i>m</i>/<i>z</i> 384.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.52 (1H, s), 7.45–7.44 (1H, d), 7.36–7.32 (1H, t), 7.29–7.27 (1H, d), 6.87–6.84 (2H, q), 5.04 (2H, s), 4.33 (2H, s), 4.27–4.20 (4H, m), and 3.59–3.56 (1H, m).</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 1-(4-((3,4-Dichlorobenzyl)oxy)-3-fluorobenzyl)azetidine-3-carboxylic Acid (<b>59</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid <b>60</b> using 4-(bromomethyl)-1,2-dichlorobenzene. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.11 min; <i>m</i>/<i>z</i> 384.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.64 (1H, s), 7.57–7.55 (1H, d), 7.41–7.40 (1H, d), 7.31–7.29 (1H, d), 7.24–7.23 (2H, q), 5.21 (2H, s), 4.31 (2H, s), 4.22–4.21 (4H, d), and 3.50–3.33 (1H, m).</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 1-(2-Fluoro-4-((3-(trifluoromethyl)benzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>60</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid <b>59</b> using 1-(bromomethyl)-3-(trifluoromethyl)benzene and 2-fluoro-4-hydroxybenzonitrile. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.08 min; <i>m</i>/<i>z</i> 384.2 (M + H)<sup>+</sup>. Purity 97%. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.75 (1H, s), 7.72–7.70 (1H, d), 7.65–7.63 (1H, d), 7.60–7.57 (1H, t), 7.45–7.42 (1H, t), 6.98–6.96 (2H, q), 5.22 (2H, s), 4.42 (2H, s), 4.36–4.29 (4H, m) and 3.70–3.63 (1H, m). HRMS: found, 383.1145 C<sub>19</sub>H<sub>17</sub>NO<sub>3</sub>F<sub>4</sub> requires 383.1145.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 1-(3-Fluoro-4-((3-(trifluoromethyl)benzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>61</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid <b>60</b> using 1-(bromomethyl)-3-(trifluoromethyl)benzene. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.08 min; <i>m</i>/<i>z</i> 384.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.76 (1H, s), 7.73–7.71 (1H, d), 7.65–7.64 (1H, d), 7.61–7.58 (1H, t), 7.31–7.28 (1H, m), 7.27–7.25 (1H, d), 7.23–7.21 (1H, m), 5.23 (2H, s), 4.33 (2H, s), 4.30–4.26 (4H, m), and 3.69–3.63 (1H, m).</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 1-(2-Chloro-4-((3-(trifluoromethyl)benzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>62</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid <b>57</b> using 1-(bromomethyl)-3-(trifluoromethyl)benzene and 2-chloro-4-hydroxybenzonitrile. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.12 min; <i>m</i>/<i>z</i> 400.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.66 (1H, s), 7.62–7.61 (1H, d), 7.55–7.53 (1H, d), 7.50–7.47 (1H, t), 7.43–7.42 (1H, d), 7.15–7.14 (1H, d), 7.01–6.98 (1H, q), 5.12 (2H, s), 4.44 (2H, s), 4.30–4.23 (4H, m), and 3.62–3.58 (1H, m).</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 1-(3-Chloro-4-((3-(trifluoromethyl)benzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>63</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(benzyloxy)-3-fluorobenzyl)azetidine-3-carboxylic acid <b>57</b> using 1-(bromomethyl)-3-(trifluoromethyl)benzene and 3-chloro-4-hydroxybenzonitrile. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.12 min; <i>m</i>/<i>z</i> 400.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.82 (1H, s), 7.77–7.76 (1H, d), 7.67–7.65 (1H, d), 7.63–7.60 (2H, q), 7.42–7.40 (1H, q), 7.27–7.26 (1H, d), 5.33 (2H, s), 4.36 (2H, s), 4.33–4.28 (4H, m), and 3.72–3.66 (1H, m).</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 1-Bromo-4-(3,4-dichlorobenzyloxy)-2-methylbenzene</h3><div class="NLM_p last">Under N<sub>2</sub>, DIAD (908 mg, 4.49 mmol) was treated with Ph<sub>3</sub>P (1.18 g, 4.49 mmol) at 0 °C in dry THF (20 mL). The mixture was stirred until there was a precipitate. Then 4-bromo-3-methylphenol (0.8 g g, 4.23 mmol) and 3,4-dicholorobenzyl alcohol (795 mg, 4.49 mmol) were added at the same time. The mixture was warmed to room temperature and stirred overnight. After concentrating, purification by silica-gel column chromatography (PE/EA = 4:1) afforded 1-bromo-4-(3,4-dichlorobenzyloxy)-2-methylbenzene as a white solid (0.94 g, yield 64%). GC-MS: <i>m</i>/<i>z</i> 345.9 (M), RT: 13.96 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): δ 7.52 (1H, s), 7.46–7.44 (1H, d), 7.42–7.40 (1H, d), 7.25–7.23 (1H, q), 6.85–6.84 (1H, d), 6.66–6.64 (1H, q), 4.97 (2H, s), and 2.36 (3H, s).</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 4-(3,4-Dichlorobenzyloxy)-2-methylbenzonitrile</h3><div class="NLM_p last">A mixture of 1-bromo-4-(3,4-dichlorobenzyloxy)-2-methylbenzene (0.94 g, 207 mmol) and CuCN (0.56 g, 6.2 mmol) in <i>N</i>-methyl-2-pyrrolidone (10 mL) was heated to 160 °C for 32 h. After cooling slightly, the warm mixture was washed with 5% NaCN and extracted with ether. The combined extract was washed with 5% NaCN, water, and brine and dried (Na<sub>2</sub>SO<sub>4</sub>). After removal of solvent in vacuo, the residue was purified by silica-gel column chromatography (PE/EA = 10:1) to afford 4-(3,4-dichlorobenzyloxy)-2-methylbenzonitrile as a white solid (496 mg, yield 63%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.46 min; <i>m</i>/<i>z</i> 292.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 4-(4,5-Dichloro-2-methylbenzyloxy)benzaldehyde</h3><div class="NLM_p last">4-(3,4-Dichlorobenzyloxy)-2-methylbenzonitrile (644 mg, 2.2 mmol) was dissolved in toluene (35 mL) and cooled to 0 °C. A portion of 1 M DIBAL (3.5 mmol, 3.5 mL) in hexane was added dropwise under N<sub>2</sub>. The solution was stirred for an hour at 0 °C. CHCl<sub>3</sub> (40 mL) was then added followed by 10% HCl (30 mL), and the solution was stirred at room temperature for 1 h. The organic layer was separated, washed with distilled water, dried (Na<sub>2</sub>SO<sub>4</sub>), and filtered. After removal of the solvent, the residue was purified by silica-gel column chromatography (PE/EA = 4:1) to afford 4-(4,5-dichloro-2-methylbenzyloxy)benzaldehyde as a white solid (345 mg, yield 53%). LCMS (<a class="ref internalNav" href="#tbl15" aria-label="Table 15">Table 15</a>, method c) RT 1.85 min; <i>m</i>/<i>z</i> 295.0 (M + H)<sup>+</sup>.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 1-(2-Methyl-4-((3-(trifluoromethyl)benzyl)oxy)benzyl)azetidine-3-carboxylic Acid (<b>69</b>)</h3><div class="NLM_p last">Prepared using the same procedure as for 1-(4-(3,4-dichlorobenzyloxy)-2-methylbenzyl)azetidine-3-carboxylic acid <b>75</b> using 1-(bromomethyl)-3-(trifluoromethyl)benzene. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.43 min; <i>m</i>/<i>z</i> 380.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.59 (1H, s), 7.56–7.54 (1H, d), 7.48–7.46 (1H, d), 7.44–7.41 (1H, t), 7.19–7.17 (1H, d), 6.82 (1H, d), 6.82–6.76 (1H, q), 5.03 (2H, s), 4.22 (2H, s), 4.06–4.05 (4H, d), 3.30–3.29 (1H, m), and 2.25(3H, s).</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 1-(4-(3,4-Dichlorobenzyloxy)-2-methylbenzyl)azetidine-3-carboxylic Acid (<b>70</b>)</h3><div class="NLM_p last">4-(4,5-Dichloro-2-methylbenzyloxy)benzaldehyde (345 mg, 1.17 mmol) was added to a stirred solution of azetidine-3-carboxylic acid (118 mg, 1.17 mmol) and HOAc (211 mg, 3.51 mmol) in 5 mL of CH<sub>3</sub>OH. The mixture was heated to 40 °C. After 15 min, NaCNBH<sub>3</sub> (218 mg, 3.51 mmol) was added in a single portion and stirred at 40 °C overnight. After being acidified with 1 M HCl prep HPLC afforded 1-(4-(3,4-dichlorobenzyloxy)-2-methylbenzyl)azetidine-3-carboxylic acid <b>75</b> (201 mg, yield 45%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.47 min; <i>m</i>/<i>z</i> 380.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.49–7.48 (1H, d), 7.42–7.40 (1H, d), 7.26–7.24 (1H, q), 7.22–7.20 (2H, d), 6.84–6.83 (1H, d), 6.80–6.78 (1H, q), 4.97 (2H, s), 4.25 (2H, s), 4.09–4.07 (4H, d), 3.35–3.28 (1H, m), and 2.29 (3H, s).</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 4-(1-Phenylethoxy)benzonitrile (<b>73</b>)</h3><div class="NLM_p last">Under N<sub>2</sub>, DIAD (1.06 g, 5.25 mmol) was treated with Ph<sub>3</sub>P (1.38 g, 5.25 mmol) at 0 °C in dry THF (15 mL). The mixture was stirred until there was a precipitate. Then 4-hydroxybenzonitrile <b>77</b> (630 mg, 5.25 mmol) and <span class="smallcaps smallerCapital">dl</span>-1-phenylethanol <b>76</b> (611 mg, 5 mmol) were added at the same time. The mixture was warmed to room temperature and stirred overnight. Concentrated and purified by silica-gel column chromatography (PE/EA from 15:1 to 10:1) to afford 4-(1-phenylethoxy)benzonitrile <b>78</b> as a white solid (0.62 g, yield 55%). GC-MS: <i>m</i>/<i>z</i> 223.1 (M), RT: 11.05 min. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.49–7.47 (2H, d), 7.36–7.32 (4H, q), 7.29–7.27 (2H, d), 5.37–5.33 (1H, q), and 1.67–1.66 (3H, d).</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 4-(1-Phenylethoxy)benzaldehyde (<b>74</b>)</h3><div class="NLM_p last">4-(1-Phenylethoxy)benzonitrile <b>76</b> (200 mg, 0.86 mmol) was dissolved in toluene (10 mL) and cooled to 0 °C. A portion of 1 M DIBAL (1.44 mmol, 1.44 mL) in hexane was added dropwise under N<sub>2</sub>. The solution was stirred for another hour at 0 °C. CHCl<sub>3</sub> (12 mL) was then added followed by 10% HCl (30 mL), and the solution was stirred at room temperature for 1 h. The organic layer was separated, washed with distilled water, dried with Na<sub>2</sub>SO<sub>4</sub>, and filtered. The solvent was almost completely removed. Purified by silica-gel column chromatography (PE/EA = 4:1) to afford 4-(1-phenylethoxy)benzaldehyde <b>77</b> as a white solid (85 mg, yield 42%).</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 1-(4-(1-Phenylethoxy)benzyl)azetidine-3-carboxylic Acid (<b>75</b>)</h3><div class="NLM_p last">4-(1-Phenylethoxy)benzaldehyde <b>74</b> (1.06 g, 4.7 mmol) was added to a stirred solution of azetidine-3-carboxylic acid (476 mg, 4.7 mmol) and HOAc (850 mg, 14.1 mmol) in 5 mL of CH<sub>3</sub>OH. The mixture was heated to 40 °C. After 15 min, NaCNBH<sub>3</sub> (889 mg, 14.1 mmol) was added in a single portion and stirred at 40 °C overnight to get compound 1-(4-(1-phenylethoxy)benzyl)azetidine-3-carboxylic acid (400 mg, yield 27%). LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 1.00 min; <i>m</i>/<i>z</i> 312.1 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>): δ 7.27–7.26 (2H, d), 7.22–7.16 (4H, m), 7.17–7.11 (1H, t), 6.85–6.83 (2H, d), 5.34–5.31 (1H, q), 4.11(2H, s), 4.03–4.02 (4H, d), 4.32–3.25 (1H, m), and 1.51–1.49 (3H, d).</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (<i>R</i>)-1-(4-(1-Phenylethoxy)benzyl)azetidine-3-carboxylic Acid (<b>76</b>)</h3><div class="NLM_p last">(<i>R</i>)-1-(4-(1-Phenylethoxy)benzyl)azetidine-3-carboxylic acid was synthesized using the same procedure as 1-(4-(1-phenylethoxy)benzyl)azetidine-3-carboxylic acid <b>75</b> starting from the chiral material (<i>S</i>)-1-phenylethanol. The configuration conversion ratio for the Mitsunobu step is 86:14(<i>R</i>:<i>S</i>). Purification by prep-chiral-HPLC afforded (<i>S</i>)-1-(4-(1-phenylethoxy)benzyl)azetidine-3-carboxylic acid <b>76</b>. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method c) RT 0.97 min; <i>m</i>/<i>z</i> 312.2 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.39–7.38 (2H, d), 7.34–7.29 (4H, m), 7.26–7.23 (1H, t), 6.98–6.96 (2H, d), 5.47–5.43 (1H, q), 4.26–4.22 (6H, m), 3.66–3.61 (1H, m), and 1.63–1.61 (3H, d). ee value: 95.4.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 4-(3,4-Dichlorobenzyloxy)benzaldehyde (<b>79</b>)</h3><div class="NLM_p last">A 2 L round bottomed flask was charged with 4-hydroxybenzaldehyde <b>78</b> (150 g, 1.22 mol) and potassium carbonate (254.64 g, 1.84 mol) in acetone (1 L) and was added 3,4-dichlorobenzyl chloride <b>77</b> (240 g, 1.22 mol) portionwise. The reaction mixture was then heated to reflux for overnight. The reaction completion was monitored by TLC and then cooled to room temperature. The cooled reaction mixture was then poured into a beaker containing cold water to get precipitate. The solid obtained was filtered, washed with water (2 × 250 mL), and dried. The solid product was then suspended in methanol (1 L) and stirred for 15 min at room temperature. The methanol was filtered off and the solid product dried to yield 272 g (79%) of 4-(3,4-dichlorobenzyloxy)benzaldehyde <b>79</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.85 (s, 1H), 7.90 (d, 2H), 7.78 (s, 1H), 7.69 (d, 1H), 7.43 (m, 1H), 7.2 (d, 2H), and 5.22 (s, 2H).</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 1-(4-(3,4-Dichlorobenzyloxy)benzyl)azetidine-3-carboxylic Acid (<b>29</b>): Large Scale</h3><div class="NLM_p last">A 3 L round bottomed flask was charged with 4-(3, 4-dichlorobenzyloxy)benzaldehyde <b>79</b> (80 g, 0.28 mol) and azetidine-3-carboxylic acid (30.4 g, 0.28 mol) was suspended in methanol (2 L), then acetic acid (8 mL) was added to the reaction mixture and stirred for 1 h. Sodium cyanoborohydride (9.6 g, 0.15 mol) was added portionwise and stirred overnight at room temperature. The completion of the reaction was monitored by TLC. Solid was filtered, washed with methanol (2 × 250 mL), and dried to yield 62 g (60%) of 1-(4-(3,4-dichlorobenzyloxy)benzyl)azetidine-3-carboxylic acid as white solid. LCMS (Table <a class="ref showTableEvent internalNav" data-ID="tbl15" href="#tbl15">15</a>, method b) RT 1.81 min. MS <i>m</i>/<i>z</i>: 366.1 (M + H)<sup>+</sup>. Purity 100%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 500 MHz) δ 3.15 (m, 1H), 3.45 (m, 2H), 3.6 (m, 2H), 3.75 (s, 2H), 5.08 (s, 2H), 6.94 (d, 2H), 7.25 (d, 2H), 7.40 (d, 1H), 7.60 (d, 1H), 7.68 (s, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 33.7, 56.0, 60.8, 67.6, 114.6, 127.7, 129.3, 129.8, 130.3, 130.6, 131.1, 138.3, 157.2, 174.3. IR (KBr pellet) 3421.1, 2923.6, 1612.2, 1512.8, 1248.7 cm<sup>–1</sup>. MP: 165.6–166.1 °C. HRMS: found, 365.0583 C<sub>18</sub>H<sub>17</sub>NO<sub>2</sub>Cl<sub>2</sub> requires 365.0585.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Inhibition of [<sup>33</sup>P]S1P Binding to S1P Receptors</h3><div class="NLM_p last">Radio-ligand binding was carried out using membranes from transiently transfected HEK cells overexpressing S1P<sub>1</sub>, S1P<sub>2</sub>, S1P<sub>3</sub>, S1P<sub>4</sub>, or S1P<sub>5</sub>. All compounds were dissolved in DMSO, and serial dilutions were carried out in DMSO prior to addition to assay buffer. Final assay DMSO concentrations were 1 or 0.5% (v/v). [<sup>33</sup>P]S1P was purchased from PerkinElmer and used at 50 pM in all assays. Frozen membranes were thawed and resuspended in assay buffer containing 50 mM HEPES pH 7.4, 100 mM NaCl, 10 mM MgCl<sub>2</sub>, and 0.1% fatty acid free BSA. Membrane was added to give 5–10 μg of membrane per well. Nonspecific binding was determined in the presence of cold 1 μM S1P. Incubations were carried out at room temperature for 45–60 min, except that S1P2 binding was incubated 90 min at 4 °C. After incubation, samples were filtered onto GF/B or GF/C filtration plates using a Packard 96 well harvester. Plates were dried before adding Microscint to each well, sealed and counted on a Topcount (PerkinElmer). Radioactivity counts are converted to percent activity, with samples containing [<sup>33</sup>P]S1P as zero inhibition and samples containing [<sup>33</sup>P]S1P plus 1 μM S1P as 100% inhibition. IC<sub>50</sub>s were determined by fitting the percent activity data to the equation percent activity = 100% – (100%/(1 + ([inhibitor]/IC<sub>50</sub>))) using nonlinear least-means-squares curve fitting.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> S1P Receptor GTPγS Assays</h3><div class="NLM_p last">The [<sup>35</sup>S]GTPγS binding assay was performed using both scintillation proximity assay and filtration methods. Both formats are advantageously run in 96-well plates and utilize membranes from stable CHO human cell lines overexpressing S1P<sub>1</sub>, S1P<sub>2</sub>, S1P<sub>3</sub>, S1P<sub>4</sub>, or S1P<sub>5</sub>. Compound stocks were made up to 10 mM using DMSO, and serial dilutions were carried out using 100% DMSO. Compounds were transferred to 96-well plates to yield a final DMSO concentration of 1 or 0.5% (v/v) for all assays. Frozen membranes were thawed and diluted in assay buffer containing of 20 mM HEPES pH 7.4, 0.1% fatty acid-free BSA, 100 mM NaCl, 5 mM MgCl<sub>2</sub>, and 10 μM GDP. For the SPA assay, membranes are premixed with WGA-SPA beads to yield a final concentration per well of 5 μg of membrane and 500 μg of bead. For the filtration assay, membranes are added directly to the incubation plate at 5 μg per well. The assay begins with the addition of 50 μL of the membrane or membrane/bead mixture to each well of the assay plate. Next, 50 μL of 0.4 nM [<sup>35</sup>S]GTPγS is added to each well and incubated for 30 min. For the SPA assay, the plates are spun and then read on the Topcount. For the filtration assay, the plate is harvested onto GF-C filtration plates using a Packard 96-well harvester.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Cardiovascular Safety Study Methods</h3><div class="NLM_p last">Male Sprague–Dawley rats (327–400 g) were anesthetized with the long acting barbiturate Inactin (100 mg/kg ip) and instrumented with vascular catheters located in femoral arteries (to measure mean arterial pressure and heart rate and to collect blood samples). An additional transducer-tip catheter was located in the left ventricle for measurement of left ventricular pressure (d<i>P</i>/d<i>t</i> at 50 mmHg), a marker of cardiac contractility. Two femoral vein catheters were inserted to deliver drug and saline (to maintain hydration). Following stabilization for at least 1 h, a 30 min baseline period was recorded followed by infusion of, <b>29</b> at 3, 10, and 30 mg/kg/30 min in 20% DMA/40% PG/40% PEG-400 vehicle (1 mL/kg); results with drug-treated animals (<i>n</i> = 4) were compared to those treated with vehicle (<i>n</i> = 5). Statistical analysis was by unpaired <i>t</i> tests. Plasma samples were taken at the end of each infusion period for exposure determinations.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> PK Methods Lymphopenia</h3><div class="NLM_p last">Female Sprague–Dawley rats (Charles River Laboratories) were administered various doses of compound suspended in 0.5% HPMC/0.02% Tween 80 or vehicle alone by oral gavage. Five hours later, blood was collected via cardiac puncture under isoflurane anesthesia into tubes containing heparin. Whole blood was analyzed for lymphocyte count using a Cell-Dyn hematology analyzer (Abbott Diagnostics). Lymphocyte count is reported as mean ± SEM (<i>n</i> = 4 or 6 per group). An aliquot of blood was centrifuged and plasma was collected and stored at −80 °C until analyzed by mass spectrometry for drug concentration. Animals were housed in an AAALAC accredited SPF facility on a 12/12 h light cycle and provided food and water ad libitum. All procedures involving animals were reviewed and approved by the internal IACUC.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Blood–Brain Barrier Model</h3><div class="NLM_p last">The assay was performed as previously described.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In short, transendothelial electrical resistance in confluent monolayers of hCMEC/D3 cells was measured using electrical cell–substrate impedance sensing model ZTheta (Applied BioPhysics, NY, USA) and 8W10E+ arrays. Then 300 μL of cell suspension (1.0 × 105 cells) was added to each well in Endothelial Cell Basal Medium-2 supplemented with 2.5% human serum and 5 ηg/mL bFGF. Cells were seeded in medium containing dimethyl sulfoxide (DMSO, <i>n</i> = 4) or <b>29</b> (10–6 M, <i>n</i> = 2). Prior to seeding, the collagen-coated ECIS arrays were equilibrated with growth medium and Rb values were calculated using ECIS software version 1.2.55.0 PC.</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Spontaneous Alternation T-Maze Assay</h3><div class="NLM_p">Male C57BL/6J mice of 2 months (<i>n</i> = 11) and 12 months old (<i>n</i> = 20) were used for the study. They were purchased from Janvier, Le Genest St. Isle, France. Body weight was 27.4 ± 0.4 (mean ± SEM) and 33.0 ± 0.5 g at the start of the experiment for 2 and 12 months old mice, respectively. Animals were group-housed with 5–7 animals per cage, containing bedding material (Mixal, Safe, Epinay-sur-Orge, France) and maintained in a room with controlled temperature (21–22 °C) with relative humidity range of 43–70% and a reversed light–dark cycle (12<i>h</i>/12h; lights on, 17:30–05:30; lights off, 05:30–17:30). Food (A04; Safe, Epinay-sur-Orge, France) and water were available ad libitum.</div><div class="NLM_p last">Animals were randomly assigned to a group, and experiments were conducted blinded to treatment. Subacute treatment consisted of single daily po administrations (10 mL/kg) for 21 days before the T-maze. On the day of the T-maze (day 21), the treatment was conducted 225 min before the trial (<i>T</i><sub>max</sub>). The T-maze apparatus was made of gray Plexiglas with a main stem (55 cm long × 10 cm wide × 20 cm high) and two arms (30 cm long × 10 cm wide × 20 cm high) positioned at 90° angle relative to the main stem. A start box (15 cm long × 10 cm wide) was separated from the main stem by a sliding door. The experimental protocol consists of one single session, which starts with 1 “forced-choice” trial, followed by 14 “free-choice” trials. A session was terminated as soon as 14 free-choice trials have been performed or 15 min have elapsed, whatever event occurred first. The percentage of alternation over the 14 free-choice trials was determined for each mouse and was used as an index of working memory performance. This percentage was defined as entry in a different arm of the T-maze over successive trials (i.e., left–right–left–right, etc.). Analysis of variance (ANOVA) was performed on data with a posthoc Tukey where appropriate. A <i>p</i>-value <0.05 was considered significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00928">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00928" class="ext-link">10.1021/acs.jmedchem.5b00928</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_001.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">GTPγS binding in membranes from S1P5-transfected HEK cells and inhibition of forskolininduced cAMP in S1P5-transfected CHO cells; data from screening compound <b>29</b> in the CEREP panel of 79 receptor binding assays; data from screening compound <b>29</b> in 129 assays in the AbbVie kinome panel; rat cardiovascular safety of compound <b>29</b> (A-971432) in anesthetized rats; summary of effects of compound <b>29</b> in the Melior Discovery panel of multiplexed in vivo assays; <sup>1</sup>H and <sup>13</sup>C NMR spectra and HRMS data for compounds <b>4</b>, <b>5</b>, <b>6</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>10</b>, <b>29</b>, <b>31</b>, <b>43</b>, and <b>60</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_001.xlsx">jm5b00928_si_001.xlsx (15.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_002.pdf">jm5b00928_si_002.pdf (1.69 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00928" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57868" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57868" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian D. Hobson</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#95f4f1e7fcf4fbbbfdfaf7e6fafbd5f4f7f7e3fcf0bbf6faf8"><span class="__cf_email__" data-cfemail="9dfcf9eff4fcf3b3f5f2ffeef2f3ddfcffffebf4f8b3fef2f0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher M. Harris</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth L. van der Kam</span> - <span class="hlFld-Affiliation affiliation">AbbVie Deutschland GmbH & Co KG, Knollstrasse 50, 67061 Ludwigshafen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean C. Turner</span> - <span class="hlFld-Affiliation affiliation">AbbVie Deutschland GmbH & Co KG, Knollstrasse 50, 67061 Ludwigshafen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayome Abibi</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana L. Aguirre</span> - <span class="hlFld-Affiliation affiliation">AbbVie,
Inc., 1 North Waukegan
Road, North Chicago, Illinois 60064, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Bousquet</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tegest Kebede</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald B. Konopacki</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Gintant</span> - <span class="hlFld-Affiliation affiliation">AbbVie,
Inc., 1 North Waukegan
Road, North Chicago, Illinois 60064, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youngjae Kim</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Larson</span> - <span class="hlFld-Affiliation affiliation">AbbVie,
Inc., 1 North Waukegan
Road, North Chicago, Illinois 60064, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John W. Maull</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel S. Moore</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Shi</span> - <span class="hlFld-Affiliation affiliation">AbbVie Bioresearch Center, 381 Plantation Street, Worcester, Massachusetts 01605, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anurupa Shrestha</span> - <span class="hlFld-Affiliation affiliation">AbbVie,
Inc., 1 North Waukegan
Road, North Chicago, Illinois 60064, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiubo Tang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
ChemPartner Co. Ltd., Building 10, 998 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peng Zhang</span> - <span class="hlFld-Affiliation affiliation">Shanghai
ChemPartner Co. Ltd., Building 10, 998 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy K. Sarris</span> - <span class="hlFld-Affiliation affiliation">AbbVie,
Inc., 1 North Waukegan
Road, North Chicago, Illinois 60064, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A. D. H., C. M. H., E. L. K., S. C. T., A. A., A. L. A., P. B., T. K., D. B. K., G. G., Y. K., K. L., J. W. M., N. S. M., D. S., A. S. and K. K. S. are/were employees of AbbVie (or Abbott Laboratories prior to separation) and may own AbbVie/Abbott stocks or stock options. X. T. and P. Z. are employees at Shanghai ChemPartner Co., Ltd. AbbVie and Shanghai ChemPartner participated in the interpretation of data, review, and approval of the publication. The financial support for this work was provided by AbbVie.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7748e6510-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74426" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74426" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Stevan W. Djuric for useful discussions and help in preparing this manuscript. The financial support for this work was provided by AbbVie, who participated in the interpretation of data, review, and approval of the manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i99" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i99"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i100" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i100"> Abbreviations Used</h2><tr><td class="NLM_term">AAALAC</td><td class="NLM_def"><p class="first last">Association for Assessment and Accreditation of Laboratory Animal Care</p></td></tr><tr><td class="NLM_term">ALT</td><td class="NLM_def"><p class="first last">alanine aminotransferase</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">ECIS</td><td class="NLM_def"><p class="first last">electrical cell–substrate impedence sensing</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">FSP<sub>3</sub></td><td class="NLM_def"><p class="first last">fraction SP<sub>3</sub> carbon</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HPMC</td><td class="NLM_def"><p class="first last">hypromellose</p></td></tr><tr><td class="NLM_term">IACUC</td><td class="NLM_def"><p class="first last">Institutional Animal Care and Use Committee</p></td></tr><tr><td class="NLM_term">IUPAC</td><td class="NLM_def"><p class="first last">International Union of Pure and Applied Chemists</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MFB</td><td class="NLM_def"><p class="first last">membrane filtration binding</p></td></tr><tr><td class="NLM_term">NAR</td><td class="NLM_def"><p class="first last">number of aromatic rings</p></td></tr><tr><td class="NLM_term">NRB</td><td class="NLM_def"><p class="first last">number of rotatable bonds</p></td></tr><tr><td class="NLM_term">PE/EA</td><td class="NLM_def"><p class="first last">petroleum ether/ethyl acetate</p></td></tr><tr><td class="NLM_term">PhMe</td><td class="NLM_def"><p class="first last">toluene</p></td></tr><tr><td class="NLM_term">PTSA</td><td class="NLM_def"><p class="first last"><i>para</i>-toluene sulfonic acid</p></td></tr><tr><td class="NLM_term">PTZ</td><td class="NLM_def"><p class="first last">pentylenetetrazole</p></td></tr><tr><td class="NLM_term">RLB</td><td class="NLM_def"><p class="first last">radio–ligand binding</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate</p></td></tr><tr><td class="NLM_term">S1P<sub>1</sub></td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate receptor 1</p></td></tr><tr><td class="NLM_term">S1P<sub>2</sub></td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate receptor 2</p></td></tr><tr><td class="NLM_term">S1P<sub>3</sub></td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate receptor 3</p></td></tr><tr><td class="NLM_term">S1P<sub>4</sub></td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate receptor 4</p></td></tr><tr><td class="NLM_term">S1P<sub>5</sub></td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate receptor 5</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SPA</td><td class="NLM_def"><p class="first last">scintillation proximity assay</p></td></tr><tr><td class="NLM_term">TEER</td><td class="NLM_def"><p class="first last">transendothelial electrical resistance</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Van Doorn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes Pinheiro, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooij, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van het Hof, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Pol, S. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Horssen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronken, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reijerkerk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H. E.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="refDoi"> DOI: 10.1186/1742-2094-9-133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1186%2F1742-2094-9-133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=22715976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2jt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=133&author=R.+Van+Doornauthor=M.+A.+Lopes+Pinheiroauthor=G.+Kooijauthor=K.+Lakemanauthor=B.+van+het+Hofauthor=S.+M.+A.+van+der+Polauthor=D.+Geertsauthor=J.+van+Horssenauthor=P.+van+der+Valkauthor=E.+van+der+Kamauthor=E.+Ronkenauthor=A.+Reijerkerkauthor=H.+E.+de+Vries&title=Sphingosine+1-phosphate+receptor+5+mediates+the+immune+quiescence+of+the+human+brain+endothelial+barrier&doi=10.1186%2F1742-2094-9-133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier</span></div><div class="casAuthors">van Doorn, Ruben; Pinheiro, Melissa A. Lopes; Kooij, Gijs; Lakeman, Kim; van het Hof, Bert; van der Pol, Susanne M. A.; Geerts, Dirk; van Horssen, Jack; van der Valk, Paul; van der Kam, Elizabeth; Ronken, Eric; Reijerkerk, Arie; de Vries, Helga E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The sphingosine 1-phosphate (S1P) receptor modulator FTY720P (Gilenya) potently reduces relapse rate and lesion activity in the neuroinflammatory disorder multiple sclerosis.  Although most of its efficacy has been shown to be related to immunosuppression through the induction of lymphopenia, it has been suggested that a no. of its beneficial effects are related to altered endothelial and blood-brain barrier (BBB) functionality.  However, to date it remains unknown whether brain endothelial S1P receptors are involved in the maintenance of the function of the BBB thereby mediating immune quiescence of the brain.  Here we demonstrate that the brain endothelial receptor S1P5 largely contributes to the maintenance of brain endothelial barrier function.  Methods: We analyzed the expression of S1P5 in human post-mortem tissues using immunohistochem.  The function of S1P5 at the BBB was assessed in cultured human brain endothelial cells (ECs) using agonists and lentivirus-mediated knockdown of S1P5.  Subsequent analyses of different aspects of the brain EC barrier included the formation of a tight barrier, the expression of BBB proteins and markers of inflammation and monocyte transmigration.  Results: We show that activation of S1P5 on cultured human brain ECs by a selective agonist elicits enhanced barrier integrity and reduced transendothelial migration of monocytes in vitro.  These results were corroborated by genetically silencing S1P5 in brain ECs.  Interestingly, functional studies with these cells revealed that S1P5 strongly contributes to brain EC barrier function and underlies the expression of specific BBB endothelial characteristics such as tight junctions and permeability.  In addn., S1P5 maintains the immunoquiescent state of brain ECs with low expression levels of leukocyte adhesion mols. and inflammatory chemokines and cytokines through lowering the activation of the transcription factor NFκB.  Conclusion: Our findings demonstrate that S1P5 in brain ECs contributes to optimal barrier formation and maintenance of immune quiescence of the barrier endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4TXZcnzDvurVg90H21EOLACvtfcHk0lhc59F3GKAiAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2jt73L&md5=ee524d8c59b03ec29711a5f6a9c2da4e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-133%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDoorn%26aufirst%3DR.%26aulast%3DLopes%2BPinheiro%26aufirst%3DM.%2BA.%26aulast%3DKooij%26aufirst%3DG.%26aulast%3DLakeman%26aufirst%3DK.%26aulast%3Dvan%2Bhet%2BHof%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BPol%26aufirst%3DS.%2BM.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3Dvan%2BHorssen%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26aulast%3Dvan%2Bder%2BKam%26aufirst%3DE.%26aulast%3DRonken%26aufirst%3DE.%26aulast%3DReijerkerk%26aufirst%3DA.%26aulast%3Dde%2BVries%26aufirst%3DH.%2BE.%26atitle%3DSphingosine%25201-phosphate%2520receptor%25205%2520mediates%2520the%2520immune%2520quiescence%2520of%2520the%2520human%2520brain%2520endothelial%2520barrier%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D133%26doi%3D10.1186%2F1742-2094-9-133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Harris, C.; Hobson, A.; Wilson, N. S.</span><span> </span><span class="NLM_article-title">Agonists and antagonists of the S1P<sub>5</sub> receptor, and methods of uses thereof</span>. WO2010093704,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Harris&author=A.+Hobson&author=N.+S.+Wilson&title=Agonists+and+antagonists+of+the+S1P5+receptor%2C+and+methods+of+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%26atitle%3DAgonists%2520and%2520antagonists%2520of%2520the%2520S1P5%2520receptor%252C%2520and%2520methods%2520of%2520uses%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Van der Kam, E.; Turner, S.; van Bergeijk, J.; Mueller, R.; Mezler, M.; Bespalov, A.; Hobson, A.; Harris, C. M.; Rendenbach-Mueller, B.; Schoemaker, H.</span><span> </span><span class="NLM_article-title">The use of selective sphingosine-1-phosphate receptor 5 agonists for the treatment of neurodegenerative disorders such as Alzheimer’s disease and lysosomal storage diseases such as Niemann Pick C disease</span>. <span class="NLM_conf-name">Alzheimer’s Association International Conference, AAIC</span>, <span class="NLM_conf-loc">Copenhagen</span>, <span class="NLM_conf-date">July 12–17, 2014</span>, abstract and presentation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+der+Kam%2C+E.%3B+Turner%2C+S.%3B+van+Bergeijk%2C+J.%3B+Mueller%2C+R.%3B+Mezler%2C+M.%3B+Bespalov%2C+A.%3B+Hobson%2C+A.%3B+Harris%2C+C.+M.%3B+Rendenbach-Mueller%2C+B.%3B+Schoemaker%2C+H.+The+use+of+selective+sphingosine-1-phosphate+receptor+5+agonists+for+the+treatment+of+neurodegenerative+disorders+such+as+Alzheimer%E2%80%99s+disease+and+lysosomal+storage+diseases+such+as+Niemann+Pick+C+disease.+Alzheimer%E2%80%99s+Association+International+Conference%2C+AAIC%2C+Copenhagen%2C+July+12%E2%80%9317%2C+2014%2C+abstract+and+presentation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BKam%26aufirst%3DE.%26atitle%3DThe%2520use%2520of%2520selective%2520sphingosine-1-phosphate%2520receptor%25205%2520agonists%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%2520such%2520as%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520lysosomal%2520storage%2520diseases%2520such%2520as%2520Niemann%2520Pick%2520C%2520disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kluk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1582</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1016/S1388-1981(02)00139-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2FS1388-1981%2802%2900139-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=12069812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD38XksF2htrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1582&publication_year=2002&pages=72-80&author=M.+J.+Klukauthor=T.+Hla&title=Signaling+of+sphingosine-1-phosphate+via+the+S1P%2FEDG-family+of+G-protein-coupled+receptors&doi=10.1016%2FS1388-1981%2802%2900139-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors</span></div><div class="casAuthors">Kluk, Michael J.; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1582</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">72-80</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate/Endothelial Differentiation Gene (S1P/EDG) family of G-protein-coupled receptors (GPCR) currently includes 5 different isoforms, which differentially regulate fundamental cellular processes such as migration, proliferation, cytoskeletal organization, adherens junction assembly, and morphogenesis.  Addnl., specific S1P/EDG isoforms can regulate important physiol. processes such as blood vessel maturation, cardiac development, and angiogenesis in vivo.  Herein, we review the current state of knowledge of the expression patterns, signaling pathways and functional characteristics of the different S1P receptors.  Further investigation in this field will likely improve our understanding of cardiovascular development as well as vascular diseases and may lead to novel therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKST9SG_-J_bVg90H21EOLACvtfcHk0lhc59F3GKAiAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksF2htrg%253D&md5=168c5ed52f5c550bb722e6c77308ccd7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2802%2900139-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252802%252900139-7%26sid%3Dliteratum%253Aachs%26aulast%3DKluk%26aufirst%3DM.%2BJ.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DSignaling%2520of%2520sphingosine-1-phosphate%2520via%2520the%2520S1P%252FEDG-family%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2002%26volume%3D1582%26spage%3D72%26epage%3D80%26doi%3D10.1016%2FS1388-1981%2802%2900139-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1126/science.1070238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1126%2Fscience.1070238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=11923495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1-Phosphate+Receptor+Agonists&doi=10.1126%2Fscience.1070238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span></div><div class="casAuthors">Mandala, Suzanne; Hajdu, Richard; Bergstrom, James; Quackenbush, Elizabeth; Xie, Jenny; Milligan, James; Thornton, Rosemary; Shei, Gan-Ju; Card, Deborah; Keohane, Carolann; Rosenbach, Mark; Hale, Jeffrey; Lynch, Christopher L.; Rupprecht, Kathleen; Parsons, William; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5566</span>),
    <span class="NLM_cas:pages">346-349</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Blood lymphocyte nos., essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs.  We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720.  Both species were high-affinity agonists of at least four of the five S1P receptors.  These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen.  S1P receptor agonists induced emptying of lymphoid sinuses by retention of lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph.  Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPvwG_lLsA8LVg90H21EOLACvtfcHk0lgxVdtNLFYjTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D&md5=b57cbcffe41d144e701dbd42459cf38a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070238%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349%26doi%3D10.1126%2Fscience.1070238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoropoulou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Auberson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1056/NEJMoa0909494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1056%2FNEJMoa0909494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=20089952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=387-401&author=L.+Kapposauthor=E.-W.+Radueauthor=P.+O%27Connorauthor=C.+Polmanauthor=R.+Hohlfeldauthor=P.+Calabresiauthor=K.+Selmajauthor=C.+Agoropoulouauthor=M.+Leykauthor=L.+Zhang-Aubersonauthor=P.+Burtin&title=A+Placebo-Controlled+Trial+of+Oral+Fingolimod+in+Relapsing+Multiple+Sclerosis&doi=10.1056%2FNEJMoa0909494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krzysztof; Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or i.m. interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis.  METHODS: In our 24-mo, double-blind, randomized study, we enrolled patients who had relapsing-remitting multiple sclerosis, were 18 to 55 years of age, had a score of 0 to 5.5 on the Expanded Disability Status Scale (which ranges from 0 to 10, with higher scores indicating greater disability), and had one or more relapses in the previous year or two or more in the previous 2 years.  Patients received oral fingolimod at a dose of 0.5 mg or 1.25 mg daily or placebo.  End points included the annualized relapse rate (the primary end point) and the time to disability progression (a secondary end point).  RESULTS: A total of 1033 of the 1272 patients (81.2%) completed the study.  The annualized relapse rate was 0.18 with 0.5 mg of fingolimod, 0.16 with 1.25 mg of fingolimod, and 0.40 with placebo (P < 0.001 for either dose vs. placebo).  Fingolimod at doses of 0.5 mg and 1.25 mg significantly reduced the risk of disability progression over the 24-mo period (hazard ratio, 0.70 and 0.68, resp.; P = 0.02 vs. placebo, for both comparisons).  The cumulative probability of disability progression (confirmed after 3 mo) was 17.7% with 0.5 mg of fingolimod, 16.6% with 1.25 mg of fingolimod, and 24.1% with placebo.  Both fingolimod doses were superior to placebo with regard to MRI-related measures (no. of new or enlarged lesions on T2 -weighted images, gadolinium-enhancing lesions, and brain-vol. loss; P < 0.001 for all comparisons at 24 mo).  Causes of study discontinuation and adverse events related to fingolimod included bradycardia and atrioventricular conduction block at the time of fingolimod initiation, macular edema, elevated liver-enzyme levels, and mild hypertension.  CONCLUSIONS: As compared with placebo, both doses of oral fingolimod improved the relapse rate, the risk of disability progression, and end points on MRI.  These benefits will need to be weighed against possible long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZV83ylA8IarVg90H21EOLACvtfcHk0lgxVdtNLFYjTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D&md5=0c1a63e4b8850f3579b2a8f6c7f28ac0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909494%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DRadue%26aufirst%3DE.-W.%26aulast%3DO%2527Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DAgoropoulou%26aufirst%3DC.%26aulast%3DLeyk%26aufirst%3DM.%26aulast%3DZhang-Auberson%26aufirst%3DL.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DA%2520Placebo-Controlled%2520Trial%2520of%2520Oral%2520Fingolimod%2520in%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D387%26epage%3D401%26doi%3D10.1056%2FNEJMoa0909494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_contrib-group">Vachal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>) receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3684</span><span class="NLM_x">–</span> <span class="NLM_lpage">3687</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2006.04.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3684-3687&author=P.+Vachalauthor=L.+M.+Tothauthor=J.+J.+Haleauthor=L.+Yanauthor=S.+G.+Millsauthor=G.+L.+Chrebetauthor=C.+A.+Koehaneauthor=R.+Hajduauthor=J.+A.+Milliganauthor=M.+J.+Rosenbachauthor=S.+Mandala&title=Highly+selective+and+potent+agonists+of+sphingosine-1-phosphate+1+%28S1P1%29+receptor&doi=10.1016%2Fj.bmcl.2006.04.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DToth%26aufirst%3DL.%2BM.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChrebet%26aufirst%3DG.%2BL.%26aulast%3DKoehane%26aufirst%3DC.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DHighly%2520selective%2520and%2520potent%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3684%26epage%3D3687%26doi%3D10.1016%2Fj.bmcl.2006.04.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_contrib-group">Clemens, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>) receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3401</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00812-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2FS0960-894X%2803%2900812-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3401-3404&author=J.+J.+Clemensauthor=M.+D.+Davisauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Highly+selective+and+potent+agonists+of+sphingosine-1-phosphate+1+%28S1P1%29+receptor&doi=10.1016%2FS0960-894X%2803%2900812-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900812-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900812-6%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DJ.%2BJ.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DHighly%2520selective%2520and%2520potent%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3401%26epage%3D3404%26doi%3D10.1016%2FS0960-894X%2803%2900812-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Discovery of a Brain-Penetrant S1P<sub>3</sub>-Sparing Direct Agonist of the S1P<sub>1</sub> and S1P<sub>5</sub> Receptors Efficacious at Low Oral Dose</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6724</span><span class="NLM_x">–</span> <span class="NLM_lpage">6733</span><span class="refDoi"> DOI: 10.1021/jm200609t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200609t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6724-6733&author=E.+H.+Demontauthor=S.+Arpinoauthor=R.+A.+Bitauthor=C.+A.+Campbellauthor=N.+Deeksauthor=S.+Desaiauthor=S.+J.+Dowellauthor=P.+Gaskinauthor=J.+R.+J.+Grayauthor=L.+A.+Harrisonauthor=A.+Haynesauthor=T.+D.+Heightmanauthor=D.+S.+Holmesauthor=P.+G.+Humphreysauthor=U.+Kumarauthor=M.+A.+Morseauthor=G.+J.+Osborneauthor=T.+Panchalauthor=K.+L.+Philpottauthor=S.+Taylorauthor=R.+Watsonauthor=R.+Willisauthor=J.+Witherington&title=Discovery+of+a+Brain-Penetrant+S1P3-Sparing+Direct+Agonist+of+the+S1P1+and+S1P5+Receptors+Efficacious+at+Low+Oral+Dose&doi=10.1021%2Fjm200609t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fjm200609t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200609t%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DArpino%26aufirst%3DS.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DCampbell%26aufirst%3DC.%2BA.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHarrison%26aufirst%3DL.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOsborne%26aufirst%3DG.%2BJ.%26aulast%3DPanchal%26aufirst%3DT.%26aulast%3DPhilpott%26aufirst%3DK.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Brain-Penetrant%2520S1P3-Sparing%2520Direct%2520Agonist%2520of%2520the%2520S1P1%2520and%2520S1P5%2520Receptors%2520Efficacious%2520at%2520Low%2520Oral%2520Dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6724%26epage%3D6733%26doi%3D10.1021%2Fjm200609t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P<sub>1</sub> Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span><span class="refDoi"> DOI: 10.1021/jm100181s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists&doi=10.1021%2Fjm100181s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211%26doi%3D10.1021%2Fjm100181s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jaillard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankoff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigrot, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calver, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalc, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubetzki, C.</span><span> </span><span class="NLM_article-title">Edg8/S1P<sub>5</sub>: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4645-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1523%2FJNEUROSCI.4645-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=15703400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Kmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1459-1469&author=C.+Jaillardauthor=S.+Harrisonauthor=B.+Stankoffauthor=M.+S.+Aigrotauthor=A.+R.+Calverauthor=G.+Duddyauthor=F.+S.+Walshauthor=M.+N.+Pangalosauthor=N.+Arimuraauthor=K.+Kaibuchiauthor=B.+Zalcauthor=C.+Lubetzki&title=Edg8%2FS1P5%3A+An+Oligodendroglial+Receptor+with+Dual+Function+on+Process+Retraction+and+Cell+Survival&doi=10.1523%2FJNEUROSCI.4645-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival</span></div><div class="casAuthors">Jaillard, C.; Harrison, S.; Stankoff, B.; Aigrot, M. S.; Calver, A. R.; Duddy, G.; Walsh, F. S.; Pangalos, M. N.; Arimura, N.; Kaibuchi, K.; Zalc, B.; Lubetzki, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1459-1469</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Endothelial differentiation gene (Edg) proteins are G-protein-coupled receptors activated by lysophospholipid mediators: sphingosine-1-phosphate (S1P) or lysophosphatidic acid.  We show that in the CNS, expression of Edg8/S1P5, a high-affinity S1P receptor, is restricted to oligodendrocytes and expressed throughout development from the immature stages to the mature myelin-forming cell.  S1P activation of Edg8/S1P5 on O4-pos. pre-oligodendrocytes induced process retraction via a Rho kinase/collapsin response-mediated protein signaling pathway, whereas no retraction was elicited by S1P on these cells derived from Edg8/S1P5-deficient mice.  Edg8/S1P5-mediated process retraction was restricted to immature cells and was no longer obsd. at later developmental stages.  In contrast, S1P activation promoted the survival of mature oligodendrocytes but not of pre-oligodendrocytes.  The S1P-induced survival of mature oligodendrocytes was mediated through a pertussis toxin-sensitive, Akt-dependent pathway.  Our data demonstrate that Edg8/S1P5 activation on oligodendroglial cells modulates two distinct functional pathways mediating either process retraction or cell survival and that these effects depend on the developmental stage of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR2Qf1RWo-5bVg90H21EOLACvtfcHk0li94kxXjHlDpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Kmu7o%253D&md5=c88004568fd9219b1d640067ffae84b0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4645-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4645-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJaillard%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DS.%26aulast%3DStankoff%26aufirst%3DB.%26aulast%3DAigrot%26aufirst%3DM.%2BS.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DDuddy%26aufirst%3DG.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DArimura%26aufirst%3DN.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DZalc%26aufirst%3DB.%26aulast%3DLubetzki%26aufirst%3DC.%26atitle%3DEdg8%252FS1P5%253A%2520An%2520Oligodendroglial%2520Receptor%2520with%2520Dual%2520Function%2520on%2520Process%2520Retraction%2520and%2520Cell%2520Survival%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D1459%26epage%3D1469%26doi%3D10.1523%2FJNEUROSCI.4645-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A.</span><span> </span><span class="NLM_article-title">Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.pharmthera.2007.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=17961662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=77-93&author=K.+K.+Devauthor=F.+Mullershausenauthor=H.+Mattesauthor=R.+R.+Kuhnauthor=G.+Bilbeauthor=D.+Hoyerauthor=A.+Mir&title=Brain+sphingosine-1-phosphate+receptors%3A+implication+for+FTY720+in+the+treatment+of+multiple+sclerosis&doi=10.1016%2Fj.pharmthera.2007.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis</span></div><div class="casAuthors">Dev, Kumlesh K.; Mullershausen, Florian; Mattes, Henri; Kuhn, Rainer R.; Bilbe, Graeme; Hoyer, Daniel; Mir, Anis</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an autoimmune, neurol. disability with unknown etiol.  The current therapies available for MS work by an immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss.  Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clin. trials.  This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (S1P) receptors.  Here, we outline the direct roles that S1P receptors play in the central nervous system (CNS) and discuss addnl. modalities by which FTY720 may provide direct neuroprotection in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYlyd4S2EeELVg90H21EOLACvtfcHk0lh3OIcVw9L7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J&md5=d5cf04a35f8bb06f3e094d2e75c698c0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%26atitle%3DBrain%2520sphingosine-1-phosphate%2520receptors%253A%2520implication%2520for%2520FTY720%2520in%2520the%2520treatment%2520of%2520multiple%2520sclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D77%26epage%3D93%26doi%3D10.1016%2Fj.pharmthera.2007.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span> </span><span class="NLM_article-title">Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2006.10.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=491-494&author=S.+Hanessianauthor=G.+Charronauthor=A.+Billichauthor=D.+Guerini&title=Constrained+azacyclic+analogues+of+the+immunomodulatory+agent+FTY720+as+molecular+probes+for+sphingosine+1-phosphate+receptors&doi=10.1016%2Fj.bmcl.2006.10.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DCharron%26aufirst%3DG.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DGuerini%26aufirst%3DD.%26atitle%3DConstrained%2520azacyclic%2520analogues%2520of%2520the%2520immunomodulatory%2520agent%2520FTY720%2520as%2520molecular%2520probes%2520for%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D491%26epage%3D494%26doi%3D10.1016%2Fj.bmcl.2006.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhelal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barske, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasdelen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haessig, S.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Selective and Potent Orally Active S1P<sub>5</sub> Agonists</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span><span class="refDoi"> DOI: 10.1002/cmdc.201000253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1002%2Fcmdc.201000253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=20815011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1693-1696&author=H.+Mattesauthor=K.+K.+Devauthor=R.+Bouhelalauthor=C.+Barskeauthor=F.+Gaspariniauthor=D.+Gueriniauthor=A.+K.+Mirauthor=D.+Orainauthor=M.+Osindeauthor=A.+Picardauthor=C.+Duboisauthor=E.+Tasdelenauthor=S.+Haessig&title=Design+and+Synthesis+of+Selective+and+Potent+Orally+Active+S1P5+Agonists&doi=10.1002%2Fcmdc.201000253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selective and potent orally active S1P5 agonists</span></div><div class="casAuthors">Mattes, Henri; Dev, Kumlesh Kumar; Bouhelal, Rochdi; Barske, Carmen; Gasparini, Fabrizio; Guerini, Danilo; Mir, Anis Khusro; Orain, David; Osinde, Maribel; Picard, Anne; Dubois, Celine; Tasdelen, Engin; Haessig, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1693-1696</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report studies of various benzamide modifications carried out to improve the selectivity, bioactivity, pharmacokinetic properties, and ancillary profile of I derivs., ultimately resulting in the discovery of potent and very selective S1P5 agonists.  These S1P5 agonists mat be beneficial in the treatment of demyelinating disorders such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp148r0CEUUKbVg90H21EOLACvtfcHk0lh3OIcVw9L7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzP&md5=7bed203140024ed148f1f11e75a2a59d</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000253%26sid%3Dliteratum%253Aachs%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DBarske%26aufirst%3DC.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%2BK.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DOsinde%26aufirst%3DM.%26aulast%3DPicard%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DC.%26aulast%3DTasdelen%26aufirst%3DE.%26aulast%3DHaessig%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%2520and%2520Potent%2520Orally%2520Active%2520S1P5%2520Agonists%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1693%26epage%3D1696%26doi%3D10.1002%2Fcmdc.201000253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. R.</span><span> </span><span class="NLM_article-title">Asymmetric Synthesis of Conformationally Constrained Fingolimod Analogues-Discovery of an Orally Active Sphingosine 1-Phosphate Receptor Type-1 Agonist and Receptor Type-3 Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6428</span><span class="refDoi"> DOI: 10.1021/jm7010172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7010172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6428&author=R.+Zhuauthor=A.+H.+Snyderauthor=Y.+Kharelauthor=L.+Schaffterauthor=Q.+Sunauthor=P.+C.+Kennedyauthor=K.+R.+Lynchauthor=T.+R.+Macdonald&title=Asymmetric+Synthesis+of+Conformationally+Constrained+Fingolimod+Analogues-Discovery+of+an+Orally+Active+Sphingosine+1-Phosphate+Receptor+Type-1+Agonist+and+Receptor+Type-3+Antagonist&doi=10.1021%2Fjm7010172"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm7010172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010172%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DSchaffter%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BR.%26atitle%3DAsymmetric%2520Synthesis%2520of%2520Conformationally%2520Constrained%2520Fingolimod%2520Analogues-Discovery%2520of%2520an%2520Orally%2520Active%2520Sphingosine%25201-Phosphate%2520Receptor%2520Type-1%2520Agonist%2520and%2520Receptor%2520Type-3%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6428%26doi%3D10.1021%2Fjm7010172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Wallace, G. A.; Breinlinger, E. C.; Cusack, K. P.; Fix-Stenzel, S. R.; Gordon, T. D.; Hobson, A. D.; Hayes, M. E.; Ansell, G.; Grongsaard, P.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptor agonist and antagonist compounds</span>. US8217027B2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+A.+Wallace&author=E.+C.+Breinlinger&author=K.+P.+Cusack&author=S.+R.+Fix-Stenzel&author=T.+D.+Gordon&author=A.+D.+Hobson&author=M.+E.+Hayes&author=G.+Ansell&author=P.+Grongsaard&title=Sphingosine-1-phosphate+receptor+agonist+and+antagonist+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DG.%2BA.%26atitle%3DSphingosine-1-phosphate%2520receptor%2520agonist%2520and%2520antagonist%2520compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span><span class="refDoi"> DOI: 10.1021/jm0492507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benzyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists&doi=10.1021%2Fjm0492507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benzyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665%26doi%3D10.1021%2Fjm0492507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span>Aldrich Market Select; <span class="NLM_publisher-name">Sigma Aldrich, LLC</span>: <span class="NLM_publisher-loc">Milwaukee, WI</span>; <a href="https://www.aldrichmarketselect.com/" class="extLink">https://www.aldrichmarketselect.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aldrich+Market+Select%3B+Sigma+Aldrich%2C+LLC%3A+Milwaukee%2C+WI%3B+https%3A%2F%2Fwww.aldrichmarketselect.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAldrich%2520Market%2520Select%26pub%3DSigma%2520Aldrich%252C%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">FitzGibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Op, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffter, L.</span><span> </span><span class="NLM_article-title">Novel Approach to Optimization of a High-Throughput Semipreparative LC/MS System</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1021/cc800209w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc800209w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFCnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=592-597&author=J.+FitzGibbonsauthor=J.+Opauthor=A.+Hobsonauthor=L.+Schaffter&title=Novel+Approach+to+Optimization+of+a+High-Throughput+Semipreparative+LC%2FMS+System&doi=10.1021%2Fcc800209w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Approach to Optimization of a High-Throughput Semipreparative LC/MS System</span></div><div class="casAuthors">FitzGibbons, Julia; Op, Sopheary; Hobson, Adrian; Schaffter, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">592-597</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Automated semipreparative LC/MS systems are now well established com. and commonly used for purifn. of early stage drug discovery compds.  A no. of vendors have instruments on the market that are capable of reliably purifying compds. with good water/acetonitrile soly.  However, these systems often fail when the sample has poor soly., extreme polarity, and/or poor ionization.  Even in cases when substantial optimization has been done prior to purifn., a certain percent of failures to recover the desired product is unavoidable.  In the past, when the majority of samples run on LC/MS semipreparative systems were large combinatorial libraries, some losses in this high throughput mode were acceptable.  However, now that more chem. labs. are making smaller more focused libraries with higher purity requirements, reliability and recovery are more crucial.  This paper describes modifications made to customize an MS-triggered semipreparative LC/MS system in order to ensure improved reliability and recovery of products from traditional medicinal chem. as well as combinatorial libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrik95KxRhh_7Vg90H21EOLACvtfcHk0ljZFrl8ShKg4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFCnurg%253D&md5=3f663ac58ef047ceae9e4fb9a3ec6501</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcc800209w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc800209w%26sid%3Dliteratum%253Aachs%26aulast%3DFitzGibbons%26aufirst%3DJ.%26aulast%3DOp%26aufirst%3DJ.%26aulast%3DHobson%26aufirst%3DA.%26aulast%3DSchaffter%26aufirst%3DL.%26atitle%3DNovel%2520Approach%2520to%2520Optimization%2520of%2520a%2520High-Throughput%2520Semipreparative%2520LC%252FMS%2520System%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2009%26volume%3D11%26spage%3D592%26epage%3D597%26doi%3D10.1021%2Fcc800209w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span><span class="refDoi"> DOI: 10.1074/jbc.M311743200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1074%2Fjbc.M311743200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=14732717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate&doi=10.1074%2Fjbc.M311743200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate</span></div><div class="casAuthors">Sanna, M. Germana; Liao, Jiayu; Jo, Euijung; Alfonso, Christopher; Ahn, Min-Young; Peterson, Melissa S.; Webb, Bill; Lefebvre, Sophie; Chun, Jerold; Gray, Nathanael; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">13839-13848</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) influences heart rate, coronary artery caliber, endothelial integrity, and lymphocyte recirculation through five related high affinity G-protein-coupled receptors.  Inhibition of lymphocyte recirculation by non-selective S1P receptor agonists produces clin. immunosuppression preventing transplant rejection but is assocd. with transient bradycardia.  Understanding the contribution of individual receptors has been limited by the embryonic lethality of the S1P1 knock-out and the unavailability of selective agonists or antagonists.  A potent, S1P1-receptor selective agonist structurally unrelated to S1P was found to activate multiple signals triggered by S1P, including guanosine 5'-3-O-(thio)triphosphate binding, calcium flux, Akt and ERK1/2 phosphorylation, and stimulation of migration of S1P1- but not S1P3-expressing cells in vitro.  The agonist also alters lymphocyte trafficking in vivo.  Use of selective agonism together with deletant mice lacking S1P3 receptor reveals that agonism of S1P1 receptor alone is sufficient to control lymphocyte recirculation.  Moreover, S1P1 receptor agonist plasma levels are causally assocd. with induction and maintenance of lymphopenia.  S1P3, and not S1P1, is directly implicated in sinus bradycardia.  The sustained bradycardia induced by S1P receptor non-selective immunosuppressive agonists in wild-type mice is abolished in S1P3-/- mice, whereas S1P1-selective agonist does not produce bradycardia.  Sepn. of receptor subtype usage for control of lymphocyte recirculation and heart rate may allow the identification of selective immunosuppressive S1P1 receptor agonists with an enhanced therapeutic window.  S1P1-selective agonists will be of broad utility in understanding cell functions in vitro, and vascular physiol. in vivo, and the success of the chem. approach for S1P1 suggests that selective tools for the resoln. of function across this broad lipid receptor family are now possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoztTB58pXPA7Vg90H21EOLACvtfcHk0ljZFrl8ShKg4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D&md5=5b720513c7c550bfdf55e5344efc8f16</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311743200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311743200%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848%26doi%3D10.1074%2Fjbc.M311743200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Topliss, J. G.</span><span> </span><span class="NLM_article-title">Utilization of Operational Schemes for Analog Synthesis in Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="refDoi"> DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006&author=J.+G.+Topliss&title=Utilization+of+Operational+Schemes+for+Analog+Synthesis+in+Drug+Design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0ljZFrl8ShKg4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520Operational%2520Schemes%2520for%2520Analog%2520Synthesis%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Lead- and drug-like compounds: the rule-of-five revolution</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1016/j.ddtec.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-341&author=C.+A.+Lipinski&title=Lead-+and+drug-like+compounds%3A+the+rule-of-five+revolution&doi=10.1016%2Fj.ddtec.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0lhw26xZOZ0YAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520and%2520drug-like%2520compounds%253A%2520the%2520rule-of-five%2520revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D341%26doi%3D10.1016%2Fj.ddtec.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0lhw26xZOZ0YAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes&doi=10.1016%2Fj.bmcl.2008.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lhw26xZOZ0YAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875%26doi%3D10.1016%2Fj.bmcl.2008.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+Properties+That+Influence+the+Oral+Bioavailability+of+Drug+Candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0li3QsfcLc8pRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520Properties%2520That%2520Influence%2520the%2520Oral%2520Bioavailability%2520of%2520Drug%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_contrib-group">Smid, P.; Iwema Bakker, W. I.; Coolen, H. K. A. C.; Sliedregt, L. A. J. M.; van Dongen, M. J. P.; den Hartog, J. A. J.; Hobson, A.</span><span> </span><span class="NLM_article-title">Fused Heterocyclic Derivatives as S1P Modulators</span>. WO2012004373,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Smid&author=W.+I.+Iwema+Bakker&author=H.+K.+A.+C.+Coolen&author=L.+A.+J.+M.+Sliedregt&author=M.+J.+P.+van+Dongen&author=J.+A.+J.+den+Hartog&author=A.+Hobson&title=Fused+Heterocyclic+Derivatives+as+S1P+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmid%26aufirst%3DP.%26atitle%3DFused%2520Heterocyclic%2520Derivatives%2520as%2520S1P%2520Modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_contrib-group">Smid, P.; Iwema Bakker, W. I.; Wouter, I.; Coolen, H. K. A. C.; Sliedregt, L. A. J. M.; Van Dongen, M. J. P.; Den Hartog, J. A. J.; Hobson, A.</span><span> </span><span class="NLM_article-title">Preparation of phenyldihydrooxazolopyridine derivatives and analogs for use as S1P modulators</span>. WO2012004373,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Smid&author=W.+I.+Iwema+Bakker&author=I.+Wouter&author=H.+K.+A.+C.+Coolen&author=L.+A.+J.+M.+Sliedregt&author=M.+J.+P.+Van+Dongen&author=J.+A.+J.+Den+Hartog&author=A.+Hobson&title=Preparation+of+phenyldihydrooxazolopyridine+derivatives+and+analogs+for+use+as+S1P+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmid%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520phenyldihydrooxazolopyridine%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520S1P%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_contrib-group">Stoit, A.; Iwema Bakker, W. I.; Wouter, I.; Coolen, H. K. A. C.; Van Dongen, M. J. P.; Leflemme, N. J.-L. D.; Hobson, A.</span><span> </span><span class="NLM_article-title">Preparation of spirocyclic amine derivatives for use as S1P modulators</span>. WO2012004378,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Stoit&author=W.+I.+Iwema+Bakker&author=I.+Wouter&author=H.+K.+A.+C.+Coolen&author=M.+J.+P.+Van+Dongen&author=N.+J.-L.+D.+Leflemme&author=A.+Hobson&title=Preparation+of+spirocyclic+amine+derivatives+for+use+as+S1P+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStoit%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520spirocyclic%2520amine%2520derivatives%2520for%2520use%2520as%2520S1P%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, S.</span><span> </span><span class="NLM_article-title">Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="refDoi"> DOI: 10.1136/jnnp-2013-307538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1136%2Fjnnp-2013-307538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=24659798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A280%3ADC%252BC2crmsVCqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=1180&author=M.+Moriauthor=S.+Kuwabara&title=Are+more+sphingosine+1-phosphate+receptor+agonists+a+better+therapeutic+option+against+multiple+sclerosis%3F&doi=10.1136%2Fjnnp-2013-307538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?</span></div><div class="casAuthors">Mori Masahiro; Kuwabara Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1180</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2CIkzhi1GIy-bLEOO4dYpfW6udTcc2eZFcpDUnPhyYbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmsVCqsg%253D%253D&md5=46ea54e0f1a20c7b5f00fc734ac10fb4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1136%2Fjnnp-2013-307538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp-2013-307538%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DM.%26aulast%3DKuwabara%26aufirst%3DS.%26atitle%3DAre%2520more%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520a%2520better%2520therapeutic%2520option%2520against%2520multiple%2520sclerosis%253F%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2014%26volume%3D85%26spage%3D1180%26doi%3D10.1136%2Fjnnp-2013-307538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>Functional GPCr platform; <span class="NLM_publisher-name">Cerep</span>: <span class="NLM_publisher-loc">Redmond, WA</span>; <a href="http://www.cerep.fr/cerep/users/pages/ProductsServices/GPCRPlatform.asp" class="extLink">http://www.cerep.fr/cerep/users/pages/ProductsServices/GPCRPlatform.asp</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Functional+GPCr+platform%3B+Cerep%3A+Redmond%2C+WA%3B+http%3A%2F%2Fwww.cerep.fr%2Fcerep%2Fusers%2Fpages%2FProductsServices%2FGPCRPlatform.asp."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DFunctional%2520GPCr%2520platform%26pub%3DCerep" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cothron, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1021/ja0455547</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0455547" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=217-224&author=J.+R.+Huthauthor=R.+Mendozaauthor=E.+T.+Olejniczakauthor=R.+W.+Johnsonauthor=D.+A.+Cothronauthor=Y.+Liuauthor=C.+G.+Lernerauthor=J.+Chenauthor=P.+J.+Hajduk&title=ALARM+NMR%3A+a+rapid+and+robust+experimental+method+to+detect+reactive+false+positives+in+biochemical+screens&doi=10.1021%2Fja0455547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens</span></div><div class="casAuthors">Huth, Jeffrey R.; Mendoza, Renaldo; Olejniczak, Edward T.; Johnson, Robert W.; Cothron, Darlene A.; Liu, Yaya; Lerner, Claude G.; Chen, Jun; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-224</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High-throughput screening (HTS) of large compd. collections typically results in numerous small mol. hits that must be carefully evaluated to identify valid drug leads.  Although several filtering mechanisms and other tools exist that can assist the chemist in this process, it is often the case that costly synthetic resources are expended in pursuing false positives.  We report here a rapid and reliable NMR-based method for identifying reactive false positives including those that oxidize or alkylate a protein target.  Importantly, the reactive species need not be the parent compd., as both reactive impurities and breakdown products can be detected.  The assay is called ALARM NMR (a La assay to detect reactive mols. by NMR) and is based on monitoring DTT-dependent 13C chem. shift changes of the human La antigen in the presence of a test compd. or mixt.  Extensive validation has been performed to demonstrate the reliability and utility of using ALARM NMR to assess thiol reactivity.  This included comparing ALARM NMR to a glutathione-based fluorescence assay, as well as testing a collection of more than 3500 compds. contg. HTS hits from 23 drug targets.  The data show that current in silico filtering tools fail to identify more than half of the compds. that can act via reactive mechanisms.  Significantly, we show how ALARM NMR data has been crit. in identifying reactive compds. that would otherwise have been prioritized for lead optimization.  In addn., a new filtering tool has been developed on the basis of the ALARM NMR data that can augment current in silico programs for identifying nuisance compds. and improving the process of hit triage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolKou1lGZ8tbVg90H21EOLACvtfcHk0li3QsfcLc8pRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurrF&md5=466332d4bdcddf6bc8a630aacbbb32ef</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja0455547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0455547%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DMendoza%26aufirst%3DR.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DJohnson%26aufirst%3DR.%2BW.%26aulast%3DCothron%26aufirst%3DD.%2BA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLerner%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DALARM%2520NMR%253A%2520a%2520rapid%2520and%2520robust%2520experimental%2520method%2520to%2520detect%2520reactive%2520false%2520positives%2520in%2520biochemical%2520screens%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D217%26epage%3D224%26doi%3D10.1021%2Fja0455547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Van Der Kam, E.; Turner, S.; Hobson, A.; Harris, C.; Ronken, E.; Mueller, R.; van Bergeijk, J.; Mezler, M.; Hempel, K.; Mendonca, N.; Rendenbach-Mueller, B.</span>; S1P<sub>5</sub> agonism: a novel treatment for age-related cognitive decline, (sphingo)lipid accumulation, and neurodegenerative disorders such as Alzheimer’s Disease and Niemann Pick C Disease. In press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+Der+Kam%2C+E.%3B+Turner%2C+S.%3B+Hobson%2C+A.%3B+Harris%2C+C.%3B+Ronken%2C+E.%3B+Mueller%2C+R.%3B+van+Bergeijk%2C+J.%3B+Mezler%2C+M.%3B+Hempel%2C+K.%3B+Mendonca%2C+N.%3B+Rendenbach-Mueller%2C+B.%3B+S1P5+agonism%3A+a+novel+treatment+for+age-related+cognitive+decline%2C+%28sphingo%29lipid+accumulation%2C+and+neurodegenerative+disorders+such+as+Alzheimer%E2%80%99s+Disease+and+Niemann+Pick+C+Disease.+In+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BKam%26aufirst%3DE.%26jtitle%3DS1P5%2520agonism%253A%2520a%2520novel%2520treatment%2520for%2520age-related%2520cognitive%2520decline%252C%2520%2528sphingo%2529lipid%2520accumulation%252C%2520and%2520neurodegenerative%2520disorders%2520such%2520as%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Niemann%2520Pick%2520C%2520Disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span>Melior Discovery; <span class="NLM_publisher-name">Melior Discovery</span>: <span class="NLM_publisher-loc">Exton, PA</span>; <a href="http://www.meliordiscovery.com" class="extLink">http://www.meliordiscovery.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Melior+Discovery%3B+Melior+Discovery%3A+Exton%2C+PA%3B+http%3A%2F%2Fwww.meliordiscovery.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMelior%2520Discovery%26pub%3DMelior%2520Discovery" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bin Ma, Kevin M. Guckian, Xiao-gao Liu, Chunhua Yang, Bing Li, Robert Scannevin, Michaël Mingueneau, Annabelle Drouillard, <span class="NLM_string-name hlFld-ContribAuthor">Thierry Walzer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Potent Selective Orally Active S1P5 Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 351-355. <a href="https://doi.org/10.1021/acsmedchemlett.0c00631" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00631</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00631%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BPotent%252BSelective%252BOrally%252BActive%252BS1P5%252BReceptor%252BAntagonists%26aulast%3DMa%26aufirst%3DBin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29112020%26date%3D13012021%26date%3D15012021%26volume%3D12%26issue%3D3%26spage%3D351%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haruto  Kurata</span>, <span class="hlFld-ContribAuthor ">Kensuke  Kusumi</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Otsuki</span>, <span class="hlFld-ContribAuthor ">Ryo  Suzuki</span>, <span class="hlFld-ContribAuthor ">Masakuni  Kurono</span>, <span class="hlFld-ContribAuthor ">Takaki  Komiya</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Hagiya</span>, <span class="hlFld-ContribAuthor ">Hirotaka  Mizuno</span>, <span class="hlFld-ContribAuthor ">Hiroki  Shioya</span>, <span class="hlFld-ContribAuthor ">Takeji  Ono</span>, <span class="hlFld-ContribAuthor ">Yuka  Takada</span>, <span class="hlFld-ContribAuthor ">Tatsuo  Maeda</span>, <span class="hlFld-ContribAuthor ">Norikazu  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Tetsu  Kondo</span>, <span class="hlFld-ContribAuthor ">Sachiko  Tominaga</span>, <span class="hlFld-ContribAuthor ">Ken-ici  Nunoya</span>, <span class="hlFld-ContribAuthor ">Hidekazu  Kiyoshi</span>, <span class="hlFld-ContribAuthor ">Masaharu  Komeno</span>, <span class="hlFld-ContribAuthor ">Shinji  Nakade</span>, and <span class="hlFld-ContribAuthor ">Hiromu  Habashita</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a 1-Methyl-3,4-dihydronaphthalene-Based Sphingosine-1-Phosphate (S1P) Receptor Agonist Ceralifimod (ONO-4641). A S1P1 and S1P5 Selective Agonist for the Treatment of Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9508-9530. <a href="https://doi.org/10.1021/acs.jmedchem.7b00785" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00785%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252B1-Methyl-3%25252C4-dihydronaphthalene-Based%252BSphingosine-1-Phosphate%252B%252528S1P%252529%252BReceptor%252BAgonist%252BCeralifimod%252B%252528ONO-4641%252529.%252BA%252BS1P1%252Band%252BS1P5%252BSelective%252BAgonist%252Bfor%252Bthe%252BTreatment%252Bof%252BAutoimmune%252BDiseases%26aulast%3DKurata%26aufirst%3DHaruto%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D29052017%26date%3D21112017%26date%3D14122017%26date%3D09112017%26volume%3D60%26issue%3D23%26spage%3D9508%26epage%3D9530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>  . </span><span class="cited-content_cbyCitation_article-title">Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5267-5289. <a href="https://doi.org/10.1021/acs.jmedchem.6b01575" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01575%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulators%252Bof%252BSphingosine-1-phosphate%252BPathway%252BBiology%25253A%252BRecent%252BAdvances%252Bof%252BSphingosine-1-phosphate%252BReceptor%252B1%252B%252528S1P1%252529%252BAgonists%252Band%252BFuture%252BPerspectives%26aulast%3DDyckman%26aufirst%3DAlaric%2BJ.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D24102016%26date%3D30032017%26date%3D13072017%26date%3D14032017%26volume%3D60%26issue%3D13%26spage%3D5267%26epage%3D5289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricio  Atanes</span>, <span class="hlFld-ContribAuthor ">Tanyel  Ashik</span>, <span class="hlFld-ContribAuthor ">Shanta J.  Persaud</span>. </span><span class="cited-content_cbyCitation_article-title">Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic regulation. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>228 </em>, 107928. <a href="https://doi.org/10.1016/j.pharmthera.2021.107928" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2021.107928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2021.107928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2021.107928%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DObesity-induced%252Bchanges%252Bin%252Bhuman%252Bislet%252BG%252Bprotein-coupled%252Breceptor%252Bexpression%25253A%252BImplications%252Bfor%252Bmetabolic%252Bregulation%26aulast%3DAtanes%26aufirst%3DPatricio%26date%3D2021%26volume%3D228%26spage%3D107928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew R.  Bogdan</span>, <span class="hlFld-ContribAuthor ">Nathan J.  Gesmundo</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Webster</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Anil  Vasudevan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Chemistry Technologies and Applications to Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-78. <a href="https://doi.org/10.1002/0471266949.bmc293" title="DOI URL">https://doi.org/10.1002/0471266949.bmc293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc293%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bin%252BChemistry%252BTechnologies%252Band%252BApplications%252Bto%252BMedicinal%252BChemistry%26aulast%3DBogdan%26aufirst%3DAndrew%2BR.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D78%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William J.  Pitts</span>, <span class="hlFld-ContribAuthor ">Alaric J.  Dyckman</span>. </span><span class="cited-content_cbyCitation_article-title">Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-43. <a href="https://doi.org/10.1002/0471266949.bmc203.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc203.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc203.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc203.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DMultiple%252BSclerosis%26aulast%3DPitts%26aufirst%3DWilliam%2BJ.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D43%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faik  Imeri</span>, <span class="hlFld-ContribAuthor ">Bisera  Stepanovska Tanturovska</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Zivkovic</span>, <span class="hlFld-ContribAuthor ">Gaby  Enzmann</span>, <span class="hlFld-ContribAuthor ">Stephanie  Schwalm</span>, <span class="hlFld-ContribAuthor ">Josef  Pfeilschifter</span>, <span class="hlFld-ContribAuthor ">Thomas  Homann</span>, <span class="hlFld-ContribAuthor ">Burkhard  Kleuser</span>, <span class="hlFld-ContribAuthor ">Britta  Engelhardt</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>, <span class="hlFld-ContribAuthor ">Andrea  Huwiler</span>. </span><span class="cited-content_cbyCitation_article-title">Novel compounds with dual S1P receptor agonist and histamine H3 receptor antagonist activities act protective in a mouse model of multiple sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2021,</strong> <em>186 </em>, 108464. <a href="https://doi.org/10.1016/j.neuropharm.2021.108464" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2021.108464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2021.108464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2021.108464%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DNovel%252Bcompounds%252Bwith%252Bdual%252BS1P%252Breceptor%252Bagonist%252Band%252Bhistamine%252BH3%252Breceptor%252Bantagonist%252Bactivities%252Bact%252Bprotective%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bmultiple%252Bsclerosis%26aulast%3DImeri%26aufirst%3DFaik%26date%3D2021%26volume%3D186%26spage%3D108464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shingo  Yasuda</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Sumioka</span>, <span class="hlFld-ContribAuthor ">Hiroki  Iwanishi</span>, <span class="hlFld-ContribAuthor ">Yuka  Okada</span>, <span class="hlFld-ContribAuthor ">Masayasu  Miyajima</span>, <span class="hlFld-ContribAuthor ">Kana  Ichikawa</span>, <span class="hlFld-ContribAuthor ">Peter S.  Reinach</span>, <span class="hlFld-ContribAuthor ">Shizuya  Saika</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of sphingosine 1-phosphate receptor 3 gene function impairs injury-induced stromal angiogenesis in mouse cornea. </span><span class="cited-content_cbyCitation_journal-name">Laboratory Investigation</span><span> <strong>2021,</strong> <em>101 </em>
                                    (2)
                                     , 245-257. <a href="https://doi.org/10.1038/s41374-020-00505-1" title="DOI URL">https://doi.org/10.1038/s41374-020-00505-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41374-020-00505-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41374-020-00505-1%26sid%3Dliteratum%253Aachs%26jtitle%3DLaboratory%2520Investigation%26atitle%3DLoss%252Bof%252Bsphingosine%252B1-phosphate%252Breceptor%252B3%252Bgene%252Bfunction%252Bimpairs%252Binjury-induced%252Bstromal%252Bangiogenesis%252Bin%252Bmouse%252Bcornea%26aulast%3DYasuda%26aufirst%3DShingo%26date%3D2021%26date%3D2020%26volume%3D101%26issue%3D2%26spage%3D245%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruobing  Ren</span>, <span class="hlFld-ContribAuthor ">Bin  Pang</span>, <span class="hlFld-ContribAuthor ">Yufei  Han</span>, <span class="hlFld-ContribAuthor ">Yihao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A Glimpse of the Structural Biology of the Metabolism of Sphingosine-1-Phosphate. </span><span class="cited-content_cbyCitation_journal-name">Contact</span><span> <strong>2021,</strong> <em>4 </em>, 251525642199560. <a href="https://doi.org/10.1177/2515256421995601" title="DOI URL">https://doi.org/10.1177/2515256421995601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2515256421995601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2515256421995601%26sid%3Dliteratum%253Aachs%26jtitle%3DContact%26atitle%3DA%252BGlimpse%252Bof%252Bthe%252BStructural%252BBiology%252Bof%252Bthe%252BMetabolism%252Bof%252BSphingosine-1-Phosphate%26aulast%3DRen%26aufirst%3DRuobing%26date%3D2021%26date%3D2021%26volume%3D4%26spage%3D251525642199560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michiel  Langeslag</span>, <span class="hlFld-ContribAuthor ">Michaela  Kress</span>. </span><span class="cited-content_cbyCitation_article-title">The ceramide-S1P pathway as a druggable target to alleviate peripheral neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2020,</strong> <em>24 </em>
                                    (9)
                                     , 869-884. <a href="https://doi.org/10.1080/14728222.2020.1787989" title="DOI URL">https://doi.org/10.1080/14728222.2020.1787989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2020.1787989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2020.1787989%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DThe%252Bceramide-S1P%252Bpathway%252Bas%252Ba%252Bdruggable%252Btarget%252Bto%252Balleviate%252Bperipheral%252Bneuropathic%252Bpain%26aulast%3DLangeslag%26aufirst%3DMichiel%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D9%26spage%3D869%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Musella</span>, <span class="hlFld-ContribAuthor ">Antonietta  Gentile</span>, <span class="hlFld-ContribAuthor ">Livia  Guadalupi</span>, <span class="hlFld-ContribAuthor ">Francesca Romana  Rizzo</span>, <span class="hlFld-ContribAuthor ">Francesca  De Vito</span>, <span class="hlFld-ContribAuthor ">Diego  Fresegna</span>, <span class="hlFld-ContribAuthor ">Antonio  Bruno</span>, <span class="hlFld-ContribAuthor ">Ettore  Dolcetti</span>, <span class="hlFld-ContribAuthor ">Valentina  Vanni</span>, <span class="hlFld-ContribAuthor ">Laura  Vitiello</span>, <span class="hlFld-ContribAuthor ">Silvia  Bullitta</span>, <span class="hlFld-ContribAuthor ">Krizia  Sanna</span>, <span class="hlFld-ContribAuthor ">Silvia  Caioli</span>, <span class="hlFld-ContribAuthor ">Sara  Balletta</span>, <span class="hlFld-ContribAuthor ">Monica  Nencini</span>, <span class="hlFld-ContribAuthor ">Fabio  Buttari</span>, <span class="hlFld-ContribAuthor ">Mario  Stampanoni Bassi</span>, <span class="hlFld-ContribAuthor ">Diego  Centonze</span>, <span class="hlFld-ContribAuthor ">Georgia  Mandolesi</span>. </span><span class="cited-content_cbyCitation_article-title">Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (5)
                                     , 1290. <a href="https://doi.org/10.3390/cells9051290" title="DOI URL">https://doi.org/10.3390/cells9051290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9051290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9051290%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DCentral%252BModulation%252Bof%252BSelective%252BSphingosine-1-Phosphate%252BReceptor%252B1%252BAmeliorates%252BExperimental%252BMultiple%252BSclerosis%26aulast%3DMusella%26aufirst%3DAlessandra%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D5%26spage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bisera  Stepanovska</span>, <span class="hlFld-ContribAuthor ">Andrea  Huwiler</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the S1P receptor signaling pathways as a promising approach for treatment of autoimmune and inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>154 </em>, 104170. <a href="https://doi.org/10.1016/j.phrs.2019.02.009" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252Bthe%252BS1P%252Breceptor%252Bsignaling%252Bpathways%252Bas%252Ba%252Bpromising%252Bapproach%252Bfor%252Btreatment%252Bof%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%26aulast%3DStepanovska%26aufirst%3DBisera%26date%3D2020%26volume%3D154%26spage%3D104170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroki  Kittaka</span>, <span class="hlFld-ContribAuthor ">Jennifer  DeBrecht</span>, <span class="hlFld-ContribAuthor ">Santosh K  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">Differential contribution of sensory transient receptor potential channels in response to the bioactive lipid sphingosine-1-phosphate. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pain</span><span> <strong>2020,</strong> <em>16 </em>, 174480692090351. <a href="https://doi.org/10.1177/1744806920903515" title="DOI URL">https://doi.org/10.1177/1744806920903515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1744806920903515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1744806920903515%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pain%26atitle%3DDifferential%252Bcontribution%252Bof%252Bsensory%252Btransient%252Breceptor%252Bpotential%252Bchannels%252Bin%252Bresponse%252Bto%252Bthe%252Bbioactive%252Blipid%252Bsphingosine-1-phosphate%26aulast%3DKittaka%26aufirst%3DHiroki%26date%3D2020%26date%3D2020%26volume%3D16%26spage%3D174480692090351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yusra Sajid  Kiani</span>, <span class="hlFld-ContribAuthor ">Ishrat  Jabeen</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the Chemical Space of Cytochrome P450 Inhibitors Using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models. </span><span class="cited-content_cbyCitation_journal-name">Computation</span><span> <strong>2019,</strong> <em>7 </em>
                                    (2)
                                     , 26. <a href="https://doi.org/10.3390/computation7020026" title="DOI URL">https://doi.org/10.3390/computation7020026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/computation7020026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcomputation7020026%26sid%3Dliteratum%253Aachs%26jtitle%3DComputation%26atitle%3DExploring%252Bthe%252BChemical%252BSpace%252Bof%252BCytochrome%252BP450%252BInhibitors%252BUsing%252BIntegrated%252BPhysicochemical%252BParameters%25252C%252BDrug%252BEfficiency%252BMetrics%252Band%252BDecision%252BTree%252BModels%26aulast%3DKiani%26aufirst%3DYusra%2BSajid%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D2%26spage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ran  Li</span>, <span class="hlFld-ContribAuthor ">Poornima  Venkat</span>, <span class="hlFld-ContribAuthor ">Michael  Chopp</span>, <span class="hlFld-ContribAuthor ">Qiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Yan</span>, <span class="hlFld-ContribAuthor ">Jieli  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">RP001 hydrochloride improves neurological outcome after subarachnoid hemorrhage. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Neurological Sciences</span><span> <strong>2019,</strong> <em>399 </em>, 6-14. <a href="https://doi.org/10.1016/j.jns.2019.02.005" title="DOI URL">https://doi.org/10.1016/j.jns.2019.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jns.2019.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jns.2019.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Neurological%2520Sciences%26atitle%3DRP001%252Bhydrochloride%252Bimproves%252Bneurological%252Boutcome%252Bafter%252Bsubarachnoid%252Bhemorrhage%26aulast%3DLi%26aufirst%3DRan%26date%3D2019%26volume%3D399%26spage%3D6%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rie  Matsushima-Nishiwaki</span>, <span class="hlFld-ContribAuthor ">Noriko  Yamada</span>, <span class="hlFld-ContribAuthor ">Kouki  Fukuchi</span>, <span class="hlFld-ContribAuthor ">Osamu  Kozawa</span>, . </span><span class="cited-content_cbyCitation_article-title">Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (12)
                                     , e0209050. <a href="https://doi.org/10.1371/journal.pone.0209050" title="DOI URL">https://doi.org/10.1371/journal.pone.0209050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0209050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0209050%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DSphingosine%252B1-phosphate%252B%252528S1P%252529%252Breduces%252Bhepatocyte%252Bgrowth%252Bfactor-induced%252Bmigration%252Bof%252Bhepatocellular%252Bcarcinoma%252Bcells%252Bvia%252BS1P%252Breceptor%252B2%26aulast%3DMatsushima-Nishiwaki%26aufirst%3DRie%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D12%26spage%3De0209050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Clausznitzer</span>, <span class="hlFld-ContribAuthor ">Cesar  Pichardo-Almarza</span>, <span class="hlFld-ContribAuthor ">Ana Lucia  Relo</span>, <span class="hlFld-ContribAuthor ">Jeroen  van Bergeijk</span>, <span class="hlFld-ContribAuthor ">Elizabeth  van der Kam</span>, <span class="hlFld-ContribAuthor ">Loic  Laplanche</span>, <span class="hlFld-ContribAuthor ">Neil  Benson</span>, <span class="hlFld-ContribAuthor ">Marjoleen  Nijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Systems Pharmacology Model for Alzheimer Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option. </span><span class="cited-content_cbyCitation_journal-name">CPT: Pharmacometrics & Systems Pharmacology</span><span> <strong>2018,</strong> <em>7 </em>
                                    (11)
                                     , 759-770. <a href="https://doi.org/10.1002/psp4.12351" title="DOI URL">https://doi.org/10.1002/psp4.12351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/psp4.12351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpsp4.12351%26sid%3Dliteratum%253Aachs%26jtitle%3DCPT%253A%2520Pharmacometrics%2520%2526%2520Systems%2520Pharmacology%26atitle%3DQuantitative%252BSystems%252BPharmacology%252BModel%252Bfor%252BAlzheimer%252BDisease%252BIndicates%252BTargeting%252BSphingolipid%252BDysregulation%252Bas%252BPotential%252BTreatment%252BOption%26aulast%3DClausznitzer%26aufirst%3DDiana%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D11%26spage%3D759%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alba  Di Pardo</span>, <span class="hlFld-ContribAuthor ">Salvatore  Castaldo</span>, <span class="hlFld-ContribAuthor ">Enrico  Amico</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Pepe</span>, <span class="hlFld-ContribAuthor ">Federico  Marracino</span>, <span class="hlFld-ContribAuthor ">Luca  Capocci</span>, <span class="hlFld-ContribAuthor ">Alfredo  Giovannelli</span>, <span class="hlFld-ContribAuthor ">Michele  Madonna</span>, <span class="hlFld-ContribAuthor ">Jeroen  van Bergeijk</span>, <span class="hlFld-ContribAuthor ">Fabio  Buttari</span>, <span class="hlFld-ContribAuthor ">Elizabeth  van der Kam</span>, <span class="hlFld-ContribAuthor ">Vittorio  Maglione</span>. </span><span class="cited-content_cbyCitation_article-title">Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood–brain barrier integrity and exerts therapeutic effect in an animal model of Huntington’s disease. </span><span class="cited-content_cbyCitation_journal-name">Human Molecular Genetics</span><span> <strong>2018,</strong> <em>27 </em>
                                    (14)
                                     , 2490-2501. <a href="https://doi.org/10.1093/hmg/ddy153" title="DOI URL">https://doi.org/10.1093/hmg/ddy153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/hmg/ddy153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fhmg%2Fddy153%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Molecular%2520Genetics%26atitle%3DStimulation%252Bof%252BS1PR5%252Bwith%252BA-971432%25252C%252Ba%252Bselective%252Bagonist%25252C%252Bpreserves%252Bblood%2525E2%252580%252593brain%252Bbarrier%252Bintegrity%252Band%252Bexerts%252Btherapeutic%252Beffect%252Bin%252Ban%252Banimal%252Bmodel%252Bof%252BHuntington%2525E2%252580%252599s%252Bdisease%26aulast%3DDi%2BPardo%26aufirst%3DAlba%26date%3D2018%26date%3D2018%26volume%3D27%26issue%3D14%26spage%3D2490%26epage%3D2501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annabelle  Drouillard</span>, <span class="hlFld-ContribAuthor ">Anne-Laure  Mathieu</span>, <span class="hlFld-ContribAuthor ">Antoine  Marçais</span>, <span class="hlFld-ContribAuthor ">Alexandre  Belot</span>, <span class="hlFld-ContribAuthor ">Sébastien  Viel</span>, <span class="hlFld-ContribAuthor ">Michaël  Mingueneau</span>, <span class="hlFld-ContribAuthor ">Kevin  Guckian</span>, <span class="hlFld-ContribAuthor ">Thierry  Walzer</span>. </span><span class="cited-content_cbyCitation_article-title">S1PR5 is essential for human natural killer cell migration toward sphingosine-1 phosphate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Allergy and Clinical Immunology</span><span> <strong>2018,</strong> <em>141 </em>
                                    (6)
                                     , 2265-2268.e1. <a href="https://doi.org/10.1016/j.jaci.2017.11.022" title="DOI URL">https://doi.org/10.1016/j.jaci.2017.11.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jaci.2017.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jaci.2017.11.022%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Allergy%2520and%2520Clinical%2520Immunology%26atitle%3DS1PR5%252Bis%252Bessential%252Bfor%252Bhuman%252Bnatural%252Bkiller%252Bcell%252Bmigration%252Btoward%252Bsphingosine-1%252Bphosphate%26aulast%3DDrouillard%26aufirst%3DAnnabelle%26date%3D2018%26volume%3D141%26issue%3D6%26spage%3D2265%26epage%3D2268.e1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Jing  Sun</span>, <span class="hlFld-ContribAuthor ">Min  Chen</span>, <span class="hlFld-ContribAuthor ">Ming-Hui  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine-1-phosphate (S1P) enhances glomerular endothelial cells activation mediated by anti-myeloperoxidase antibody-positive IgG. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2018,</strong> <em>22 </em>
                                    (3)
                                     , 1769-1777. <a href="https://doi.org/10.1111/jcmm.13458" title="DOI URL">https://doi.org/10.1111/jcmm.13458</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.13458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.13458%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DSphingosine-1-phosphate%252B%252528S1P%252529%252Benhances%252Bglomerular%252Bendothelial%252Bcells%252Bactivation%252Bmediated%252Bby%252Banti-myeloperoxidase%252Bantibody-positive%252BIgG%26aulast%3DSun%26aufirst%3DXiao-Jing%26date%3D2018%26date%3D2017%26volume%3D22%26issue%3D3%26spage%3D1769%26epage%3D1777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Axel R.  Stoit</span>, <span class="hlFld-ContribAuthor ">Jos H.M.  Lange</span>, <span class="hlFld-ContribAuthor ">Hein K.A.C.  Coolen</span>, <span class="hlFld-ContribAuthor ">Annemieke  Rensink</span>, <span class="hlFld-ContribAuthor ">Adri  van den Hoogenband</span>, <span class="hlFld-ContribAuthor ">Arnold P.  den Hartog</span>, <span class="hlFld-ContribAuthor ">Sjoerd  van Schaik</span>, <span class="hlFld-ContribAuthor ">Chris G.  Kruse</span>. </span><span class="cited-content_cbyCitation_article-title">Spiro-1-benzofuranpiperidinylalkanoic acids as a novel and selective sphingosine S1P5 receptor agonist chemotype. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 459-465. <a href="https://doi.org/10.1016/j.bmcl.2017.12.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSpiro-1-benzofuranpiperidinylalkanoic%252Bacids%252Bas%252Ba%252Bnovel%252Band%252Bselective%252Bsphingosine%252BS1P5%252Breceptor%252Bagonist%252Bchemotype%26aulast%3DStoit%26aufirst%3DAxel%2BR.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D459%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Vogt</span>, <span class="hlFld-ContribAuthor ">Holger  Stark</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2017,</strong> <em>37 </em>
                                    (1)
                                     , 3-51. <a href="https://doi.org/10.1002/med.21402" title="DOI URL">https://doi.org/10.1002/med.21402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21402%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTherapeutic%252BStrategies%252Band%252BPharmacological%252BTools%252BInfluencing%252BS1P%252BSignaling%252Band%252BMetabolism%26aulast%3DVogt%26aufirst%3DDominik%26date%3D2017%26date%3D2016%26volume%3D37%26issue%3D1%26spage%3D3%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Longjiang  Huang</span>, <span class="hlFld-ContribAuthor ">Yuan  Tian</span>, <span class="hlFld-ContribAuthor ">Dawei  Teng</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient synthesis of 1′,4′-dihydro-2′H-spiro[azetidin-2,3′-quinolin]-2′-one. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2017,</strong> <em>43 </em>
                                    (1)
                                     , 219-228. <a href="https://doi.org/10.1007/s11164-016-2616-6" title="DOI URL">https://doi.org/10.1007/s11164-016-2616-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-016-2616-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-016-2616-6%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DAn%252Befficient%252Bsynthesis%252Bof%252B1%2525E2%252580%2525B2%25252C4%2525E2%252580%2525B2-dihydro-2%2525E2%252580%2525B2H-spiro%25255Bazetidin-2%25252C3%2525E2%252580%2525B2-quinolin%25255D-2%2525E2%252580%2525B2-one%26aulast%3DHuang%26aufirst%3DLongjiang%26date%3D2017%26date%3D2016%26volume%3D43%26issue%3D1%26spage%3D219%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wooyoung  Hur</span>, <span class="hlFld-ContribAuthor ">Hugh  Rosen</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">A benzo[ b ]thiophene-based selective type 4 S1P receptor agonist. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (1)
                                     , 1-5. <a href="https://doi.org/10.1016/j.bmcl.2016.11.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bbenzo%25255B%252Bb%252B%25255Dthiophene-based%252Bselective%252Btype%252B4%252BS1P%252Breceptor%252Bagonist%26aulast%3DHur%26aufirst%3DWooyoung%26date%3D2017%26volume%3D27%26issue%3D1%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Yin</span>, <span class="hlFld-ContribAuthor ">Ainash  Garifullina</span>, <span class="hlFld-ContribAuthor ">Fujie  Tanaka</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of pyrrolidine-3-carboxylic acid derivatives
              via
              asymmetric Michael addition reactions of carboxylate-substituted enones. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (29)
                                     , 6089-6092. <a href="https://doi.org/10.1039/C7OB01484H" title="DOI URL">https://doi.org/10.1039/C7OB01484H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB01484H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB01484H%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bpyrrolidine-3-carboxylic%252Bacid%252Bderivatives%252Bvia%252Basymmetric%252BMichael%252Baddition%252Breactions%252Bof%252Bcarboxylate-substituted%252Benones%26aulast%3DYin%26aufirst%3DFeng%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D29%26spage%3D6089%26epage%3D6092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wee Siong  Chew</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Deron R.  Herr</span>. </span><span class="cited-content_cbyCitation_article-title">To fingolimod and beyond: The rich pipeline of drug candidates that target S1P signaling. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2016,</strong> <em>113 </em>, 521-532. <a href="https://doi.org/10.1016/j.phrs.2016.09.025" title="DOI URL">https://doi.org/10.1016/j.phrs.2016.09.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2016.09.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2016.09.025%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTo%252Bfingolimod%252Band%252Bbeyond%25253A%252BThe%252Brich%252Bpipeline%252Bof%252Bdrug%252Bcandidates%252Bthat%252Btarget%252BS1P%252Bsignaling%26aulast%3DChew%26aufirst%3DWee%2BSiong%26date%3D2016%26volume%3D113%26spage%3D521%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0001.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of literature S1P<sub>1</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Reductive Amination of an Aldehyde with Azetidine-3-carboxylic Acid Using Polymer Supported NaCNBH<sub>3</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Regions of compound <b>6</b> selected for SAR investigation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route toward 1,2-Diphenylethane Analogues <b>42</b> and <b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) ethane-1,2-diol, PTSA, PhMe; (b) Mg, I<sub>2</sub>, Et<sub>2</sub>O; (c) <b>36</b>, Et<sub>2</sub>O; (d) 10% HCl, THF, reflux; (e) azetidine-carboxylic acid, NaCNBH<sub>3</sub>, MeOH; (f) 1% H<sub>2</sub>SO<sub>4</sub>/EtOH, Pd/C, H<sub>2</sub>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route toward (Benzyloxy)benzene Analogues <b>57</b>–<b>63</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P, DIAD, THF; (b) DIBAL, PhMe; (c) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route toward Substituted 1-(4-(Benzyloxy)-2-methylbenzyl)azetidine-3-carboxylic Acids <b>69</b> and <b>70</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P, DIAD, THF; (b) CuCN, NMP; (c) DIBAL, PhMe; (d) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route toward Substituted 1-(4-(Benzyloxy)-2-methylbenzyl)azetidine-3-carboxylic Acids <b>75</b> and <b>76</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: Ph<sub>3</sub>P, DIAD, THF; (b) DIBAL, PhMe; (c) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of five compounds selected for scale up to enable additional profiling.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative examples from each library design showing (a) excellent calculated physicochemical properties, (b) good projected clearance and oral absorption, and (c) predicted reduced risk of toxicity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0015.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Large Scale Synthetic Route for 1-(4-((3,4-Dichlorobenzyl)oxy)benzyl)azetidine-3-carboxylic Acid <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone, reflux; (b) azetidine-3-carboxylic acid, NaCNBH<sub>3</sub>, MeOH.</p></p></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro functional S1P<sub>5</sub> assays. (a) GTPγS binding in membranes from S1P<sub>5</sub>-transfected HEK cells. (b) Inhibition of forskolin-induced cAMP in S1P<sub>5</sub>-transfected CHO cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Selectivity of <b>29</b> against S1P<sub>1</sub> is confirmed by a lack of lymphopenia. Sprague–Dawley rats were administered 10, 30, or 100 mg/kg of <b>29</b> or vehicle (0.5% HPMC/0.02% Tween 80) by oral gavage. Five hours later, blood was collected via cardiac puncture under isoflurane anesthesia. Mean number of lymphocytes ± SEM are reported (<i>n</i> = 4). Plasma exposures were determined to be 1800, 5000, and 15000 ng/mL respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>29</b> does not cause bradycardia in anesthetized rats. <b>29</b> was administered by three sequential 30 min IV infusions at 3, 10, and 30 mg/kg. No effects on heart rate were observed through the highest mean exposure of 20.3 μg/mL. Similarly, no statistically significant effects on mean arterial pressure were observed. Cardiac contractility (d<i>P</i>/d<i>t</i><sub>50</sub>) was decreased 10% (change from baseline) during the end of the third infusion period (<i>P</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0008.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>29</b> impacts transendothelial electrical resistance as assessed through ECIS in hCMEC/D3 cells; DMSO (<i>n</i> = 4) or 1 μM <b>29</b> (<i>n</i> = 2) was added to the cell layer and resistance (Ω·cm<sup>2</sup>) was assessed over 75 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/medium/jm-2015-00928e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0009.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. <b>29</b> reverses age-related cognitive decline as seen in the spontaneous alternation assay in the T-maze in aged male C57BL6J mice after subacute treatment. <b>29</b> (0.1 mg/kg) was administered for 21 days, qd. Testing was performed 225 min after the final dose. One-way ANOVA: ** <i>p</i> < 0.05 in comparison to young vehicle-treated animals, <sup>∧ </sup><i>p</i> < 0.05 in comparison to aged vehicle-treated animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-23/acs.jmedchem.5b00928/20151204/images/large/jm-2015-00928e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00928&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i101">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Van Doorn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes Pinheiro, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooij, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lakeman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van het Hof, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Pol, S. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Horssen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Valk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronken, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reijerkerk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, H. E.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="refDoi"> DOI: 10.1186/1742-2094-9-133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1186%2F1742-2094-9-133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=22715976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhsl2jt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=133&author=R.+Van+Doornauthor=M.+A.+Lopes+Pinheiroauthor=G.+Kooijauthor=K.+Lakemanauthor=B.+van+het+Hofauthor=S.+M.+A.+van+der+Polauthor=D.+Geertsauthor=J.+van+Horssenauthor=P.+van+der+Valkauthor=E.+van+der+Kamauthor=E.+Ronkenauthor=A.+Reijerkerkauthor=H.+E.+de+Vries&title=Sphingosine+1-phosphate+receptor+5+mediates+the+immune+quiescence+of+the+human+brain+endothelial+barrier&doi=10.1186%2F1742-2094-9-133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier</span></div><div class="casAuthors">van Doorn, Ruben; Pinheiro, Melissa A. Lopes; Kooij, Gijs; Lakeman, Kim; van het Hof, Bert; van der Pol, Susanne M. A.; Geerts, Dirk; van Horssen, Jack; van der Valk, Paul; van der Kam, Elizabeth; Ronken, Eric; Reijerkerk, Arie; de Vries, Helga E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">133</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The sphingosine 1-phosphate (S1P) receptor modulator FTY720P (Gilenya) potently reduces relapse rate and lesion activity in the neuroinflammatory disorder multiple sclerosis.  Although most of its efficacy has been shown to be related to immunosuppression through the induction of lymphopenia, it has been suggested that a no. of its beneficial effects are related to altered endothelial and blood-brain barrier (BBB) functionality.  However, to date it remains unknown whether brain endothelial S1P receptors are involved in the maintenance of the function of the BBB thereby mediating immune quiescence of the brain.  Here we demonstrate that the brain endothelial receptor S1P5 largely contributes to the maintenance of brain endothelial barrier function.  Methods: We analyzed the expression of S1P5 in human post-mortem tissues using immunohistochem.  The function of S1P5 at the BBB was assessed in cultured human brain endothelial cells (ECs) using agonists and lentivirus-mediated knockdown of S1P5.  Subsequent analyses of different aspects of the brain EC barrier included the formation of a tight barrier, the expression of BBB proteins and markers of inflammation and monocyte transmigration.  Results: We show that activation of S1P5 on cultured human brain ECs by a selective agonist elicits enhanced barrier integrity and reduced transendothelial migration of monocytes in vitro.  These results were corroborated by genetically silencing S1P5 in brain ECs.  Interestingly, functional studies with these cells revealed that S1P5 strongly contributes to brain EC barrier function and underlies the expression of specific BBB endothelial characteristics such as tight junctions and permeability.  In addn., S1P5 maintains the immunoquiescent state of brain ECs with low expression levels of leukocyte adhesion mols. and inflammatory chemokines and cytokines through lowering the activation of the transcription factor NFκB.  Conclusion: Our findings demonstrate that S1P5 in brain ECs contributes to optimal barrier formation and maintenance of immune quiescence of the barrier endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4TXZcnzDvurVg90H21EOLACvtfcHk0ljmtiZgZnLleg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhsl2jt73L&md5=ee524d8c59b03ec29711a5f6a9c2da4e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-9-133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-9-133%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDoorn%26aufirst%3DR.%26aulast%3DLopes%2BPinheiro%26aufirst%3DM.%2BA.%26aulast%3DKooij%26aufirst%3DG.%26aulast%3DLakeman%26aufirst%3DK.%26aulast%3Dvan%2Bhet%2BHof%26aufirst%3DB.%26aulast%3Dvan%2Bder%2BPol%26aufirst%3DS.%2BM.%2BA.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3Dvan%2BHorssen%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BValk%26aufirst%3DP.%26aulast%3Dvan%2Bder%2BKam%26aufirst%3DE.%26aulast%3DRonken%26aufirst%3DE.%26aulast%3DReijerkerk%26aufirst%3DA.%26aulast%3Dde%2BVries%26aufirst%3DH.%2BE.%26atitle%3DSphingosine%25201-phosphate%2520receptor%25205%2520mediates%2520the%2520immune%2520quiescence%2520of%2520the%2520human%2520brain%2520endothelial%2520barrier%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2012%26volume%3D9%26spage%3D133%26doi%3D10.1186%2F1742-2094-9-133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Harris, C.; Hobson, A.; Wilson, N. S.</span><span> </span><span class="NLM_article-title">Agonists and antagonists of the S1P<sub>5</sub> receptor, and methods of uses thereof</span>. WO2010093704,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Harris&author=A.+Hobson&author=N.+S.+Wilson&title=Agonists+and+antagonists+of+the+S1P5+receptor%2C+and+methods+of+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%26atitle%3DAgonists%2520and%2520antagonists%2520of%2520the%2520S1P5%2520receptor%252C%2520and%2520methods%2520of%2520uses%2520thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Van der Kam, E.; Turner, S.; van Bergeijk, J.; Mueller, R.; Mezler, M.; Bespalov, A.; Hobson, A.; Harris, C. M.; Rendenbach-Mueller, B.; Schoemaker, H.</span><span> </span><span class="NLM_article-title">The use of selective sphingosine-1-phosphate receptor 5 agonists for the treatment of neurodegenerative disorders such as Alzheimer’s disease and lysosomal storage diseases such as Niemann Pick C disease</span>. <span class="NLM_conf-name">Alzheimer’s Association International Conference, AAIC</span>, <span class="NLM_conf-loc">Copenhagen</span>, <span class="NLM_conf-date">July 12–17, 2014</span>, abstract and presentation.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+der+Kam%2C+E.%3B+Turner%2C+S.%3B+van+Bergeijk%2C+J.%3B+Mueller%2C+R.%3B+Mezler%2C+M.%3B+Bespalov%2C+A.%3B+Hobson%2C+A.%3B+Harris%2C+C.+M.%3B+Rendenbach-Mueller%2C+B.%3B+Schoemaker%2C+H.+The+use+of+selective+sphingosine-1-phosphate+receptor+5+agonists+for+the+treatment+of+neurodegenerative+disorders+such+as+Alzheimer%E2%80%99s+disease+and+lysosomal+storage+diseases+such+as+Niemann+Pick+C+disease.+Alzheimer%E2%80%99s+Association+International+Conference%2C+AAIC%2C+Copenhagen%2C+July+12%E2%80%9317%2C+2014%2C+abstract+and+presentation."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bder%2BKam%26aufirst%3DE.%26atitle%3DThe%2520use%2520of%2520selective%2520sphingosine-1-phosphate%2520receptor%25205%2520agonists%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%2520such%2520as%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520lysosomal%2520storage%2520diseases%2520such%2520as%2520Niemann%2520Pick%2520C%2520disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kluk, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hla, T.</span><span> </span><span class="NLM_article-title">Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1582</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1016/S1388-1981(02)00139-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2FS1388-1981%2802%2900139-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=12069812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD38XksF2htrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1582&publication_year=2002&pages=72-80&author=M.+J.+Klukauthor=T.+Hla&title=Signaling+of+sphingosine-1-phosphate+via+the+S1P%2FEDG-family+of+G-protein-coupled+receptors&doi=10.1016%2FS1388-1981%2802%2900139-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors</span></div><div class="casAuthors">Kluk, Michael J.; Hla, Timothy</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1582</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">72-80</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The sphingosine-1-phosphate/Endothelial Differentiation Gene (S1P/EDG) family of G-protein-coupled receptors (GPCR) currently includes 5 different isoforms, which differentially regulate fundamental cellular processes such as migration, proliferation, cytoskeletal organization, adherens junction assembly, and morphogenesis.  Addnl., specific S1P/EDG isoforms can regulate important physiol. processes such as blood vessel maturation, cardiac development, and angiogenesis in vivo.  Herein, we review the current state of knowledge of the expression patterns, signaling pathways and functional characteristics of the different S1P receptors.  Further investigation in this field will likely improve our understanding of cardiovascular development as well as vascular diseases and may lead to novel therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKST9SG_-J_bVg90H21EOLACvtfcHk0liI-kgo9dO6hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksF2htrg%253D&md5=168c5ed52f5c550bb722e6c77308ccd7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2802%2900139-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252802%252900139-7%26sid%3Dliteratum%253Aachs%26aulast%3DKluk%26aufirst%3DM.%2BJ.%26aulast%3DHla%26aufirst%3DT.%26atitle%3DSignaling%2520of%2520sphingosine-1-phosphate%2520via%2520the%2520S1P%252FEDG-family%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2002%26volume%3D1582%26spage%3D72%26epage%3D80%26doi%3D10.1016%2FS1388-1981%2802%2900139-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span><span class="refDoi"> DOI: 10.1126/science.1070238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1126%2Fscience.1070238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=11923495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.-J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1-Phosphate+Receptor+Agonists&doi=10.1126%2Fscience.1070238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists</span></div><div class="casAuthors">Mandala, Suzanne; Hajdu, Richard; Bergstrom, James; Quackenbush, Elizabeth; Xie, Jenny; Milligan, James; Thornton, Rosemary; Shei, Gan-Ju; Card, Deborah; Keohane, Carolann; Rosenbach, Mark; Hale, Jeffrey; Lynch, Christopher L.; Rupprecht, Kathleen; Parsons, William; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5566</span>),
    <span class="NLM_cas:pages">346-349</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Blood lymphocyte nos., essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs.  We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720.  Both species were high-affinity agonists of at least four of the five S1P receptors.  These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen.  S1P receptor agonists induced emptying of lymphoid sinuses by retention of lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph.  Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPvwG_lLsA8LVg90H21EOLACvtfcHk0liI-kgo9dO6hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVWhsrc%253D&md5=b57cbcffe41d144e701dbd42459cf38a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1070238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1070238%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349%26doi%3D10.1126%2Fscience.1070238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohlfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selmaj, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoropoulou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leyk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang-Auberson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burtin, P.</span><span> </span><span class="NLM_article-title">A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span><span class="refDoi"> DOI: 10.1056/NEJMoa0909494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1056%2FNEJMoa0909494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=20089952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2010&pages=387-401&author=L.+Kapposauthor=E.-W.+Radueauthor=P.+O%27Connorauthor=C.+Polmanauthor=R.+Hohlfeldauthor=P.+Calabresiauthor=K.+Selmajauthor=C.+Agoropoulouauthor=M.+Leykauthor=L.+Zhang-Aubersonauthor=P.+Burtin&title=A+Placebo-Controlled+Trial+of+Oral+Fingolimod+in+Relapsing+Multiple+Sclerosis&doi=10.1056%2FNEJMoa0909494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Radue, Ernst-Wilhelm; O'Connor, Paul; Polman, Chris; Hohlfeld, Reinhard; Calabresi, Peter; Selmaj, Krzysztof; Agoropoulou, Catherine; Leyk, Malgorzata; Zhang-Auberson, Lixin; Burtin, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or i.m. interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis.  METHODS: In our 24-mo, double-blind, randomized study, we enrolled patients who had relapsing-remitting multiple sclerosis, were 18 to 55 years of age, had a score of 0 to 5.5 on the Expanded Disability Status Scale (which ranges from 0 to 10, with higher scores indicating greater disability), and had one or more relapses in the previous year or two or more in the previous 2 years.  Patients received oral fingolimod at a dose of 0.5 mg or 1.25 mg daily or placebo.  End points included the annualized relapse rate (the primary end point) and the time to disability progression (a secondary end point).  RESULTS: A total of 1033 of the 1272 patients (81.2%) completed the study.  The annualized relapse rate was 0.18 with 0.5 mg of fingolimod, 0.16 with 1.25 mg of fingolimod, and 0.40 with placebo (P < 0.001 for either dose vs. placebo).  Fingolimod at doses of 0.5 mg and 1.25 mg significantly reduced the risk of disability progression over the 24-mo period (hazard ratio, 0.70 and 0.68, resp.; P = 0.02 vs. placebo, for both comparisons).  The cumulative probability of disability progression (confirmed after 3 mo) was 17.7% with 0.5 mg of fingolimod, 16.6% with 1.25 mg of fingolimod, and 24.1% with placebo.  Both fingolimod doses were superior to placebo with regard to MRI-related measures (no. of new or enlarged lesions on T2 -weighted images, gadolinium-enhancing lesions, and brain-vol. loss; P < 0.001 for all comparisons at 24 mo).  Causes of study discontinuation and adverse events related to fingolimod included bradycardia and atrioventricular conduction block at the time of fingolimod initiation, macular edema, elevated liver-enzyme levels, and mild hypertension.  CONCLUSIONS: As compared with placebo, both doses of oral fingolimod improved the relapse rate, the risk of disability progression, and end points on MRI.  These benefits will need to be weighed against possible long-term risks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZV83ylA8IarVg90H21EOLACvtfcHk0liI-kgo9dO6hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvVWltr4%253D&md5=0c1a63e4b8850f3579b2a8f6c7f28ac0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909494%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DRadue%26aufirst%3DE.-W.%26aulast%3DO%2527Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%26aulast%3DHohlfeld%26aufirst%3DR.%26aulast%3DCalabresi%26aufirst%3DP.%26aulast%3DSelmaj%26aufirst%3DK.%26aulast%3DAgoropoulou%26aufirst%3DC.%26aulast%3DLeyk%26aufirst%3DM.%26aulast%3DZhang-Auberson%26aufirst%3DL.%26aulast%3DBurtin%26aufirst%3DP.%26atitle%3DA%2520Placebo-Controlled%2520Trial%2520of%2520Oral%2520Fingolimod%2520in%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D362%26spage%3D387%26epage%3D401%26doi%3D10.1056%2FNEJMoa0909494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_contrib-group">Vachal, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toth, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>) receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3684</span><span class="NLM_x">–</span> <span class="NLM_lpage">3687</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.04.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2006.04.064" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3684-3687&author=P.+Vachalauthor=L.+M.+Tothauthor=J.+J.+Haleauthor=L.+Yanauthor=S.+G.+Millsauthor=G.+L.+Chrebetauthor=C.+A.+Koehaneauthor=R.+Hajduauthor=J.+A.+Milliganauthor=M.+J.+Rosenbachauthor=S.+Mandala&title=Highly+selective+and+potent+agonists+of+sphingosine-1-phosphate+1+%28S1P1%29+receptor&doi=10.1016%2Fj.bmcl.2006.04.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.04.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.04.064%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DToth%26aufirst%3DL.%2BM.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChrebet%26aufirst%3DG.%2BL.%26aulast%3DKoehane%26aufirst%3DC.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DHighly%2520selective%2520and%2520potent%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3684%26epage%3D3687%26doi%3D10.1016%2Fj.bmcl.2006.04.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_contrib-group">Clemens, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P<sub>1</sub>) receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3401</span><span class="NLM_x">–</span> <span class="NLM_lpage">3404</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00812-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2FS0960-894X%2803%2900812-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3401-3404&author=J.+J.+Clemensauthor=M.+D.+Davisauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Highly+selective+and+potent+agonists+of+sphingosine-1-phosphate+1+%28S1P1%29+receptor&doi=10.1016%2FS0960-894X%2803%2900812-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900812-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900812-6%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DJ.%2BJ.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DHighly%2520selective%2520and%2520potent%2520agonists%2520of%2520sphingosine-1-phosphate%25201%2520%2528S1P1%2529%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3401%26epage%3D3404%26doi%3D10.1016%2FS0960-894X%2803%2900812-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_contrib-group">Demont, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arpino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deeks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaskin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haynes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heightman, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morse, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panchal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philpott, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witherington, J.</span><span> </span><span class="NLM_article-title">Discovery of a Brain-Penetrant S1P<sub>3</sub>-Sparing Direct Agonist of the S1P<sub>1</sub> and S1P<sub>5</sub> Receptors Efficacious at Low Oral Dose</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6724</span><span class="NLM_x">–</span> <span class="NLM_lpage">6733</span><span class="refDoi"> DOI: 10.1021/jm200609t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200609t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6724-6733&author=E.+H.+Demontauthor=S.+Arpinoauthor=R.+A.+Bitauthor=C.+A.+Campbellauthor=N.+Deeksauthor=S.+Desaiauthor=S.+J.+Dowellauthor=P.+Gaskinauthor=J.+R.+J.+Grayauthor=L.+A.+Harrisonauthor=A.+Haynesauthor=T.+D.+Heightmanauthor=D.+S.+Holmesauthor=P.+G.+Humphreysauthor=U.+Kumarauthor=M.+A.+Morseauthor=G.+J.+Osborneauthor=T.+Panchalauthor=K.+L.+Philpottauthor=S.+Taylorauthor=R.+Watsonauthor=R.+Willisauthor=J.+Witherington&title=Discovery+of+a+Brain-Penetrant+S1P3-Sparing+Direct+Agonist+of+the+S1P1+and+S1P5+Receptors+Efficacious+at+Low+Oral+Dose&doi=10.1021%2Fjm200609t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1021%2Fjm200609t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200609t%26sid%3Dliteratum%253Aachs%26aulast%3DDemont%26aufirst%3DE.%2BH.%26aulast%3DArpino%26aufirst%3DS.%26aulast%3DBit%26aufirst%3DR.%2BA.%26aulast%3DCampbell%26aufirst%3DC.%2BA.%26aulast%3DDeeks%26aufirst%3DN.%26aulast%3DDesai%26aufirst%3DS.%26aulast%3DDowell%26aufirst%3DS.%2BJ.%26aulast%3DGaskin%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHarrison%26aufirst%3DL.%2BA.%26aulast%3DHaynes%26aufirst%3DA.%26aulast%3DHeightman%26aufirst%3DT.%2BD.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DHumphreys%26aufirst%3DP.%2BG.%26aulast%3DKumar%26aufirst%3DU.%26aulast%3DMorse%26aufirst%3DM.%2BA.%26aulast%3DOsborne%26aufirst%3DG.%2BJ.%26aulast%3DPanchal%26aufirst%3DT.%26aulast%3DPhilpott%26aufirst%3DK.%2BL.%26aulast%3DTaylor%26aufirst%3DS.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DWillis%26aufirst%3DR.%26aulast%3DWitherington%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520Brain-Penetrant%2520S1P3-Sparing%2520Direct%2520Agonist%2520of%2520the%2520S1P1%2520and%2520S1P5%2520Receptors%2520Efficacious%2520at%2520Low%2520Oral%2520Dose%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6724%26epage%3D6733%26doi%3D10.1021%2Fjm200609t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_contrib-group">Bolli, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bravo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathys, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyhart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nayler, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sippel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span> </span><span class="NLM_article-title">2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P<sub>1</sub> Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4198</span><span class="NLM_x">–</span> <span class="NLM_lpage">4211</span><span class="refDoi"> DOI: 10.1021/jm100181s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100181s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4198-4211&author=M.+H.+Bolliauthor=S.+Abeleauthor=C.+Binkertauthor=R.+Bravoauthor=S.+Buchmannauthor=D.+Burauthor=J.+Gatfieldauthor=P.+Hessauthor=C.+Kohlauthor=C.+Mangoldauthor=B.+Mathysauthor=K.+Menyhartauthor=C.+M%C3%BCllerauthor=O.+Naylerauthor=M.+Scherzauthor=G.+Schmidtauthor=V.+Sippelauthor=B.+Steinerauthor=D.+Strasserauthor=A.+Treiberauthor=T.+Weller&title=2-Imino-thiazolidin-4-one+Derivatives+as+Potent%2C+Orally+Active+S1P1+Receptor+Agonists&doi=10.1021%2Fjm100181s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1021%2Fjm100181s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100181s%26sid%3Dliteratum%253Aachs%26aulast%3DBolli%26aufirst%3DM.%2BH.%26aulast%3DAbele%26aufirst%3DS.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DBravo%26aufirst%3DR.%26aulast%3DBuchmann%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DGatfield%26aufirst%3DJ.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DKohl%26aufirst%3DC.%26aulast%3DMangold%26aufirst%3DC.%26aulast%3DMathys%26aufirst%3DB.%26aulast%3DMenyhart%26aufirst%3DK.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%26aulast%3DNayler%26aufirst%3DO.%26aulast%3DScherz%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DG.%26aulast%3DSippel%26aufirst%3DV.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DStrasser%26aufirst%3DD.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DWeller%26aufirst%3DT.%26atitle%3D2-Imino-thiazolidin-4-one%2520Derivatives%2520as%2520Potent%252C%2520Orally%2520Active%2520S1P1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4198%26epage%3D4211%26doi%3D10.1021%2Fjm100181s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jaillard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stankoff, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigrot, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calver, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaibuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalc, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubetzki, C.</span><span> </span><span class="NLM_article-title">Edg8/S1P<sub>5</sub>: An Oligodendroglial Receptor with Dual Function on Process Retraction and Cell Survival</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1459</span><span class="NLM_x">–</span> <span class="NLM_lpage">1469</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4645-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1523%2FJNEUROSCI.4645-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=15703400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Kmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=1459-1469&author=C.+Jaillardauthor=S.+Harrisonauthor=B.+Stankoffauthor=M.+S.+Aigrotauthor=A.+R.+Calverauthor=G.+Duddyauthor=F.+S.+Walshauthor=M.+N.+Pangalosauthor=N.+Arimuraauthor=K.+Kaibuchiauthor=B.+Zalcauthor=C.+Lubetzki&title=Edg8%2FS1P5%3A+An+Oligodendroglial+Receptor+with+Dual+Function+on+Process+Retraction+and+Cell+Survival&doi=10.1523%2FJNEUROSCI.4645-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival</span></div><div class="casAuthors">Jaillard, C.; Harrison, S.; Stankoff, B.; Aigrot, M. S.; Calver, A. R.; Duddy, G.; Walsh, F. S.; Pangalos, M. N.; Arimura, N.; Kaibuchi, K.; Zalc, B.; Lubetzki, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1459-1469</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Endothelial differentiation gene (Edg) proteins are G-protein-coupled receptors activated by lysophospholipid mediators: sphingosine-1-phosphate (S1P) or lysophosphatidic acid.  We show that in the CNS, expression of Edg8/S1P5, a high-affinity S1P receptor, is restricted to oligodendrocytes and expressed throughout development from the immature stages to the mature myelin-forming cell.  S1P activation of Edg8/S1P5 on O4-pos. pre-oligodendrocytes induced process retraction via a Rho kinase/collapsin response-mediated protein signaling pathway, whereas no retraction was elicited by S1P on these cells derived from Edg8/S1P5-deficient mice.  Edg8/S1P5-mediated process retraction was restricted to immature cells and was no longer obsd. at later developmental stages.  In contrast, S1P activation promoted the survival of mature oligodendrocytes but not of pre-oligodendrocytes.  The S1P-induced survival of mature oligodendrocytes was mediated through a pertussis toxin-sensitive, Akt-dependent pathway.  Our data demonstrate that Edg8/S1P5 activation on oligodendroglial cells modulates two distinct functional pathways mediating either process retraction or cell survival and that these effects depend on the developmental stage of the cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoR2Qf1RWo-5bVg90H21EOLACvtfcHk0ljtedOl6mw51A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Kmu7o%253D&md5=c88004568fd9219b1d640067ffae84b0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4645-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4645-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJaillard%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DS.%26aulast%3DStankoff%26aufirst%3DB.%26aulast%3DAigrot%26aufirst%3DM.%2BS.%26aulast%3DCalver%26aufirst%3DA.%2BR.%26aulast%3DDuddy%26aufirst%3DG.%26aulast%3DWalsh%26aufirst%3DF.%2BS.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DArimura%26aufirst%3DN.%26aulast%3DKaibuchi%26aufirst%3DK.%26aulast%3DZalc%26aufirst%3DB.%26aulast%3DLubetzki%26aufirst%3DC.%26atitle%3DEdg8%252FS1P5%253A%2520An%2520Oligodendroglial%2520Receptor%2520with%2520Dual%2520Function%2520on%2520Process%2520Retraction%2520and%2520Cell%2520Survival%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D1459%26epage%3D1469%26doi%3D10.1523%2FJNEUROSCI.4645-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullershausen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A.</span><span> </span><span class="NLM_article-title">Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.pharmthera.2007.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=17961662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=77-93&author=K.+K.+Devauthor=F.+Mullershausenauthor=H.+Mattesauthor=R.+R.+Kuhnauthor=G.+Bilbeauthor=D.+Hoyerauthor=A.+Mir&title=Brain+sphingosine-1-phosphate+receptors%3A+implication+for+FTY720+in+the+treatment+of+multiple+sclerosis&doi=10.1016%2Fj.pharmthera.2007.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis</span></div><div class="casAuthors">Dev, Kumlesh K.; Mullershausen, Florian; Mattes, Henri; Kuhn, Rainer R.; Bilbe, Graeme; Hoyer, Daniel; Mir, Anis</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">77-93</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Multiple sclerosis (MS) is an autoimmune, neurol. disability with unknown etiol.  The current therapies available for MS work by an immunomodulatory action, preventing T-cell- and macrophage-mediated destruction of brain-resident oligodendrocytes and axonal loss.  Recently, FTY720 (fingolimod) was shown to significantly reduce relapse rates in MS patients and is currently in Phase III clin. trials.  This drug attenuates trafficking of harmful T cells entering the brain by regulating sphingosine-1-phosphate (S1P) receptors.  Here, we outline the direct roles that S1P receptors play in the central nervous system (CNS) and discuss addnl. modalities by which FTY720 may provide direct neuroprotection in MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYlyd4S2EeELVg90H21EOLACvtfcHk0liYhBFxageORg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3J&md5=d5cf04a35f8bb06f3e094d2e75c698c0</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DMullershausen%26aufirst%3DF.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DKuhn%26aufirst%3DR.%2BR.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DHoyer%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%26atitle%3DBrain%2520sphingosine-1-phosphate%2520receptors%253A%2520implication%2520for%2520FTY720%2520in%2520the%2520treatment%2520of%2520multiple%2520sclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26spage%3D77%26epage%3D93%26doi%3D10.1016%2Fj.pharmthera.2007.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span> </span><span class="NLM_article-title">Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2006.10.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=491-494&author=S.+Hanessianauthor=G.+Charronauthor=A.+Billichauthor=D.+Guerini&title=Constrained+azacyclic+analogues+of+the+immunomodulatory+agent+FTY720+as+molecular+probes+for+sphingosine+1-phosphate+receptors&doi=10.1016%2Fj.bmcl.2006.10.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DCharron%26aufirst%3DG.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DGuerini%26aufirst%3DD.%26atitle%3DConstrained%2520azacyclic%2520analogues%2520of%2520the%2520immunomodulatory%2520agent%2520FTY720%2520as%2520molecular%2520probes%2520for%2520sphingosine%25201-phosphate%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D491%26epage%3D494%26doi%3D10.1016%2Fj.bmcl.2006.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mattes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dev, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhelal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barske, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mir, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osinde, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasdelen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haessig, S.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Selective and Potent Orally Active S1P<sub>5</sub> Agonists</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1693</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span><span class="refDoi"> DOI: 10.1002/cmdc.201000253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1002%2Fcmdc.201000253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=20815011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=1693-1696&author=H.+Mattesauthor=K.+K.+Devauthor=R.+Bouhelalauthor=C.+Barskeauthor=F.+Gaspariniauthor=D.+Gueriniauthor=A.+K.+Mirauthor=D.+Orainauthor=M.+Osindeauthor=A.+Picardauthor=C.+Duboisauthor=E.+Tasdelenauthor=S.+Haessig&title=Design+and+Synthesis+of+Selective+and+Potent+Orally+Active+S1P5+Agonists&doi=10.1002%2Fcmdc.201000253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selective and potent orally active S1P5 agonists</span></div><div class="casAuthors">Mattes, Henri; Dev, Kumlesh Kumar; Bouhelal, Rochdi; Barske, Carmen; Gasparini, Fabrizio; Guerini, Danilo; Mir, Anis Khusro; Orain, David; Osinde, Maribel; Picard, Anne; Dubois, Celine; Tasdelen, Engin; Haessig, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1693-1696</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">We report studies of various benzamide modifications carried out to improve the selectivity, bioactivity, pharmacokinetic properties, and ancillary profile of I derivs., ultimately resulting in the discovery of potent and very selective S1P5 agonists.  These S1P5 agonists mat be beneficial in the treatment of demyelinating disorders such as multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp148r0CEUUKbVg90H21EOLACvtfcHk0liYhBFxageORg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCkurzP&md5=7bed203140024ed148f1f11e75a2a59d</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201000253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201000253%26sid%3Dliteratum%253Aachs%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DDev%26aufirst%3DK.%2BK.%26aulast%3DBouhelal%26aufirst%3DR.%26aulast%3DBarske%26aufirst%3DC.%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DMir%26aufirst%3DA.%2BK.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DOsinde%26aufirst%3DM.%26aulast%3DPicard%26aufirst%3DA.%26aulast%3DDubois%26aufirst%3DC.%26aulast%3DTasdelen%26aufirst%3DE.%26aulast%3DHaessig%26aufirst%3DS.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%2520and%2520Potent%2520Orally%2520Active%2520S1P5%2520Agonists%26jtitle%3DChemMedChem%26date%3D2010%26volume%3D5%26spage%3D1693%26epage%3D1696%26doi%3D10.1002%2Fcmdc.201000253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. R.</span><span> </span><span class="NLM_article-title">Asymmetric Synthesis of Conformationally Constrained Fingolimod Analogues-Discovery of an Orally Active Sphingosine 1-Phosphate Receptor Type-1 Agonist and Receptor Type-3 Antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6428</span><span class="refDoi"> DOI: 10.1021/jm7010172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7010172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6428&author=R.+Zhuauthor=A.+H.+Snyderauthor=Y.+Kharelauthor=L.+Schaffterauthor=Q.+Sunauthor=P.+C.+Kennedyauthor=K.+R.+Lynchauthor=T.+R.+Macdonald&title=Asymmetric+Synthesis+of+Conformationally+Constrained+Fingolimod+Analogues-Discovery+of+an+Orally+Active+Sphingosine+1-Phosphate+Receptor+Type-1+Agonist+and+Receptor+Type-3+Antagonist&doi=10.1021%2Fjm7010172"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm7010172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010172%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DSchaffter%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BR.%26atitle%3DAsymmetric%2520Synthesis%2520of%2520Conformationally%2520Constrained%2520Fingolimod%2520Analogues-Discovery%2520of%2520an%2520Orally%2520Active%2520Sphingosine%25201-Phosphate%2520Receptor%2520Type-1%2520Agonist%2520and%2520Receptor%2520Type-3%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6428%26doi%3D10.1021%2Fjm7010172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Wallace, G. A.; Breinlinger, E. C.; Cusack, K. P.; Fix-Stenzel, S. R.; Gordon, T. D.; Hobson, A. D.; Hayes, M. E.; Ansell, G.; Grongsaard, P.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptor agonist and antagonist compounds</span>. US8217027B2,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+A.+Wallace&author=E.+C.+Breinlinger&author=K.+P.+Cusack&author=S.+R.+Fix-Stenzel&author=T.+D.+Gordon&author=A.+D.+Hobson&author=M.+E.+Hayes&author=G.+Ansell&author=P.+Grongsaard&title=Sphingosine-1-phosphate+receptor+agonist+and+antagonist+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DG.%2BA.%26atitle%3DSphingosine-1-phosphate%2520receptor%2520agonist%2520and%2520antagonist%2520compounds%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span><span class="refDoi"> DOI: 10.1021/jm0492507</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+Mandala&title=A+rational+utilization+of+high-throughput+screening+affords+selective%2C+orally+bioavailable+1-benzyl-3-carboxyazetidine+sphingosine-1-phosphate-1+receptor+agonists&doi=10.1021%2Fjm0492507"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DA%2520rational%2520utilization%2520of%2520high-throughput%2520screening%2520affords%2520selective%252C%2520orally%2520bioavailable%25201-benzyl-3-carboxyazetidine%2520sphingosine-1-phosphate-1%2520receptor%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665%26doi%3D10.1021%2Fjm0492507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span>Aldrich Market Select; <span class="NLM_publisher-name">Sigma Aldrich, LLC</span>: <span class="NLM_publisher-loc">Milwaukee, WI</span>; <a href="https://www.aldrichmarketselect.com/" class="extLink">https://www.aldrichmarketselect.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aldrich+Market+Select%3B+Sigma+Aldrich%2C+LLC%3A+Milwaukee%2C+WI%3B+https%3A%2F%2Fwww.aldrichmarketselect.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAldrich%2520Market%2520Select%26pub%3DSigma%2520Aldrich%252C%2520LLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">FitzGibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Op, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffter, L.</span><span> </span><span class="NLM_article-title">Novel Approach to Optimization of a High-Throughput Semipreparative LC/MS System</span> <span class="citation_source-journal">J. Comb. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">592</span><span class="NLM_x">–</span> <span class="NLM_lpage">597</span><span class="refDoi"> DOI: 10.1021/cc800209w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc800209w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsFCnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=592-597&author=J.+FitzGibbonsauthor=J.+Opauthor=A.+Hobsonauthor=L.+Schaffter&title=Novel+Approach+to+Optimization+of+a+High-Throughput+Semipreparative+LC%2FMS+System&doi=10.1021%2Fcc800209w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Approach to Optimization of a High-Throughput Semipreparative LC/MS System</span></div><div class="casAuthors">FitzGibbons, Julia; Op, Sopheary; Hobson, Adrian; Schaffter, Lisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">592-597</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Automated semipreparative LC/MS systems are now well established com. and commonly used for purifn. of early stage drug discovery compds.  A no. of vendors have instruments on the market that are capable of reliably purifying compds. with good water/acetonitrile soly.  However, these systems often fail when the sample has poor soly., extreme polarity, and/or poor ionization.  Even in cases when substantial optimization has been done prior to purifn., a certain percent of failures to recover the desired product is unavoidable.  In the past, when the majority of samples run on LC/MS semipreparative systems were large combinatorial libraries, some losses in this high throughput mode were acceptable.  However, now that more chem. labs. are making smaller more focused libraries with higher purity requirements, reliability and recovery are more crucial.  This paper describes modifications made to customize an MS-triggered semipreparative LC/MS system in order to ensure improved reliability and recovery of products from traditional medicinal chem. as well as combinatorial libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrik95KxRhh_7Vg90H21EOLACvtfcHk0lidPE5BfKre_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsFCnurg%253D&md5=3f663ac58ef047ceae9e4fb9a3ec6501</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcc800209w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc800209w%26sid%3Dliteratum%253Aachs%26aulast%3DFitzGibbons%26aufirst%3DJ.%26aulast%3DOp%26aufirst%3DJ.%26aulast%3DHobson%26aufirst%3DA.%26aulast%3DSchaffter%26aufirst%3DL.%26atitle%3DNovel%2520Approach%2520to%2520Optimization%2520of%2520a%2520High-Throughput%2520Semipreparative%2520LC%252FMS%2520System%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2009%26volume%3D11%26spage%3D592%26epage%3D597%26doi%3D10.1021%2Fcc800209w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub> and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13839</span><span class="NLM_x">–</span> <span class="NLM_lpage">13848</span><span class="refDoi"> DOI: 10.1074/jbc.M311743200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1074%2Fjbc.M311743200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=14732717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13839-13848&author=M.+G.+Sannaauthor=J.+Liaoauthor=E.+Joauthor=C.+Alfonsoauthor=M.-Y.+Ahnauthor=M.+S.+Petersonauthor=B.+Webbauthor=S.+Lefebvreauthor=J.+Chunauthor=N.+Grayauthor=H.+Rosen&title=Sphingosine+1-phosphate+%28S1P%29+receptor+subtypes+S1P1+and+S1P3%2C+respectively%2C+regulate+lymphocyte+recirculation+and+heart+rate&doi=10.1074%2Fjbc.M311743200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate</span></div><div class="casAuthors">Sanna, M. Germana; Liao, Jiayu; Jo, Euijung; Alfonso, Christopher; Ahn, Min-Young; Peterson, Melissa S.; Webb, Bill; Lefebvre, Sophie; Chun, Jerold; Gray, Nathanael; Rosen, Hugh</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">13839-13848</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) influences heart rate, coronary artery caliber, endothelial integrity, and lymphocyte recirculation through five related high affinity G-protein-coupled receptors.  Inhibition of lymphocyte recirculation by non-selective S1P receptor agonists produces clin. immunosuppression preventing transplant rejection but is assocd. with transient bradycardia.  Understanding the contribution of individual receptors has been limited by the embryonic lethality of the S1P1 knock-out and the unavailability of selective agonists or antagonists.  A potent, S1P1-receptor selective agonist structurally unrelated to S1P was found to activate multiple signals triggered by S1P, including guanosine 5'-3-O-(thio)triphosphate binding, calcium flux, Akt and ERK1/2 phosphorylation, and stimulation of migration of S1P1- but not S1P3-expressing cells in vitro.  The agonist also alters lymphocyte trafficking in vivo.  Use of selective agonism together with deletant mice lacking S1P3 receptor reveals that agonism of S1P1 receptor alone is sufficient to control lymphocyte recirculation.  Moreover, S1P1 receptor agonist plasma levels are causally assocd. with induction and maintenance of lymphopenia.  S1P3, and not S1P1, is directly implicated in sinus bradycardia.  The sustained bradycardia induced by S1P receptor non-selective immunosuppressive agonists in wild-type mice is abolished in S1P3-/- mice, whereas S1P1-selective agonist does not produce bradycardia.  Sepn. of receptor subtype usage for control of lymphocyte recirculation and heart rate may allow the identification of selective immunosuppressive S1P1 receptor agonists with an enhanced therapeutic window.  S1P1-selective agonists will be of broad utility in understanding cell functions in vitro, and vascular physiol. in vivo, and the success of the chem. approach for S1P1 suggests that selective tools for the resoln. of function across this broad lipid receptor family are now possible.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoztTB58pXPA7Vg90H21EOLACvtfcHk0lidPE5BfKre_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXis1elsb8%253D&md5=5b720513c7c550bfdf55e5344efc8f16</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M311743200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M311743200%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DJo%26aufirst%3DE.%26aulast%3DAlfonso%26aufirst%3DC.%26aulast%3DAhn%26aufirst%3DM.-Y.%26aulast%3DPeterson%26aufirst%3DM.%2BS.%26aulast%3DWebb%26aufirst%3DB.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DSphingosine%25201-phosphate%2520%2528S1P%2529%2520receptor%2520subtypes%2520S1P1%2520and%2520S1P3%252C%2520respectively%252C%2520regulate%2520lymphocyte%2520recirculation%2520and%2520heart%2520rate%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13839%26epage%3D13848%26doi%3D10.1074%2Fjbc.M311743200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Topliss, J. G.</span><span> </span><span class="NLM_article-title">Utilization of Operational Schemes for Analog Synthesis in Drug Design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1006</span><span class="refDoi"> DOI: 10.1021/jm00280a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00280a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1972&pages=1006&author=J.+G.+Topliss&title=Utilization+of+Operational+Schemes+for+Analog+Synthesis+in+Drug+Design&doi=10.1021%2Fjm00280a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Utilization of operational schemes for analog synthesis in drug design</span></div><div class="casAuthors">Topliss, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1006-11</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Proposals were presented for stepwise selection for synthesis of new analogs of a biol. active compd. which were designed to maximize the chances of synthesizing the most potent compds. in the series as early as possible.  The schemes were based on a fundamental assumption of the Hansch method that a particular substituent may modify activity relative to the parent compd. by virtue of resulting changes in hydrophobic, electronic, and steric effects.  The effectiveness of the method was illustrated by retrospective application to several existing series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-zymvXigwSbVg90H21EOLACvtfcHk0lidPE5BfKre_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhtFChug%253D%253D&md5=acf62a05dbdb3d1d17f91097f66ab8c1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm00280a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00280a002%26sid%3Dliteratum%253Aachs%26aulast%3DTopliss%26aufirst%3DJ.%2BG.%26atitle%3DUtilization%2520of%2520Operational%2520Schemes%2520for%2520Analog%2520Synthesis%2520in%2520Drug%2520Design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1972%26volume%3D15%26spage%3D1006%26doi%3D10.1021%2Fjm00280a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span> </span><span class="NLM_article-title">Lead- and drug-like compounds: the rule-of-five revolution</span> <span class="citation_source-journal">Drug Discovery Today: Technol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1016/j.ddtec.2004.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.ddtec.2004.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=24981612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=337-341&author=C.+A.+Lipinski&title=Lead-+and+drug-like+compounds%3A+the+rule-of-five+revolution&doi=10.1016%2Fj.ddtec.2004.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lead- and drug-like compounds: the rule-of-five revolution</span></div><div class="casAuthors">Lipinski, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today: Technologies</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">337-341</span>CODEN:
                <span class="NLM_cas:coden">DDTTB5</span>;
        ISSN:<span class="NLM_cas:issn">1740-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Citations in CAS SciFinder to the rule-of-five (RO5) publication will exceed 1000 by year-end 2004.  Trends in the RO5 literature explosion that can be discerned are the further definitions of drug-like.  This topic is explored in terms of drug-like physicochem. features, drug-like structural features, a comparison of drug-like and non-drug-like in drug discovery and a discussion of how drug-like features relate to clin. success.  Physicochem. features of CNS drugs and features related to CNS blood-brain transporter affinity are briefly reviewed.  Recent literature on features of non-oral drugs is reviewed and how features of lead-like compds. differ from those of drug-like compds. is discussed.  Most recently, partly driven by NIH roadmap initiatives, considerations have arisen as to what tool-like means in the search for chem. tools to probe biol. space.  All these topics frame the scope of this short review/perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjiyP3CY7lLVg90H21EOLACvtfcHk0lgkyVilaegeig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqsrg%253D&md5=952c29b47003b884116d790ae9e4721f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ddtec.2004.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ddtec.2004.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26atitle%3DLead-%2520and%2520drug-like%2520compounds%253A%2520the%2520rule-of-five%2520revolution%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technol.%26date%3D2004%26volume%3D1%26spage%3D337%26epage%3D341%26doi%3D10.1016%2Fj.ddtec.2004.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dress, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M.</span><span> </span><span class="NLM_article-title">Using the Golden Triangle to optimize clearance and oral absorption</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5560</span><span class="NLM_x">–</span> <span class="NLM_lpage">5564</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2009.08.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2009.08.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=19720530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5560-5564&author=T.+W.+Johnsonauthor=K.+R.+Dressauthor=M.+Edwards&title=Using+the+Golden+Triangle+to+optimize+clearance+and+oral+absorption&doi=10.1016%2Fj.bmcl.2009.08.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Using the Golden Triangle to optimize clearance and oral absorption</span></div><div class="casAuthors">Johnson, Ted W.; Dress, Klaus R.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5560-5564</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Golden Triangle is a visualization tool developed from in vitro permeability, in vitro clearance and computational data designed to aid medicinal chemists in achieving metabolically stable, permeable and potent drug candidates.  Classifying compds. as permeable and stable and plotting mol. wt. (MW) vs. octanol:buffer (pH 7.4) distribution coeffs. (log D) or estd. octanol:buffer (pH 7.4) distribution coeffs. (elog D) reveals useful trends.  Anal. of at least 2 orthogonal trends, such as permeability and clearance, can be extremely effective in balancing and optimizing multiple properties.  In addn., mol. wt. and log D impact potency-efficiency calcns., allowing potency, clearance and permeability to be optimized simultaneously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjGjEaOp0237Vg90H21EOLACvtfcHk0lgkyVilaegeig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFaktbfE&md5=3cfed1288ec451eb4419f1db753ae4b4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.045%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DDress%26aufirst%3DK.%2BR.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DUsing%2520the%2520Golden%2520Triangle%2520to%2520optimize%2520clearance%2520and%2520oral%2520absorption%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5560%26epage%3D5564%26doi%3D10.1016%2Fj.bmcl.2009.08.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.07.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes&doi=10.1016%2Fj.bmcl.2008.07.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lgkyVilaegeig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875%26doi%3D10.1016%2Fj.bmcl.2008.07.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span><span class="refDoi"> DOI: 10.1021/jm020017n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+Properties+That+Influence+the+Oral+Bioavailability+of+Drug+Candidates&doi=10.1021%2Fjm020017n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0lh5MnztpIdaWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520Properties%2520That%2520Influence%2520the%2520Oral%2520Bioavailability%2520of%2520Drug%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623%26doi%3D10.1021%2Fjm020017n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_contrib-group">Smid, P.; Iwema Bakker, W. I.; Coolen, H. K. A. C.; Sliedregt, L. A. J. M.; van Dongen, M. J. P.; den Hartog, J. A. J.; Hobson, A.</span><span> </span><span class="NLM_article-title">Fused Heterocyclic Derivatives as S1P Modulators</span>. WO2012004373,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Smid&author=W.+I.+Iwema+Bakker&author=H.+K.+A.+C.+Coolen&author=L.+A.+J.+M.+Sliedregt&author=M.+J.+P.+van+Dongen&author=J.+A.+J.+den+Hartog&author=A.+Hobson&title=Fused+Heterocyclic+Derivatives+as+S1P+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmid%26aufirst%3DP.%26atitle%3DFused%2520Heterocyclic%2520Derivatives%2520as%2520S1P%2520Modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_contrib-group">Smid, P.; Iwema Bakker, W. I.; Wouter, I.; Coolen, H. K. A. C.; Sliedregt, L. A. J. M.; Van Dongen, M. J. P.; Den Hartog, J. A. J.; Hobson, A.</span><span> </span><span class="NLM_article-title">Preparation of phenyldihydrooxazolopyridine derivatives and analogs for use as S1P modulators</span>. WO2012004373,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+Smid&author=W.+I.+Iwema+Bakker&author=I.+Wouter&author=H.+K.+A.+C.+Coolen&author=L.+A.+J.+M.+Sliedregt&author=M.+J.+P.+Van+Dongen&author=J.+A.+J.+Den+Hartog&author=A.+Hobson&title=Preparation+of+phenyldihydrooxazolopyridine+derivatives+and+analogs+for+use+as+S1P+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSmid%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520phenyldihydrooxazolopyridine%2520derivatives%2520and%2520analogs%2520for%2520use%2520as%2520S1P%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_contrib-group">Stoit, A.; Iwema Bakker, W. I.; Wouter, I.; Coolen, H. K. A. C.; Van Dongen, M. J. P.; Leflemme, N. J.-L. D.; Hobson, A.</span><span> </span><span class="NLM_article-title">Preparation of spirocyclic amine derivatives for use as S1P modulators</span>. WO2012004378,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Stoit&author=W.+I.+Iwema+Bakker&author=I.+Wouter&author=H.+K.+A.+C.+Coolen&author=M.+J.+P.+Van+Dongen&author=N.+J.-L.+D.+Leflemme&author=A.+Hobson&title=Preparation+of+spirocyclic+amine+derivatives+for+use+as+S1P+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStoit%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520spirocyclic%2520amine%2520derivatives%2520for%2520use%2520as%2520S1P%2520modulators%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Mori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, S.</span><span> </span><span class="NLM_article-title">Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?</span> <span class="citation_source-journal">J. Neurol., Neurosurg. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1180</span><span class="refDoi"> DOI: 10.1136/jnnp-2013-307538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=10.1136%2Fjnnp-2013-307538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=24659798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A280%3ADC%252BC2crmsVCqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=1180&author=M.+Moriauthor=S.+Kuwabara&title=Are+more+sphingosine+1-phosphate+receptor+agonists+a+better+therapeutic+option+against+multiple+sclerosis%3F&doi=10.1136%2Fjnnp-2013-307538"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?</span></div><div class="casAuthors">Mori Masahiro; Kuwabara Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1180</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2CIkzhi1GIy-bLEOO4dYpfW6udTcc2eZmKbLpDH5Oo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmsVCqsg%253D%253D&md5=46ea54e0f1a20c7b5f00fc734ac10fb4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1136%2Fjnnp-2013-307538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp-2013-307538%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DM.%26aulast%3DKuwabara%26aufirst%3DS.%26atitle%3DAre%2520more%2520sphingosine%25201-phosphate%2520receptor%2520agonists%2520a%2520better%2520therapeutic%2520option%2520against%2520multiple%2520sclerosis%253F%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2014%26volume%3D85%26spage%3D1180%26doi%3D10.1136%2Fjnnp-2013-307538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>Functional GPCr platform; <span class="NLM_publisher-name">Cerep</span>: <span class="NLM_publisher-loc">Redmond, WA</span>; <a href="http://www.cerep.fr/cerep/users/pages/ProductsServices/GPCRPlatform.asp" class="extLink">http://www.cerep.fr/cerep/users/pages/ProductsServices/GPCRPlatform.asp</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Functional+GPCr+platform%3B+Cerep%3A+Redmond%2C+WA%3B+http%3A%2F%2Fwww.cerep.fr%2Fcerep%2Fusers%2Fpages%2FProductsServices%2FGPCRPlatform.asp."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DFunctional%2520GPCr%2520platform%26pub%3DCerep" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Huth, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cothron, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1021/ja0455547</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0455547" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=217-224&author=J.+R.+Huthauthor=R.+Mendozaauthor=E.+T.+Olejniczakauthor=R.+W.+Johnsonauthor=D.+A.+Cothronauthor=Y.+Liuauthor=C.+G.+Lernerauthor=J.+Chenauthor=P.+J.+Hajduk&title=ALARM+NMR%3A+a+rapid+and+robust+experimental+method+to+detect+reactive+false+positives+in+biochemical+screens&doi=10.1021%2Fja0455547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens</span></div><div class="casAuthors">Huth, Jeffrey R.; Mendoza, Renaldo; Olejniczak, Edward T.; Johnson, Robert W.; Cothron, Darlene A.; Liu, Yaya; Lerner, Claude G.; Chen, Jun; Hajduk, Philip J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-224</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High-throughput screening (HTS) of large compd. collections typically results in numerous small mol. hits that must be carefully evaluated to identify valid drug leads.  Although several filtering mechanisms and other tools exist that can assist the chemist in this process, it is often the case that costly synthetic resources are expended in pursuing false positives.  We report here a rapid and reliable NMR-based method for identifying reactive false positives including those that oxidize or alkylate a protein target.  Importantly, the reactive species need not be the parent compd., as both reactive impurities and breakdown products can be detected.  The assay is called ALARM NMR (a La assay to detect reactive mols. by NMR) and is based on monitoring DTT-dependent 13C chem. shift changes of the human La antigen in the presence of a test compd. or mixt.  Extensive validation has been performed to demonstrate the reliability and utility of using ALARM NMR to assess thiol reactivity.  This included comparing ALARM NMR to a glutathione-based fluorescence assay, as well as testing a collection of more than 3500 compds. contg. HTS hits from 23 drug targets.  The data show that current in silico filtering tools fail to identify more than half of the compds. that can act via reactive mechanisms.  Significantly, we show how ALARM NMR data has been crit. in identifying reactive compds. that would otherwise have been prioritized for lead optimization.  In addn., a new filtering tool has been developed on the basis of the ALARM NMR data that can augment current in silico programs for identifying nuisance compds. and improving the process of hit triage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolKou1lGZ8tbVg90H21EOLACvtfcHk0lgtVTKdnaoxug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCrurrF&md5=466332d4bdcddf6bc8a630aacbbb32ef</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fja0455547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0455547%26sid%3Dliteratum%253Aachs%26aulast%3DHuth%26aufirst%3DJ.%2BR.%26aulast%3DMendoza%26aufirst%3DR.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DJohnson%26aufirst%3DR.%2BW.%26aulast%3DCothron%26aufirst%3DD.%2BA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLerner%26aufirst%3DC.%2BG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DALARM%2520NMR%253A%2520a%2520rapid%2520and%2520robust%2520experimental%2520method%2520to%2520detect%2520reactive%2520false%2520positives%2520in%2520biochemical%2520screens%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D217%26epage%3D224%26doi%3D10.1021%2Fja0455547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Van Der Kam, E.; Turner, S.; Hobson, A.; Harris, C.; Ronken, E.; Mueller, R.; van Bergeijk, J.; Mezler, M.; Hempel, K.; Mendonca, N.; Rendenbach-Mueller, B.</span>; S1P<sub>5</sub> agonism: a novel treatment for age-related cognitive decline, (sphingo)lipid accumulation, and neurodegenerative disorders such as Alzheimer’s Disease and Niemann Pick C Disease. In press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Van+Der+Kam%2C+E.%3B+Turner%2C+S.%3B+Hobson%2C+A.%3B+Harris%2C+C.%3B+Ronken%2C+E.%3B+Mueller%2C+R.%3B+van+Bergeijk%2C+J.%3B+Mezler%2C+M.%3B+Hempel%2C+K.%3B+Mendonca%2C+N.%3B+Rendenbach-Mueller%2C+B.%3B+S1P5+agonism%3A+a+novel+treatment+for+age-related+cognitive+decline%2C+%28sphingo%29lipid+accumulation%2C+and+neurodegenerative+disorders+such+as+Alzheimer%E2%80%99s+Disease+and+Niemann+Pick+C+Disease.+In+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BDer%2BKam%26aufirst%3DE.%26jtitle%3DS1P5%2520agonism%253A%2520a%2520novel%2520treatment%2520for%2520age-related%2520cognitive%2520decline%252C%2520%2528sphingo%2529lipid%2520accumulation%252C%2520and%2520neurodegenerative%2520disorders%2520such%2520as%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Niemann%2520Pick%2520C%2520Disease" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span>Melior Discovery; <span class="NLM_publisher-name">Melior Discovery</span>: <span class="NLM_publisher-loc">Exton, PA</span>; <a href="http://www.meliordiscovery.com" class="extLink">http://www.meliordiscovery.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Melior+Discovery%3B+Melior+Discovery%3A+Exton%2C+PA%3B+http%3A%2F%2Fwww.meliordiscovery.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DMelior%2520Discovery%26pub%3DMelior%2520Discovery" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i96"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00928">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45204"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00928">10.1021/acs.jmedchem.5b00928</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_001.xlsx">XLSX</a>)</p></li><li><p class="inline">GTPγS binding in membranes from S1P5-transfected HEK cells and inhibition of forskolininduced cAMP in S1P5-transfected CHO cells; data from screening compound <b>29</b> in the CEREP panel of 79 receptor binding assays; data from screening compound <b>29</b> in 129 assays in the AbbVie kinome panel; rat cardiovascular safety of compound <b>29</b> (A-971432) in anesthetized rats; summary of effects of compound <b>29</b> in the Melior Discovery panel of multiplexed in vivo assays; <sup>1</sup>H and <sup>13</sup>C NMR spectra and HRMS data for compounds <b>4</b>, <b>5</b>, <b>6</b>, <b>7</b>, <b>8</b>, <b>9</b>, <b>10</b>, <b>29</b>, <b>31</b>, <b>43</b>, and <b>60</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_001.xlsx">jm5b00928_si_001.xlsx (15.88 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00928/suppl_file/jm5b00928_si_002.pdf">jm5b00928_si_002.pdf (1.69 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00928&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00928%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-23%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00928" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679928cf2fb23da6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
